<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xml:base="https://www.alzforum.org"  xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
 <title>Alzforum - Papers of the Week: 11-17 Sep 2026</title>
 <link>https://www.alzforum.org</link>
 <description></description>
 <language>en</language>
<item>
 <title>Systematic Dissection of Key Driver Perturbation Signatures in Single Cells via ECCITE-seq.</title>
 <link>https://www.alzforum.org/papers/systematic-dissection-key-driver-perturbation-signatures-single-cells-eccite-seq</link>
 <description>Methods Mol Biol. 2027;3074:193-208. &lt;br&gt;Authors: Zhang J, Brennand KJ, Zhang B, Wang M, Li A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42734752&quot;&gt;42734752&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/systematic-dissection-key-driver-perturbation-signatures-single-cells-eccite-seq#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/systematic-dissection-key-driver-perturbation-signatures-single-cells-eccite-seq#comments</comments>
</item>
<item>
 <title>Physical exercise as a therapeutic strategy in animal models of Alzheimer&#039;s disease: Molecular, behavioral, and histopathological evidence.</title>
 <link>https://www.alzforum.org/papers/physical-exercise-therapeutic-strategy-animal-models-alzheimers-disease-molecular-behavioral</link>
 <description>Biochem Biophys Rep. 2026 Dec;48:102765.  Epub 2026 Sep 4&lt;br&gt;Authors: Behrouzfar H, Gholami M, Hassani S, Maghsoudi AS, Bekheir SA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42733706&quot;&gt;42733706&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/physical-exercise-therapeutic-strategy-animal-models-alzheimers-disease-molecular-behavioral#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/physical-exercise-therapeutic-strategy-animal-models-alzheimers-disease-molecular-behavioral#comments</comments>
</item>
<item>
 <title>Effective amyloid clearance with lecanemab in a female with Alzheimer&#039;s disease: A case report.</title>
 <link>https://www.alzforum.org/papers/effective-amyloid-clearance-lecanemab-female-alzheimers-disease-case-report</link>
 <description>Radiol Case Rep. 2026 Dec;21(12):5973-5977.  Epub 2026 Sep 7&lt;br&gt;Authors: Noguchi-Shinohara M, Ono K&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42750750&quot;&gt;42750750&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/effective-amyloid-clearance-lecanemab-female-alzheimers-disease-case-report#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/effective-amyloid-clearance-lecanemab-female-alzheimers-disease-case-report#comments</comments>
</item>
<item>
 <title>Research advances in the microbiota‑gut‑brain axis and Parkinson&#039;s disease (Review).</title>
 <link>https://www.alzforum.org/papers/research-advances-microbiota-gut-brain-axis-and-parkinsons-disease-review</link>
 <description>Mol Med Rep. 2026 Nov;34(5) Epub 2026 Sep 11&lt;br&gt;Authors: Meng Y, Liu Q, Zou H, Zhu X, Mi X, Li S, Xia Y, Ma Y, Yang Q, Peng J, Li J, Liu X, Chen J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42725392&quot;&gt;42725392&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/research-advances-microbiota-gut-brain-axis-and-parkinsons-disease-review#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/research-advances-microbiota-gut-brain-axis-and-parkinsons-disease-review#comments</comments>
</item>
<item>
 <title>Advances in N- and S-Heterocycles as c-Jun-N-Terminal Kinase 3 Inhibitors for Alzheimer&#039;s Disease Treatment.</title>
 <link>https://www.alzforum.org/papers/advances-n-and-s-heterocycles-c-jun-n-terminal-kinase-3-inhibitors-alzheimers-disease</link>
 <description>Drug Dev Res. 2026 Nov;87(7):e70381. &lt;br&gt;Authors: Yadav P, Mishra D, Singh R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42747078&quot;&gt;42747078&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/advances-n-and-s-heterocycles-c-jun-n-terminal-kinase-3-inhibitors-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/advances-n-and-s-heterocycles-c-jun-n-terminal-kinase-3-inhibitors-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Mechanisms of NMDA receptor inhibition by fluoroethylnormemantine - comparison with memantine.</title>
 <link>https://www.alzforum.org/papers/mechanisms-nmda-receptor-inhibition-fluoroethylnormemantine-comparison-memantine</link>
 <description>Eur J Pharmacol. 2026 Oct 28;1034:179334.  Epub 2026 Sep 11&lt;br&gt;Authors: Furman VV, Zhigulin AS, Barygin OI&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42727691&quot;&gt;42727691&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/mechanisms-nmda-receptor-inhibition-fluoroethylnormemantine-comparison-memantine#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/mechanisms-nmda-receptor-inhibition-fluoroethylnormemantine-comparison-memantine#comments</comments>
</item>
<item>
 <title>Multi-functional bionic nanoparticles for precise neuronal targeting and synergistic therapy in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/multi-functional-bionic-nanoparticles-precise-neuronal-targeting-and-synergistic-therapy</link>
 <description>Mater Today Bio. 2026 Oct;40:103617.  Epub 2026 Aug 28&lt;br&gt;Authors: Na Y, Liu C, Bi X, Liu S, Xing Y, Zhang B, Liu T, Zhang N, Geng F&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42725138&quot;&gt;42725138&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/multi-functional-bionic-nanoparticles-precise-neuronal-targeting-and-synergistic-therapy#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/multi-functional-bionic-nanoparticles-precise-neuronal-targeting-and-synergistic-therapy#comments</comments>
</item>
<item>
 <title>An Integrated Analysis of Manganese Metabolism-Related Genes and Their Association With Biomarkers, Immune Infiltration, and Clinical Subtypes in Alzheimer&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/integrated-analysis-manganese-metabolism-related-genes-and-their-association-biomarkers</link>
 <description>Genes Brain Behav. 2026 Oct;25(5):e70059. &lt;br&gt;Authors: Shu S, Hu J, Hu S, Yao Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42723412&quot;&gt;42723412&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/integrated-analysis-manganese-metabolism-related-genes-and-their-association-biomarkers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/integrated-analysis-manganese-metabolism-related-genes-and-their-association-biomarkers#comments</comments>
</item>
<item>
 <title>Targeting TLR4/NF-κB/NLRP3 signaling with 6-hydroxyflavanone mitigates amyloid-β-induced Alzheimer&#039;s disease in mice.</title>
 <link>https://www.alzforum.org/papers/targeting-tlr4nf-kbnlrp3-signaling-6-hydroxyflavanone-mitigates-amyloid-v-induced-alzheimers</link>
 <description>Biomed Pharmacother. 2026 Oct;203:119833.  Epub 2026 Sep 12&lt;br&gt;Authors: Rakshit D, Nema M, Mishra A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42731509&quot;&gt;42731509&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/targeting-tlr4nf-kbnlrp3-signaling-6-hydroxyflavanone-mitigates-amyloid-v-induced-alzheimers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/targeting-tlr4nf-kbnlrp3-signaling-6-hydroxyflavanone-mitigates-amyloid-v-induced-alzheimers#comments</comments>
</item>
<item>
 <title>Full-length brain-derived α-synuclein fibril models reveal fuzzy-coat control of peptide recognition.</title>
 <link>https://www.alzforum.org/papers/full-length-brain-derived-synuclein-fibril-models-reveal-fuzzy-coat-control-peptide</link>
 <description>Protein Sci. 2026 Oct;35(10):e70782. &lt;br&gt;Authors: Pintado-Grima C, Bárcenas O, Tesei G, Thomasen FE, Lindorff-Larsen K, Ventura S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42742050&quot;&gt;42742050&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/full-length-brain-derived-synuclein-fibril-models-reveal-fuzzy-coat-control-peptide#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/full-length-brain-derived-synuclein-fibril-models-reveal-fuzzy-coat-control-peptide#comments</comments>
</item>
<item>
 <title>Function within disorder: Small heat shock proteins use different functional regions to chaperone tau aggregation.</title>
 <link>https://www.alzforum.org/papers/function-within-disorder-small-heat-shock-proteins-use-different-functional-regions-0</link>
 <description>Protein Sci. 2026 Oct;35(10):e70780. &lt;br&gt;Authors: Cervantes M, Janowska MK, Tuttle LM, Guttman M, Nath A, Klevit RE&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42747073&quot;&gt;42747073&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/function-within-disorder-small-heat-shock-proteins-use-different-functional-regions-0#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/function-within-disorder-small-heat-shock-proteins-use-different-functional-regions-0#comments</comments>
</item>
<item>
 <title>Thioperamide, a histamine H3 receptor antagonist, attenuates neuroimmune activation and inflammation in the SOD1G93A mouse model of amyotrophic lateral sclerosis.</title>
 <link>https://www.alzforum.org/papers/thioperamide-histamine-h3-receptor-antagonist-attenuates-neuroimmune-activation-and</link>
 <description>Immunopharmacol Immunotoxicol. 2026 Sep 18;:1-12.  Epub 2026 Sep 18&lt;br&gt;Authors: Aldossari AA, Alsaad AM, Nadeem A, Ansari MA, Attia SM, Bakheet SA, Al-Mazroua HA, Almutairi MM, Alhamami HN, Sarawi WS, Alomar HA, Algonaiah MA, Alshamrani AA, Alanteet AA, Hussein MH, Mahmoud MA, Ahmad SF&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42745510&quot;&gt;42745510&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/thioperamide-histamine-h3-receptor-antagonist-attenuates-neuroimmune-activation-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/thioperamide-histamine-h3-receptor-antagonist-attenuates-neuroimmune-activation-and#comments</comments>
</item>
<item>
 <title>Dynamic contributions of astrocytes in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/dynamic-contributions-astrocytes-alzheimers-disease</link>
 <description>Exp Neurol. 2026 Sep 18;407:116032.  Epub 2026 Sep 18&lt;br&gt;Authors: Guo F, Li T, He XB&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42753898&quot;&gt;42753898&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/dynamic-contributions-astrocytes-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/dynamic-contributions-astrocytes-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Interpretable multimodal MRI fusion in Alzheimer&#039;s disease classification using extended parallel multilink joint ICA and 3D ResNet.</title>
 <link>https://www.alzforum.org/papers/interpretable-multimodal-mri-fusion-alzheimers-disease-classification-using-extended-parallel</link>
 <description>iScience. 2026 Sep 18;29(9):117313.  Epub 2026 Sep 7&lt;br&gt;Authors: Lv C, Liu T, Chen H, Huang W, Huang M, Zang L, Shen C, Guo Y, Chen F&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42750836&quot;&gt;42750836&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/interpretable-multimodal-mri-fusion-alzheimers-disease-classification-using-extended-parallel#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/interpretable-multimodal-mri-fusion-alzheimers-disease-classification-using-extended-parallel#comments</comments>
</item>
<item>
 <title>A caution in interpreting reliable cognitive decline in older adults at risk for Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/caution-interpreting-reliable-cognitive-decline-older-adults-risk-alzheimers-disease</link>
 <description>Int Psychogeriatr. 2026 Sep 17;:100272.  Epub 2026 Sep 17&lt;br&gt;Authors: Thomas ML&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42754468&quot;&gt;42754468&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/caution-interpreting-reliable-cognitive-decline-older-adults-risk-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/caution-interpreting-reliable-cognitive-decline-older-adults-risk-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Fault Lines in the Genome: Somatic DNA Mutations in Aging and Neurodegeneration.</title>
 <link>https://www.alzforum.org/papers/fault-lines-genome-somatic-dna-mutations-aging-and-neurodegeneration</link>
 <description>Annu Rev Pathol. 2026 Sep 17; Epub 2026 Sep 17&lt;br&gt;Authors: Um J, Adelman JW, Pollina EA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42754244&quot;&gt;42754244&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/fault-lines-genome-somatic-dna-mutations-aging-and-neurodegeneration#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/fault-lines-genome-somatic-dna-mutations-aging-and-neurodegeneration#comments</comments>
</item>
<item>
 <title>Deletion of NLRP3 gene blocks traumatic brain injury induced abnormal immune response in mice with a genetic background for AD.</title>
 <link>https://www.alzforum.org/papers/deletion-nlrp3-gene-blocks-traumatic-brain-injury-induced-abnormal-immune-response-mice</link>
 <description>Exp Neurol. 2026 Sep 17;:116030.  Epub 2026 Sep 17&lt;br&gt;Authors: Green J, Liu Z, Timis S, Nelson C, Pedin A, Guo C, Wang XY, Zhang S, Sun D&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42753897&quot;&gt;42753897&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/deletion-nlrp3-gene-blocks-traumatic-brain-injury-induced-abnormal-immune-response-mice#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/deletion-nlrp3-gene-blocks-traumatic-brain-injury-induced-abnormal-immune-response-mice#comments</comments>
</item>
<item>
 <title>Word-Form and Lemma Dependency Networks of Connected Speech in Probable Alzheimer&#039;s Disease: Morphological Impacts on Syntactic Topological Metrics.</title>
 <link>https://www.alzforum.org/papers/word-form-and-lemma-dependency-networks-connected-speech-probable-alzheimers-disease</link>
 <description>Semin Speech Lang. 2026 Sep 17; Epub 2026 Sep 17&lt;br&gt;Authors: Shi H&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42753807&quot;&gt;42753807&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/word-form-and-lemma-dependency-networks-connected-speech-probable-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/word-form-and-lemma-dependency-networks-connected-speech-probable-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Genomic and transcriptomic quality control for an autologous iPSC-derived cell therapy for Parkinson&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/genomic-and-transcriptomic-quality-control-autologous-ipsc-derived-cell-therapy-parkinsons</link>
 <description>Cell Stem Cell. 2026 Sep 17; Epub 2026 Sep 17&lt;br&gt;Authors: Bratt-Leal AM, Gorba T, Williams RM, Mossman JA, Hills R, Tran H, Barken D, Beauvais G, Fremgen D, Zhang A, Pivaroff C, Lynch C, Liu Y, Chandrasekaran C, Tastad D, Bridge C, Wakeman DR, Nguyen U, Chamberlain B, Lane EL, Lelos MJ, Loring JF, Wirth ED 3rd, Zhang X&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42753738&quot;&gt;42753738&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/genomic-and-transcriptomic-quality-control-autologous-ipsc-derived-cell-therapy-parkinsons#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/genomic-and-transcriptomic-quality-control-autologous-ipsc-derived-cell-therapy-parkinsons#comments</comments>
</item>
<item>
 <title>A clinically interpretable nomogram for predicting discharge outcomes in cerebral amyloid angiopathy-related lobar intracerebral hemorrhage: development and internal validation.</title>
 <link>https://www.alzforum.org/papers/clinically-interpretable-nomogram-predicting-discharge-outcomes-cerebral-amyloid-angiopathy</link>
 <description>J Clin Neurosci. 2026 Sep 17;154:112293.  Epub 2026 Sep 17&lt;br&gt;Authors: Zhang Y, Jia J, Wu X, Zhong Y, Huang X, Wang D, Ju Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42753527&quot;&gt;42753527&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/clinically-interpretable-nomogram-predicting-discharge-outcomes-cerebral-amyloid-angiopathy#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/clinically-interpretable-nomogram-predicting-discharge-outcomes-cerebral-amyloid-angiopathy#comments</comments>
</item>
<item>
 <title>40 Hz vibrotactile stimulation ameliorates amyloid pathology and cognitive deficits in 5xFAD mice and is associated with alterations in Piezo1, ERK, and GSK-3β/p65 signaling.</title>
 <link>https://www.alzforum.org/papers/40-hz-vibrotactile-stimulation-ameliorates-amyloid-pathology-and-cognitive-deficits-5xfad</link>
 <description>Neurotherapeutics. 2026 Sep 17;23(6):e01077.  Epub 2026 Sep 17&lt;br&gt;Authors: Nam MH, Park HJ, Lee HY, Chen ZY, Yun HD, Kim Y, Lee JY, Shin CH, Ha JY, Seo YK&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42753292&quot;&gt;42753292&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/40-hz-vibrotactile-stimulation-ameliorates-amyloid-pathology-and-cognitive-deficits-5xfad#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/40-hz-vibrotactile-stimulation-ameliorates-amyloid-pathology-and-cognitive-deficits-5xfad#comments</comments>
</item>
<item>
 <title>Exosomes in Alzheimer&#039;s Disease: From Pathological Mechanisms to Biomarker Potential and Therapeutic Applications.</title>
 <link>https://www.alzforum.org/papers/exosomes-alzheimers-disease-pathological-mechanisms-biomarker-potential-and-therapeutic</link>
 <description>Mol Neurobiol. 2026 Sep 17;63(1)&lt;br&gt;Authors: Aydın AC&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42753025&quot;&gt;42753025&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/exosomes-alzheimers-disease-pathological-mechanisms-biomarker-potential-and-therapeutic#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/exosomes-alzheimers-disease-pathological-mechanisms-biomarker-potential-and-therapeutic#comments</comments>
</item>
<item>
 <title>A Lipoylation-PDH-TCA Transcriptional Deficit in the Alzheimer&#039;s Disease Cortex - Donor-level Multi-cohort Evidence with Neuronal-composition, Disease-specificity and Matched-null Controls.</title>
 <link>https://www.alzforum.org/papers/lipoylation-pdh-tca-transcriptional-deficit-alzheimers-disease-cortex-donor-level-multi</link>
 <description>J Mol Neurosci. 2026 Sep 17;76(4)&lt;br&gt;Authors: Zhang T, Chen X, Wang Y, Wang Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42752765&quot;&gt;42752765&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/lipoylation-pdh-tca-transcriptional-deficit-alzheimers-disease-cortex-donor-level-multi#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/lipoylation-pdh-tca-transcriptional-deficit-alzheimers-disease-cortex-donor-level-multi#comments</comments>
</item>
<item>
 <title>Amyloid-beta-targeting monoclonal antibodies in early Alzheimer&#039;s disease: a cochrane review summary and appraisal for the neurological community.</title>
 <link>https://www.alzforum.org/papers/amyloid-beta-targeting-monoclonal-antibodies-early-alzheimers-disease-cochrane-review-summary</link>
 <description>Neurol Sci. 2026 Sep 17;47(10)&lt;br&gt;Authors: Santos DH, da Silva AM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42752707&quot;&gt;42752707&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/amyloid-beta-targeting-monoclonal-antibodies-early-alzheimers-disease-cochrane-review-summary#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/amyloid-beta-targeting-monoclonal-antibodies-early-alzheimers-disease-cochrane-review-summary#comments</comments>
</item>
<item>
 <title>A Molecularly Anchored Spatial Transcriptomic Framework for Precise CA1-Subiculum Parcellation and Region-Resolved Analysis in Alzheimer&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/molecularly-anchored-spatial-transcriptomic-framework-precise-ca1-subiculum-parcellation-and</link>
 <description>Gigascience. 2026 Sep 17; Epub 2026 Sep 17&lt;br&gt;Authors: Liu Y, He Y, Wei Y, Wang P, Huang C, Tao Q, Zhu L, Xu X, Liu L, Liu S, Han L, Zhang J, Wang L&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42752570&quot;&gt;42752570&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/molecularly-anchored-spatial-transcriptomic-framework-precise-ca1-subiculum-parcellation-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/molecularly-anchored-spatial-transcriptomic-framework-precise-ca1-subiculum-parcellation-and#comments</comments>
</item>
<item>
 <title>Evidence for multiple prion conformers in natural scrapie isolates.</title>
 <link>https://www.alzforum.org/papers/evidence-multiple-prion-conformers-natural-scrapie-isolates</link>
 <description>PLoS Pathog. 2026 Sep 17;22(9):e1014283.  Epub 2026 Sep 17&lt;br&gt;Authors: Imamura M, Miyazawa K, Okada H, Ohno M, Iguchi H, Matsuura Y, Iwamaru Y, Takatsuki H, Mori T, Ma J, Atarashi R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42752506&quot;&gt;42752506&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/evidence-multiple-prion-conformers-natural-scrapie-isolates#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/evidence-multiple-prion-conformers-natural-scrapie-isolates#comments</comments>
</item>
<item>
 <title>Empathy on the edge: A neurocognitive model of empathy in aging and dementia.</title>
 <link>https://www.alzforum.org/papers/empathy-edge-neurocognitive-model-empathy-aging-and-dementia</link>
 <description>Psychol Aging. 2026 Sep 17; Epub 2026 Sep 17&lt;br&gt;Authors: Abo Foul Y, Shamay-Tsoory S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42752160&quot;&gt;42752160&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/empathy-edge-neurocognitive-model-empathy-aging-and-dementia#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/empathy-edge-neurocognitive-model-empathy-aging-and-dementia#comments</comments>
</item>
<item>
 <title>Chronic Hypertension and the Brain&#039;s Waste Drainage System.</title>
 <link>https://www.alzforum.org/papers/chronic-hypertension-and-brains-waste-drainage-system</link>
 <description>Hypertension. 2026 Sep 17; Epub 2026 Sep 17&lt;br&gt;Authors: Alian M, Le C, Williams A, Wardlaw J, Benveniste H&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42751772&quot;&gt;42751772&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/chronic-hypertension-and-brains-waste-drainage-system#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/chronic-hypertension-and-brains-waste-drainage-system#comments</comments>
</item>
<item>
 <title>Cerebellar cortical amyloid deposition biases 18F-Florbetapir PET quantification with whole cerebellum as reference region.</title>
 <link>https://www.alzforum.org/papers/cerebellar-cortical-amyloid-deposition-biases-18f-florbetapir-pet-quantification-whole</link>
 <description>Eur J Nucl Med Mol Imaging. 2026 Sep 17; Epub 2026 Sep 17&lt;br&gt;Authors: Wang M, Bi S, Xue H, Guan L, Wang Y, Zhang X, Liu X, Xu X, Zhang C, Qi Z, Zhao Z, Yan S, Lu J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42749937&quot;&gt;42749937&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/cerebellar-cortical-amyloid-deposition-biases-18f-florbetapir-pet-quantification-whole#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/cerebellar-cortical-amyloid-deposition-biases-18f-florbetapir-pet-quantification-whole#comments</comments>
</item>
<item>
 <title>Erratum: Li et al., &quot;Amelioration of Symptomatic Alzheimer&#039;s Disease after Selective Impairment of p75NTR Function in Adult Forebrain Excitatory Neurons&quot;.</title>
 <link>https://www.alzforum.org/papers/erratum-li-et-al-amelioration-symptomatic-alzheimers-disease-after-selective-impairment</link>
 <description>J Neurosci. 2026 Sep 16;46(37)&lt;br&gt;Authors: &lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42728093&quot;&gt;42728093&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/erratum-li-et-al-amelioration-symptomatic-alzheimers-disease-after-selective-impairment#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/erratum-li-et-al-amelioration-symptomatic-alzheimers-disease-after-selective-impairment#comments</comments>
</item>
<item>
 <title>The longevity gene APOE2 enhances pericyte function and reduces lipid droplets.</title>
 <link>https://www.alzforum.org/papers/longevity-gene-apoe2-enhances-pericyte-function-and-reduces-lipid-droplets</link>
 <description>Brain. 2026 Sep 16; Epub 2026 Sep 16&lt;br&gt;Authors: Reskiawan A Kadir R, Bons J, Vega Hormazabal G, Vadhana Ashok Kumaar P, Gerónimo-Olvera C, Tshilenge KT, Pihán P, Galicia Aguirre C, Schneider K, Roberts A, Ambrose BD, Lerner C, Devanney NA, Sandholm AM, Hady M, Alderfer S, Hetz C, Furman D, Gerencser AA, Verdin E, Schilling B, Ellerby LM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42744302&quot;&gt;42744302&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/longevity-gene-apoe2-enhances-pericyte-function-and-reduces-lipid-droplets#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/longevity-gene-apoe2-enhances-pericyte-function-and-reduces-lipid-droplets#comments</comments>
</item>
<item>
 <title>Corrigendum to &quot;Ginsenoside Rg1 alleviates cognitive impairment in vascular dementia by modulating Adcy1/Kdr-mediated cholinergic synapse and PI3K-AKT pathway&quot; [Phytomedicine, 143 (2025) 156882].</title>
 <link>https://www.alzforum.org/papers/corrigendum-ginsenoside-rg1-alleviates-cognitive-impairment-vascular-dementia-modulating</link>
 <description>Phytomedicine. 2026 Sep 16;:158758.  Epub 2026 Sep 16&lt;br&gt;Authors: Wang Y, Wei X, Wang H, Zhang Y, Li P, Zhou Y, Jiang S, Rong Y, Chen L, Zhao H&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42749573&quot;&gt;42749573&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/corrigendum-ginsenoside-rg1-alleviates-cognitive-impairment-vascular-dementia-modulating#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/corrigendum-ginsenoside-rg1-alleviates-cognitive-impairment-vascular-dementia-modulating#comments</comments>
</item>
<item>
 <title>Neuropsychiatric symptoms as predictors of progression to Alzheimer&#039;s disease in mild cognitive impairment: A comparative meta-analysis of apathy, depression, and anxiety.</title>
 <link>https://www.alzforum.org/papers/neuropsychiatric-symptoms-predictors-progression-alzheimers-disease-mild-cognitive-impairment</link>
 <description>Int Psychogeriatr. 2026 Sep 16;:100275.  Epub 2026 Sep 16&lt;br&gt;Authors: Sun Y, Cao Y, Ma J, Li W, Li H, Tan Z&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42749536&quot;&gt;42749536&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/neuropsychiatric-symptoms-predictors-progression-alzheimers-disease-mild-cognitive-impairment#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/neuropsychiatric-symptoms-predictors-progression-alzheimers-disease-mild-cognitive-impairment#comments</comments>
</item>
<item>
 <title>Alzheimer&#039;s disease burden in China (ABC) study: protocol for a nationwide multicentre cross-sectional and prospective cohort study.</title>
 <link>https://www.alzforum.org/papers/alzheimers-disease-burden-china-abc-study-protocol-nationwide-multicentre-cross-sectional-and</link>
 <description>BMJ Open. 2026 Sep 16;16(9):e122035. &lt;br&gt;Authors: Wang Y, Qin Q, Yang K, Yu M, Yao Y, Gong C, Guo J, Yang L, Tang Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42749375&quot;&gt;42749375&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/alzheimers-disease-burden-china-abc-study-protocol-nationwide-multicentre-cross-sectional-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/alzheimers-disease-burden-china-abc-study-protocol-nationwide-multicentre-cross-sectional-and#comments</comments>
</item>
<item>
 <title>Inflection points and transitions in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/inflection-points-and-transitions-alzheimers-disease</link>
 <description>Nature. 2026 Sep 16; Epub 2026 Sep 16&lt;br&gt;Authors: De Strooper B, Karran E&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42749285&quot;&gt;42749285&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/inflection-points-and-transitions-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/inflection-points-and-transitions-alzheimers-disease#comments</comments>
</item>
<item>
 <title>From systems to cells: Metabolic mechanisms underlying risk divergence in Alzheimer&#039;s disease and amyotrophic lateral sclerosis.</title>
 <link>https://www.alzforum.org/papers/systems-cells-metabolic-mechanisms-underlying-risk-divergence-alzheimers-disease-and</link>
 <description>Neurosci Biobehav Rev. 2026 Sep 16;191:106982.  Epub 2026 Sep 16&lt;br&gt;Authors: Knezovic A, Krsnik A, Homolak J, Babic Perhoc A, Deskin A, Virag D, Salkovic-Petrisic M, Osmanovic Barilar J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42749235&quot;&gt;42749235&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/systems-cells-metabolic-mechanisms-underlying-risk-divergence-alzheimers-disease-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/systems-cells-metabolic-mechanisms-underlying-risk-divergence-alzheimers-disease-and#comments</comments>
</item>
<item>
 <title>β-Amyloid and glutathione dysregulation cooperatively drive lipid peroxidation and ferroptosis in neuron-like cells.</title>
 <link>https://www.alzforum.org/papers/v-amyloid-and-glutathione-dysregulation-cooperatively-drive-lipid-peroxidation-and-0</link>
 <description>Free Radic Biol Med. 2026 Sep 16;256:545-560.  Epub 2026 Sep 16&lt;br&gt;Authors: Radeen KR, Hao C, Wei Z, Fan X&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42749199&quot;&gt;42749199&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/v-amyloid-and-glutathione-dysregulation-cooperatively-drive-lipid-peroxidation-and-0#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/v-amyloid-and-glutathione-dysregulation-cooperatively-drive-lipid-peroxidation-and-0#comments</comments>
</item>
<item>
 <title>Adaptive hypergraph learning reveals high-order functional network alterations in mild cognitive impairment.</title>
 <link>https://www.alzforum.org/papers/adaptive-hypergraph-learning-reveals-high-order-functional-network-alterations-mild-cognitive</link>
 <description>Neuroscience. 2026 Sep 16; Epub 2026 Sep 16&lt;br&gt;Authors: Wu B, Jiang Z, Lv J, Zou L&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42749078&quot;&gt;42749078&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/adaptive-hypergraph-learning-reveals-high-order-functional-network-alterations-mild-cognitive#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/adaptive-hypergraph-learning-reveals-high-order-functional-network-alterations-mild-cognitive#comments</comments>
</item>
<item>
 <title>The double-edged sentinel: cGAS-STING as a context-dependent regulator of microglial senescence and neuronal genotoxic stress in neurodegeneration.</title>
 <link>https://www.alzforum.org/papers/double-edged-sentinel-cgas-sting-context-dependent-regulator-microglial-senescence-and</link>
 <description>Brain Res Bull. 2026 Sep 16;245:112118.  Epub 2026 Sep 16&lt;br&gt;Authors: Zhang C, Yang Z&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42748981&quot;&gt;42748981&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/double-edged-sentinel-cgas-sting-context-dependent-regulator-microglial-senescence-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/double-edged-sentinel-cgas-sting-context-dependent-regulator-microglial-senescence-and#comments</comments>
</item>
<item>
 <title>The Glymphatic System in Neurological Diseases: Mechanisms, Imaging Surrogates, and Translational Uncertainties.</title>
 <link>https://www.alzforum.org/papers/glymphatic-system-neurological-diseases-mechanisms-imaging-surrogates-and-translational</link>
 <description>Curr Neurol Neurosci Rep. 2026 Sep 16;26(1)&lt;br&gt;Authors: Raihane AS, Di Napoli M, Bragin D, Cáceres E, Ortiz MM, Moore MN, Divani AA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42747694&quot;&gt;42747694&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/glymphatic-system-neurological-diseases-mechanisms-imaging-surrogates-and-translational#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/glymphatic-system-neurological-diseases-mechanisms-imaging-surrogates-and-translational#comments</comments>
</item>
<item>
 <title>TLR2 Regulates α-Synuclein Phosphorylation and Release in an Enteroendocrine Cell Model.</title>
 <link>https://www.alzforum.org/papers/tlr2-regulates-synuclein-phosphorylation-and-release-enteroendocrine-cell-model</link>
 <description>Mol Neurobiol. 2026 Sep 16;63(1)&lt;br&gt;Authors: Hu J, Elsaid S, Wu X, Ambye N, Tee SS&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42747668&quot;&gt;42747668&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/tlr2-regulates-synuclein-phosphorylation-and-release-enteroendocrine-cell-model#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/tlr2-regulates-synuclein-phosphorylation-and-release-enteroendocrine-cell-model#comments</comments>
</item>
<item>
 <title>Unraveling the regulatory nexus of aggrephagy in ALS: identification of novel candidate biomarkers and molecular triggers.</title>
 <link>https://www.alzforum.org/papers/unraveling-regulatory-nexus-aggrephagy-als-identification-novel-candidate-biomarkers-and</link>
 <description>Metab Brain Dis. 2026 Sep 16;41(1)&lt;br&gt;Authors: Zhang Y, Wei K, Lin H, Guo Z, Lu Y, Ma T&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42747562&quot;&gt;42747562&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/unraveling-regulatory-nexus-aggrephagy-als-identification-novel-candidate-biomarkers-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/unraveling-regulatory-nexus-aggrephagy-als-identification-novel-candidate-biomarkers-and#comments</comments>
</item>
<item>
 <title>Alzheimer&#039;s Co-Pathology Burden on Basal Forebrain Atrophy and Cognitive Impairment in Dementia with Lewy Bodies: A Cross-Sectional Pilot Study.</title>
 <link>https://www.alzforum.org/papers/alzheimers-co-pathology-burden-basal-forebrain-atrophy-and-cognitive-impairment-dementia-lewy</link>
 <description>Ann Neurol. 2026 Sep 16; Epub 2026 Sep 16&lt;br&gt;Authors: Urso D, Giannelli T, Tafuri B, Giannoni-Luza S, Gnoni V, Giugno A, Vilella D, Zecca C, De Blasi R, Nigro S, Aarsland D, Logroscino G&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42747246&quot;&gt;42747246&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/alzheimers-co-pathology-burden-basal-forebrain-atrophy-and-cognitive-impairment-dementia-lewy#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/alzheimers-co-pathology-burden-basal-forebrain-atrophy-and-cognitive-impairment-dementia-lewy#comments</comments>
</item>
<item>
 <title>Artificial Intelligence-Based Detection of ARIA on MRI During Alzheimer Disease Therapy: Expert Opinion on Responsible Clinical Integration.</title>
 <link>https://www.alzforum.org/papers/artificial-intelligence-based-detection-aria-mri-during-alzheimer-disease-therapy-expert</link>
 <description>AJR Am J Roentgenol. 2026 Sep 16; Epub 2026 Sep 16&lt;br&gt;Authors: Petrella JR, Barkhof F, Benzinger TL, Cogswell PM, Franceschi AM, Sabbagh MN, Salloway SP, Zaharchuk G, Doraiswamy PM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42747213&quot;&gt;42747213&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/artificial-intelligence-based-detection-aria-mri-during-alzheimer-disease-therapy-expert#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/artificial-intelligence-based-detection-aria-mri-during-alzheimer-disease-therapy-expert#comments</comments>
</item>
<item>
 <title>Validation of plasma core biomarkers of Alzheimer&#039;s disease: A multicenter study in usual practice conditions.</title>
 <link>https://www.alzforum.org/papers/validation-plasma-core-biomarkers-alzheimers-disease-multicenter-study-usual-practice</link>
 <description>J Alzheimers Dis. 2026 Sep 16;:13872877261487171.  Epub 2026 Sep 16&lt;br&gt;Authors: Sánchez-Soblechero A, Villarejo A, Carreras MT, Berbel Á, Puertas C, Fernández-Bullido Y, Vieira A, Gundín I, Blanco-Palmero V, González-Sánchez M, Llamas S, Lapeña T, de Luis P, Lucio B, Ibáñez MD, Heredia P, Grandas F, Olazarán J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42746979&quot;&gt;42746979&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/validation-plasma-core-biomarkers-alzheimers-disease-multicenter-study-usual-practice#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/validation-plasma-core-biomarkers-alzheimers-disease-multicenter-study-usual-practice#comments</comments>
</item>
<item>
 <title>L-serine-enriched diet restores impaired adult neurogenesis in the hippocampus of 3xTg-AD mice.</title>
 <link>https://www.alzforum.org/papers/l-serine-enriched-diet-restores-impaired-adult-neurogenesis-hippocampus-3xtg-ad-mice</link>
 <description>J Alzheimers Dis. 2026 Sep 16;:13872877261487394.  Epub 2026 Sep 16&lt;br&gt;Authors: Than-Trong E, Torres L, Gaudin-Guérif M, Jan C, Ghettas A, Amadio A, Brainbank Neuro-CEB Neuropathology Network 5, Oliet SH, Panatier A, Bonvento G&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42746964&quot;&gt;42746964&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/l-serine-enriched-diet-restores-impaired-adult-neurogenesis-hippocampus-3xtg-ad-mice#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/l-serine-enriched-diet-restores-impaired-adult-neurogenesis-hippocampus-3xtg-ad-mice#comments</comments>
</item>
<item>
 <title>Recognition memory as a neuropsychological marker of progression in early-stage Alzheimer&#039;s disease: a 24-month prospective cohort study.</title>
 <link>https://www.alzforum.org/papers/recognition-memory-neuropsychological-marker-progression-early-stage-alzheimers-disease-24</link>
 <description>J Clin Exp Neuropsychol. 2026 Sep 16;:1-16.  Epub 2026 Sep 16&lt;br&gt;Authors: Russo MJ, Bueri J, Alba-Ferrara L, Sevlever G, Allegri RF&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42746710&quot;&gt;42746710&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/recognition-memory-neuropsychological-marker-progression-early-stage-alzheimers-disease-24#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/recognition-memory-neuropsychological-marker-progression-early-stage-alzheimers-disease-24#comments</comments>
</item>
<item>
 <title>Sex-dependent Hippocampal Astrocytic Signaling and Synaptic Alterations Associated With Behavioral Impairments in Intracerebroventricular Streptozotocin-treated Rats.</title>
 <link>https://www.alzforum.org/papers/sex-dependent-hippocampal-astrocytic-signaling-and-synaptic-alterations-associated-behavioral</link>
 <description>Mol Neurobiol. 2026 Sep 16;63(1)&lt;br&gt;Authors: Hanotte JL, Peralta F, Escartin C, Carrillo-de Sauvage MÁ, Reggiani PC&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42744995&quot;&gt;42744995&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/sex-dependent-hippocampal-astrocytic-signaling-and-synaptic-alterations-associated-behavioral#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/sex-dependent-hippocampal-astrocytic-signaling-and-synaptic-alterations-associated-behavioral#comments</comments>
</item>
<item>
 <title>Deep Learning-Powered Plasmonic Platform for Decoding Dynamic Protein Aggregation Landscapes in Parkinson&#039;s Disease Progression.</title>
 <link>https://www.alzforum.org/papers/deep-learning-powered-plasmonic-platform-decoding-dynamic-protein-aggregation-landscapes</link>
 <description>Adv Mater. 2026 Sep 16;:e74985.  Epub 2026 Sep 16&lt;br&gt;Authors: Zhou Y, Liu H, Yang X, Huang A, Li M, Dai Z, Liu S, Lu Y, Guo J, Liu S, Li C, Jiang C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42750405&quot;&gt;42750405&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/deep-learning-powered-plasmonic-platform-decoding-dynamic-protein-aggregation-landscapes#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/deep-learning-powered-plasmonic-platform-decoding-dynamic-protein-aggregation-landscapes#comments</comments>
</item>
<item>
 <title>Temporal Trajectories of the Tau Aggregate Interactome Reveal Stage-Specific Vulnerabilities in Alzheimer&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/temporal-trajectories-tau-aggregate-interactome-reveal-stage-specific-vulnerabilities</link>
 <description>Adv Sci (Weinh). 2026 Sep 16;:e77822.  Epub 2026 Sep 16&lt;br&gt;Authors: Böken D, Lobo PB, Wu Y, Rowe LA, Fertan E, Croft CL, Jimenez-Sanchez M, Cox D, Klenerman D&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42750204&quot;&gt;42750204&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/temporal-trajectories-tau-aggregate-interactome-reveal-stage-specific-vulnerabilities#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/temporal-trajectories-tau-aggregate-interactome-reveal-stage-specific-vulnerabilities#comments</comments>
</item>
<item>
 <title>Alzheimer&#039;s Disease Beyond Amyloid: Lessons From Atherosclerosis.</title>
 <link>https://www.alzforum.org/papers/alzheimers-disease-beyond-amyloid-lessons-atherosclerosis</link>
 <description>Ann Clin Transl Neurol. 2026 Sep 16; Epub 2026 Sep 16&lt;br&gt;Authors: Ciaccio M, Agnello L&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42750145&quot;&gt;42750145&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/alzheimers-disease-beyond-amyloid-lessons-atherosclerosis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/alzheimers-disease-beyond-amyloid-lessons-atherosclerosis#comments</comments>
</item>
<item>
 <title>Disrupted TFEB/GDNF-cAMP/ATP Coupling Underlies Astrocytic Dysfunction and Depression in LRRK2 G2019S Parkinson&#039;s Mice.</title>
 <link>https://www.alzforum.org/papers/disrupted-tfebgdnf-campatp-coupling-underlies-astrocytic-dysfunction-and-depression-lrrk2</link>
 <description>Adv Sci (Weinh). 2026 Sep 16;:e22066.  Epub 2026 Sep 16&lt;br&gt;Authors: Yao L, Hatami M, Koc S, Jiang Q, Skutella T, Zhang Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42750142&quot;&gt;42750142&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/disrupted-tfebgdnf-campatp-coupling-underlies-astrocytic-dysfunction-and-depression-lrrk2#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/disrupted-tfebgdnf-campatp-coupling-underlies-astrocytic-dysfunction-and-depression-lrrk2#comments</comments>
</item>
<item>
 <title>Brain region-resolved pharmacodynamics of an antisense oligonucleotide targeting human SNCA 3&#039;UTR in BAC-hSNCA rats.</title>
 <link>https://www.alzforum.org/papers/brain-region-resolved-pharmacodynamics-antisense-oligonucleotide-targeting-human-snca-3utr</link>
 <description>Transl Neurodegener. 2026 Sep 16;15(1)&lt;br&gt;Authors: Naki M, Kattan FG, Pantazopoulou M, Skea S, Zisis D, Pilalis E, Fouka M, Koronaiou E, Fotis C, Riess O, Chatziioannou A, Alexopoulos LG, Stefanis L, Doxakis E&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42750047&quot;&gt;42750047&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/brain-region-resolved-pharmacodynamics-antisense-oligonucleotide-targeting-human-snca-3utr#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/brain-region-resolved-pharmacodynamics-antisense-oligonucleotide-targeting-human-snca-3utr#comments</comments>
</item>
<item>
 <title>Quercetin-Based Nanotherapeutics for Targeted Drug Delivery in Alzheimer&#039;s Disease: Comparative Insights into Molecular Mechanisms, Blood-Brain Barrier Targeting and Therapeutic Perspectives.</title>
 <link>https://www.alzforum.org/papers/quercetin-based-nanotherapeutics-targeted-drug-delivery-alzheimers-disease-comparative</link>
 <description>Mol Neurobiol. 2026 Sep 16;63(1)&lt;br&gt;Authors: Begum MY, Rajkumar M, Govindaraj P, Velmani S, Rajkumar P, Sudha PN, Alhamod M, Alotaibi H&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42749965&quot;&gt;42749965&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/quercetin-based-nanotherapeutics-targeted-drug-delivery-alzheimers-disease-comparative#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/quercetin-based-nanotherapeutics-targeted-drug-delivery-alzheimers-disease-comparative#comments</comments>
</item>
<item>
 <title>Unconventional animal models of Alzheimer&#039;s disease and aging: key insights from the UAMAA 2026 conference.</title>
 <link>https://www.alzforum.org/papers/unconventional-animal-models-alzheimers-disease-and-aging-key-insights-uamaa-2026-conference</link>
 <description>Lab Anim (NY). 2026 Sep 16; Epub 2026 Sep 16&lt;br&gt;Authors: Garduño BM, Melgarejo T, Cogram P, Holmes TC, Xu X&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42749851&quot;&gt;42749851&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/unconventional-animal-models-alzheimers-disease-and-aging-key-insights-uamaa-2026-conference#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/unconventional-animal-models-alzheimers-disease-and-aging-key-insights-uamaa-2026-conference#comments</comments>
</item>
<item>
 <title>Targeting C/EBPβ/ Calbindin 1 pathway bolsters the neural resilience to tau pathology and improves tau-impaired episodic memory.</title>
 <link>https://www.alzforum.org/papers/targeting-cebpv-calbindin-1-pathway-bolsters-neural-resilience-tau-pathology-and-improves-tau</link>
 <description>Mol Psychiatry. 2026 Sep 16; Epub 2026 Sep 16&lt;br&gt;Authors: Liu J, Zhang F, Zhong T, Wang J, Lei H, Zhao J, Lin F, Fan T, He T, Xiong R, Wang X, Wei L, Sun F, Xiao Y, Pi G, Kang D, Bian Y, Li H, Wang Q, Ke D, Wang JZ, Yang X, Wang ZH, Yang Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42749775&quot;&gt;42749775&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/targeting-cebpv-calbindin-1-pathway-bolsters-neural-resilience-tau-pathology-and-improves-tau#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/targeting-cebpv-calbindin-1-pathway-bolsters-neural-resilience-tau-pathology-and-improves-tau#comments</comments>
</item>
<item>
 <title>Map of brain &#039;microproteins&#039; could offer new clues to Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/map-brain-microproteins-could-offer-new-clues-alzheimers-disease</link>
 <description>Nature. 2026 Sep 16; Epub 2026 Sep 16&lt;br&gt;Authors: Naddaf M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42749769&quot;&gt;42749769&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/map-brain-microproteins-could-offer-new-clues-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/map-brain-microproteins-could-offer-new-clues-alzheimers-disease#comments</comments>
</item>
<item>
 <title>The hnRNPA1 D262V amyotrophic lateral sclerosis (ALS) mutation is linked to mitochondrial dysfunction.</title>
 <link>https://www.alzforum.org/papers/hnrnpa1-d262v-amyotrophic-lateral-sclerosis-als-mutation-linked-mitochondrial-dysfunction</link>
 <description>Genes Dev. 2026 Sep 15; Epub 2026 Sep 15&lt;br&gt;Authors: Lee YJ, Shen K, Dillin A, Rio DC&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42744617&quot;&gt;42744617&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/hnrnpa1-d262v-amyotrophic-lateral-sclerosis-als-mutation-linked-mitochondrial-dysfunction#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/hnrnpa1-d262v-amyotrophic-lateral-sclerosis-als-mutation-linked-mitochondrial-dysfunction#comments</comments>
</item>
<item>
 <title>Structural brain imaging for newly diagnosed cognitive impairment by Medicare coverage type.</title>
 <link>https://www.alzforum.org/papers/structural-brain-imaging-newly-diagnosed-cognitive-impairment-medicare-coverage-type</link>
 <description>J Am Coll Radiol. 2026 Sep 15; Epub 2026 Sep 15&lt;br&gt;Authors: Mattke S, Liu Y, Ye W, Altunkaynak K&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42744196&quot;&gt;42744196&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/structural-brain-imaging-newly-diagnosed-cognitive-impairment-medicare-coverage-type#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/structural-brain-imaging-newly-diagnosed-cognitive-impairment-medicare-coverage-type#comments</comments>
</item>
<item>
 <title>Alternative splicing in Alzheimer&#039;s disease: event-level evidence, risk-locus biology, and RNA-based therapeutic perspectives.</title>
 <link>https://www.alzforum.org/papers/alternative-splicing-alzheimers-disease-event-level-evidence-risk-locus-biology-and-rna-based</link>
 <description>Gene. 2026 Sep 15;1013:150397.  Epub 2026 Sep 15&lt;br&gt;Authors: Li J, Yue D, Xie W, Xiong Z, Wang X&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42744164&quot;&gt;42744164&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/alternative-splicing-alzheimers-disease-event-level-evidence-risk-locus-biology-and-rna-based#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/alternative-splicing-alzheimers-disease-event-level-evidence-risk-locus-biology-and-rna-based#comments</comments>
</item>
<item>
 <title>Amyloid-β aggregation inhibitory activity and neuroprotective effects of metabolites of Trichoderma pluripenicillatum.</title>
 <link>https://www.alzforum.org/papers/amyloid-v-aggregation-inhibitory-activity-and-neuroprotective-effects-metabolites-trichoderma</link>
 <description>Bioorg Med Chem Lett. 2026 Sep 15;142:130778.  Epub 2026 Sep 15&lt;br&gt;Authors: Yoshikawa H, Matsumoto T, Yoshida E, Ohta T, Yoshida T, Noda Y, Shimohama S, Takata K&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42744151&quot;&gt;42744151&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/amyloid-v-aggregation-inhibitory-activity-and-neuroprotective-effects-metabolites-trichoderma#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/amyloid-v-aggregation-inhibitory-activity-and-neuroprotective-effects-metabolites-trichoderma#comments</comments>
</item>
<item>
 <title>Autopsy findings in Alzheimer&#039;s disease clinical trial participants demonstrate a high frequency of off-target coexisting pathologic features.</title>
 <link>https://www.alzforum.org/papers/autopsy-findings-alzheimers-disease-clinical-trial-participants-demonstrate-high-frequency</link>
 <description>J Prev Alzheimers Dis. 2026 Sep 15;13(10):100669.  Epub 2026 Sep 15&lt;br&gt;Authors: Coskun EP, Barber J, Bojarski L, McLouth CJ, Abner EL, Van Eldik LJ, Nelson PT, Jicha GA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42743907&quot;&gt;42743907&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/autopsy-findings-alzheimers-disease-clinical-trial-participants-demonstrate-high-frequency#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/autopsy-findings-alzheimers-disease-clinical-trial-participants-demonstrate-high-frequency#comments</comments>
</item>
<item>
 <title>Dimethyl fumarate ameliorates amyloid-beta generated cognitive deficits by inhibiting RIPK1/RIPK3/MLKL necroptosis signalling in rats.</title>
 <link>https://www.alzforum.org/papers/dimethyl-fumarate-ameliorates-amyloid-beta-generated-cognitive-deficits-inhibiting</link>
 <description>Int Immunopharmacol. 2026 Sep 15;189:117407.  Epub 2026 Sep 15&lt;br&gt;Authors: Guin S, Jangli A, Dandekar MP&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42743871&quot;&gt;42743871&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/dimethyl-fumarate-ameliorates-amyloid-beta-generated-cognitive-deficits-inhibiting#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/dimethyl-fumarate-ameliorates-amyloid-beta-generated-cognitive-deficits-inhibiting#comments</comments>
</item>
<item>
 <title>Disease Course Map progression markers transfer from isolated REM sleep behavior disorder to non-RBD prodromal alpha-synucleinopathy: a PPMI study of 1,499 participants.</title>
 <link>https://www.alzforum.org/papers/disease-course-map-progression-markers-transfer-isolated-rem-sleep-behavior-disorder-non-rbd</link>
 <description>Parkinsonism Relat Disord. 2026 Sep 15;152:108985.  Epub 2026 Sep 15&lt;br&gt;Authors: Fontana JC, Guimarães RL, de Faria AS, Braz KM, de Sá Pereira JF, Corrêa EM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42743773&quot;&gt;42743773&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/disease-course-map-progression-markers-transfer-isolated-rem-sleep-behavior-disorder-non-rbd#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/disease-course-map-progression-markers-transfer-isolated-rem-sleep-behavior-disorder-non-rbd#comments</comments>
</item>
<item>
 <title>Corrigendum to &quot;Real-world long-term continuation of lecanemab therapy and the clinical utility of phosphorylated tau 181&quot; [The Journal of Prevention of Alzheimer&#039;s Disease (2026) 100664].</title>
 <link>https://www.alzforum.org/papers/corrigendum-real-world-long-term-continuation-lecanemab-therapy-and-clinical-utility</link>
 <description>J Prev Alzheimers Dis. 2026 Sep 15;13(9):100668.  Epub 2026 Sep 15&lt;br&gt;Authors: Noguchi-Shinohara M, Muramatsu D, Shima A, Sakashita Y, Tada Y, Yamaguchi H, Komatsu J, Ikeda T, Ono K&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42743693&quot;&gt;42743693&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/corrigendum-real-world-long-term-continuation-lecanemab-therapy-and-clinical-utility#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/corrigendum-real-world-long-term-continuation-lecanemab-therapy-and-clinical-utility#comments</comments>
</item>
<item>
 <title>From Proof of Principle to Therapeutic Discipline: Strategies to Improve the Benefit/Risk Profile of Amyloid-Targeting Treatments for Alzheimer&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/proof-principle-therapeutic-discipline-strategies-improve-benefitrisk-profile-amyloid</link>
 <description>CNS Drugs. 2026 Sep 15; Epub 2026 Sep 15&lt;br&gt;Authors: Perneczky R, Jessen F, Grimmer T, Levin J, Hufnagel A, Flöel A, Peters O, Froelich L, Hofmann A, Working Group New Therapies, Monitoring of the German Network Memory Clinics&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42742914&quot;&gt;42742914&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/proof-principle-therapeutic-discipline-strategies-improve-benefitrisk-profile-amyloid#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/proof-principle-therapeutic-discipline-strategies-improve-benefitrisk-profile-amyloid#comments</comments>
</item>
<item>
 <title>Pharmacological modulation of cGAS-STING-NLRP3 signaling by nano-immunomodulators in Alzheimer and Parkinson disease.</title>
 <link>https://www.alzforum.org/papers/pharmacological-modulation-cgas-sting-nlrp3-signaling-nano-immunomodulators-alzheimer-and</link>
 <description>Inflammopharmacology. 2026 Sep 15; Epub 2026 Sep 15&lt;br&gt;Authors: Abdel-Rasol MA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42742907&quot;&gt;42742907&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/pharmacological-modulation-cgas-sting-nlrp3-signaling-nano-immunomodulators-alzheimer-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/pharmacological-modulation-cgas-sting-nlrp3-signaling-nano-immunomodulators-alzheimer-and#comments</comments>
</item>
<item>
 <title>Peripheral TDP-43 pathology in amyotrophic lateral sclerosis: toward a systemic proteinopathy.</title>
 <link>https://www.alzforum.org/papers/peripheral-tdp-43-pathology-amyotrophic-lateral-sclerosis-toward-systemic-proteinopathy</link>
 <description>Acta Neuropathol. 2026 Sep 15;152(1)&lt;br&gt;Authors: Codron P, Miranda M, Garnier M, He S, Gouju J, Cassereau J, Leblanc P, Letournel F&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42742812&quot;&gt;42742812&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/peripheral-tdp-43-pathology-amyotrophic-lateral-sclerosis-toward-systemic-proteinopathy#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/peripheral-tdp-43-pathology-amyotrophic-lateral-sclerosis-toward-systemic-proteinopathy#comments</comments>
</item>
<item>
 <title>A new era of genome-wide association studies in the field of Alzheimer&#039;s disease and overlapping co-pathologies: lessons learned from a neuropathology-centered approach.</title>
 <link>https://www.alzforum.org/papers/new-era-genome-wide-association-studies-field-alzheimers-disease-and-overlapping-co</link>
 <description>Acta Neuropathol. 2026 Sep 15;152(1)&lt;br&gt;Authors: Laureyssen C, Thal DR, Sleegers K&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42742642&quot;&gt;42742642&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/new-era-genome-wide-association-studies-field-alzheimers-disease-and-overlapping-co#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/new-era-genome-wide-association-studies-field-alzheimers-disease-and-overlapping-co#comments</comments>
</item>
<item>
 <title>Toward a Blood-Based Diagnosis of Progressive Supranuclear Palsy.</title>
 <link>https://www.alzforum.org/papers/toward-blood-based-diagnosis-progressive-supranuclear-palsy</link>
 <description>Mov Disord Clin Pract. 2026 Sep 15; Epub 2026 Sep 15&lt;br&gt;Authors: Barton N, Ghosh P, Kassavetis P&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42742623&quot;&gt;42742623&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/toward-blood-based-diagnosis-progressive-supranuclear-palsy#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/toward-blood-based-diagnosis-progressive-supranuclear-palsy#comments</comments>
</item>
<item>
 <title>Reply to: &quot;Rare-Variant Burden in Mitochondrial Parkinson&#039;s Disease&quot;.</title>
 <link>https://www.alzforum.org/papers/reply-rare-variant-burden-mitochondrial-parkinsons-disease</link>
 <description>Mov Disord. 2026 Sep 15; Epub 2026 Sep 15&lt;br&gt;Authors: Percetti M, Yahya V, Di Fonzo A, Monfrini E&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42742600&quot;&gt;42742600&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/reply-rare-variant-burden-mitochondrial-parkinsons-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/reply-rare-variant-burden-mitochondrial-parkinsons-disease#comments</comments>
</item>
<item>
 <title>A parsimonious three-gene mitochondrial classifier from frontal cortex for Alzheimer&#039;s disease: Nested cross-validation and multicenter external validation.</title>
 <link>https://www.alzforum.org/papers/parsimonious-three-gene-mitochondrial-classifier-frontal-cortex-alzheimers-disease-nested</link>
 <description>J Alzheimers Dis. 2026 Sep 15;:13872877261487424.  Epub 2026 Sep 15&lt;br&gt;Authors: Wang M, Jing C, Wu T, Wang D&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42742534&quot;&gt;42742534&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/parsimonious-three-gene-mitochondrial-classifier-frontal-cortex-alzheimers-disease-nested#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/parsimonious-three-gene-mitochondrial-classifier-frontal-cortex-alzheimers-disease-nested#comments</comments>
</item>
<item>
 <title>Lower baseline cerebrospinal fluid amyloid-β 42 is associated with amyloid-related imaging abnormalities during real-world lecanemab treatment.</title>
 <link>https://www.alzforum.org/papers/lower-baseline-cerebrospinal-fluid-amyloid-v-42-associated-amyloid-related-imaging</link>
 <description>J Alzheimers Dis. 2026 Sep 15;:13872877261488874.  Epub 2026 Sep 15&lt;br&gt;Authors: Takahashi R, Kashibayashi T, Fujita J, Yoshida K, Hashiramoto A, Kowa H, Mizuta E&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42742530&quot;&gt;42742530&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/lower-baseline-cerebrospinal-fluid-amyloid-v-42-associated-amyloid-related-imaging#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/lower-baseline-cerebrospinal-fluid-amyloid-v-42-associated-amyloid-related-imaging#comments</comments>
</item>
<item>
 <title>Associations of plasma lipid burden with cognitive performance and decline across dementia with Lewy bodies, Alzheimer&#039;s disease, and Parkinson&#039;s disease dementia.</title>
 <link>https://www.alzforum.org/papers/associations-plasma-lipid-burden-cognitive-performance-and-decline-across-dementia-lewy</link>
 <description>J Alzheimers Dis. 2026 Sep 15;:13872877261487127.  Epub 2026 Sep 15&lt;br&gt;Authors: Su Z, Liu M, Su L, Kuai J, Xu B, Wang C, Su M, Zheng Y, Peng J, Bao X, Zuo M, Guo X&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42742528&quot;&gt;42742528&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/associations-plasma-lipid-burden-cognitive-performance-and-decline-across-dementia-lewy#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/associations-plasma-lipid-burden-cognitive-performance-and-decline-across-dementia-lewy#comments</comments>
</item>
<item>
 <title>Altered neurovascular coupling in mild cognitive impairment and Alzheimer&#039;s disease: Associations with polysomnography-derived sleep parameters and cognition.</title>
 <link>https://www.alzforum.org/papers/altered-neurovascular-coupling-mild-cognitive-impairment-and-alzheimers-disease-associations</link>
 <description>J Alzheimers Dis. 2026 Sep 15;:13872877261487585.  Epub 2026 Sep 15&lt;br&gt;Authors: Xu Z, Bao L, Zhou S, Xue C, Peng L, Xiao C, Dong J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42742525&quot;&gt;42742525&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/altered-neurovascular-coupling-mild-cognitive-impairment-and-alzheimers-disease-associations#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/altered-neurovascular-coupling-mild-cognitive-impairment-and-alzheimers-disease-associations#comments</comments>
</item>
<item>
 <title>APOE4 moderates the association of sleep disturbance with cerebral amyloid burden but not with clinical conversion in cognitively normal older adults.</title>
 <link>https://www.alzforum.org/papers/apoe4-moderates-association-sleep-disturbance-cerebral-amyloid-burden-not-clinical-conversion</link>
 <description>J Alzheimers Dis. 2026 Sep 15;:13872877261487625.  Epub 2026 Sep 15&lt;br&gt;Authors: Lee MJ, Kim JH, Choi HJ, Keum M, Byeon G, Ryu V, Suh GH, Kim JW, Choe YM, Alzheimer&amp;#039;s Disease Neuroimaging Initiative&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42742523&quot;&gt;42742523&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/apoe4-moderates-association-sleep-disturbance-cerebral-amyloid-burden-not-clinical-conversion#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/apoe4-moderates-association-sleep-disturbance-cerebral-amyloid-burden-not-clinical-conversion#comments</comments>
</item>
<item>
 <title>Creutzfeldt-Jakob Disease in the Era of Diagnostic Triumph and Therapeutic Defeat: A Perspective from the Bedside.</title>
 <link>https://www.alzforum.org/papers/creutzfeldt-jakob-disease-era-diagnostic-triumph-and-therapeutic-defeat-perspective-bedside</link>
 <description>Restor Neurol Neurosci. 2026 Sep 15;:9226028261488180.  Epub 2026 Sep 15&lt;br&gt;Authors: Zhang X, Tian Y, Li C, Li M, Wang Z&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42742480&quot;&gt;42742480&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/creutzfeldt-jakob-disease-era-diagnostic-triumph-and-therapeutic-defeat-perspective-bedside#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/creutzfeldt-jakob-disease-era-diagnostic-triumph-and-therapeutic-defeat-perspective-bedside#comments</comments>
</item>
<item>
 <title>Rethinking the concept of disease modification in an evolving Parkinson&#039;s disease treatment landscape.</title>
 <link>https://www.alzforum.org/papers/rethinking-concept-disease-modification-evolving-parkinsons-disease-treatment-landscape</link>
 <description>J Parkinsons Dis. 2026 Sep 15;:1877718X261481704.  Epub 2026 Sep 15&lt;br&gt;Authors: Antonini A, Gross RE, De Leon M, Kwok K, Foltynie T, Höglinger G, Gasser T, Corvol JC, Pedrosa DJ, Volkmann J, Henchcliffe C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42742463&quot;&gt;42742463&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/rethinking-concept-disease-modification-evolving-parkinsons-disease-treatment-landscape#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/rethinking-concept-disease-modification-evolving-parkinsons-disease-treatment-landscape#comments</comments>
</item>
<item>
 <title>ALS Research and Healey ALS MyMatch.</title>
 <link>https://www.alzforum.org/papers/als-research-and-healey-als-mymatch</link>
 <description>Ann Neurol. 2026 Sep 15; Epub 2026 Sep 15&lt;br&gt;Authors: Jacobson R, Babu S, Hurley J, Zawar I&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42742283&quot;&gt;42742283&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/als-research-and-healey-als-mymatch#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/als-research-and-healey-als-mymatch#comments</comments>
</item>
<item>
 <title>Social Media Claims About Blood Tests for Alzheimer&#039;s Disease and Dementia: A Cross-Sectional Content Analysis.</title>
 <link>https://www.alzforum.org/papers/social-media-claims-about-blood-tests-alzheimers-disease-and-dementia-cross-sectional-content</link>
 <description>J Am Geriatr Soc. 2026 Sep 15; Epub 2026 Sep 15&lt;br&gt;Authors: Sujana RS, McCaffery KJ, Nickel B, Fox R, Naganathan V, Cumming RG, Smith J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42742271&quot;&gt;42742271&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/social-media-claims-about-blood-tests-alzheimers-disease-and-dementia-cross-sectional-content#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/social-media-claims-about-blood-tests-alzheimers-disease-and-dementia-cross-sectional-content#comments</comments>
</item>
<item>
 <title>Resilience mechanisms in Parkinson&#039;s disease: a domain-specific conceptual framework.</title>
 <link>https://www.alzforum.org/papers/resilience-mechanisms-parkinsons-disease-domain-specific-conceptual-framework</link>
 <description>Brain. 2026 Sep 15; Epub 2026 Sep 15&lt;br&gt;Authors: Ruppert-Junck MC, van Eimeren T, Giehl K, Helmich RC, Hönig M, Johansson ME, Mitterová K, Rektorová I, Waldthaler J, Pedrosa D, TRACE-PD consortium, the&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42742269&quot;&gt;42742269&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/resilience-mechanisms-parkinsons-disease-domain-specific-conceptual-framework#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/resilience-mechanisms-parkinsons-disease-domain-specific-conceptual-framework#comments</comments>
</item>
<item>
 <title>Structural abnormalities in gray matter, white matter, and cerebrospinal fluid in parkinson&#039;s disease: a voxel-based morphometry study.</title>
 <link>https://www.alzforum.org/papers/structural-abnormalities-gray-matter-white-matter-and-cerebrospinal-fluid-parkinsons-disease</link>
 <description>Neurol Res. 2026 Sep 15;:1-14.  Epub 2026 Sep 15&lt;br&gt;Authors: Shi Y, Zhang Y, Zhang Y, Wu Y, Liu X, Feng K, Cheng Y, Yin S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42742255&quot;&gt;42742255&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/structural-abnormalities-gray-matter-white-matter-and-cerebrospinal-fluid-parkinsons-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/structural-abnormalities-gray-matter-white-matter-and-cerebrospinal-fluid-parkinsons-disease#comments</comments>
</item>
<item>
 <title>UA-30 ameliorates motor deficits through RalA-mediated mitophagy in ALS mice.</title>
 <link>https://www.alzforum.org/papers/ua-30-ameliorates-motor-deficits-through-rala-mediated-mitophagy-als-mice</link>
 <description>J Clin Invest. 2026 Sep 15;136(18) Epub 2026 Sep 15&lt;br&gt;Authors: Zhang B, He Y, Su T, Li X, Zhang X, Liu R, Han X, Zhang R, Yang C, Liu X, Hou Q, Zhang Z, Xie Y, Liu G, Yang X&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42741938&quot;&gt;42741938&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/ua-30-ameliorates-motor-deficits-through-rala-mediated-mitophagy-als-mice#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/ua-30-ameliorates-motor-deficits-through-rala-mediated-mitophagy-als-mice#comments</comments>
</item>
<item>
 <title>Brain fluorodeoxyglucose PET anatomical segmentation via AI: extensive validation in the neurodegenerative spectrum.</title>
 <link>https://www.alzforum.org/papers/brain-fluorodeoxyglucose-pet-anatomical-segmentation-ai-extensive-validation</link>
 <description>Brain. 2026 Sep 15; Epub 2026 Sep 15&lt;br&gt;Authors: Silva LC, Oliveira FP, Costa DC, Alzheimer&amp;#039;s Disease Neuroimaging Initiative and for the Frontotemporal Lobar Degeneration Neuroimaging Initiative&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42740541&quot;&gt;42740541&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/brain-fluorodeoxyglucose-pet-anatomical-segmentation-ai-extensive-validation#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/brain-fluorodeoxyglucose-pet-anatomical-segmentation-ai-extensive-validation#comments</comments>
</item>
<item>
 <title>The diagnostic biomarker problem in amyotrophic lateral sclerosis.</title>
 <link>https://www.alzforum.org/papers/diagnostic-biomarker-problem-amyotrophic-lateral-sclerosis</link>
 <description>Brain. 2026 Sep 15; Epub 2026 Sep 15&lt;br&gt;Authors: Benatar M, Wuu J, Turner MR, Macklin EA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42736600&quot;&gt;42736600&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/diagnostic-biomarker-problem-amyotrophic-lateral-sclerosis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/diagnostic-biomarker-problem-amyotrophic-lateral-sclerosis#comments</comments>
</item>
<item>
 <title>Non-coding RNAs and Mitochondrial Dysfunction in Alzheimer&#039;s Disease: A Systematic Review.</title>
 <link>https://www.alzforum.org/papers/non-coding-rnas-and-mitochondrial-dysfunction-alzheimers-disease-systematic-review</link>
 <description>Mol Neurobiol. 2026 Sep 15;63(1)&lt;br&gt;Authors: Mocrei-Rebrean ȘM, Răzniceanu V, Pintilie SR, Berindan-Neagoe I&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42736501&quot;&gt;42736501&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/non-coding-rnas-and-mitochondrial-dysfunction-alzheimers-disease-systematic-review#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/non-coding-rnas-and-mitochondrial-dysfunction-alzheimers-disease-systematic-review#comments</comments>
</item>
<item>
 <title>Conversion between the Brief assessment of Impaired Cognition, Brief Assessment of Impaired Cognition Questionnaire, and Mini-Mental State Examination in a mixed clinical sample.</title>
 <link>https://www.alzforum.org/papers/conversion-between-brief-assessment-impaired-cognition-brief-assessment-impaired-cognition</link>
 <description>Neurol Sci. 2026 Sep 15;47(10)&lt;br&gt;Authors: Jørgensen K, Nielsen TR, Kjaergaard D, Waldorff FB, Nielsen A, Nørgaard A, Salem LC, Langkilde TR, Waldemar G&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42736410&quot;&gt;42736410&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/conversion-between-brief-assessment-impaired-cognition-brief-assessment-impaired-cognition#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/conversion-between-brief-assessment-impaired-cognition-brief-assessment-impaired-cognition#comments</comments>
</item>
<item>
 <title>Characterising the motif composition and allele length distribution of ZFHX3 GGC repeat expansions in amyotrophic lateral sclerosis.</title>
 <link>https://www.alzforum.org/papers/characterising-motif-composition-and-allele-length-distribution-zfhx3-ggc-repeat-expansions</link>
 <description>J Hum Genet. 2026 Sep 15; Epub 2026 Sep 15&lt;br&gt;Authors: Zussa ZN, Smith AN, van Vugt JJ, O&amp;#039;Shaughnessy DS, Grima N, Chan Moi Fat S, Blair IP, Rowe DB, Pamphlett R, Nicholson GA, Kiernan MC, van Rheenen W, Veldink J, Project MinE ALS sequencing consortium, Williams KL, Henden L&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42736322&quot;&gt;42736322&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/characterising-motif-composition-and-allele-length-distribution-zfhx3-ggc-repeat-expansions#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/characterising-motif-composition-and-allele-length-distribution-zfhx3-ggc-repeat-expansions#comments</comments>
</item>
<item>
 <title>Induction of ferroptotic and amyloidogenic signatures linked to Alzheimer&#039;s disease by chemically distinct air pollutants.</title>
 <link>https://www.alzforum.org/papers/induction-ferroptotic-and-amyloidogenic-signatures-linked-alzheimers-disease-chemically-0</link>
 <description>Redox Biol. 2026 Sep 15;97:104390.  Epub 2026 Sep 15&lt;br&gt;Authors: Shkirkova K, Sta Maria NS, Anson H, Aghaei Y, Badami MM, Chakhoyan A, Godoy-Lugo JA, Chung C, Durra S, Tang-Tan A, Zhao L, Demetriou A, Morales M, Daggupati S, Bent I, Park H, Franklin C, Chen S, Chahine G, Dodds-Lewis S, Morishita M, Jacobs RE, Gout JF, Mack WJ, Forman HJ, Benayoun BA, Vermulst M, Cohen MD, Campen M, Sioutas C, Mack WJ, Finch CE, Thorwald MA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42748655&quot;&gt;42748655&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/induction-ferroptotic-and-amyloidogenic-signatures-linked-alzheimers-disease-chemically-0#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/induction-ferroptotic-and-amyloidogenic-signatures-linked-alzheimers-disease-chemically-0#comments</comments>
</item>
<item>
 <title>Capillary blood sampling in neurodegenerative diseases - the future for screening and monitoring brain health?</title>
 <link>https://www.alzforum.org/papers/capillary-blood-sampling-neurodegenerative-diseases-future-screening-and-monitoring-brain</link>
 <description>Expert Rev Neurother. 2026 Sep 15;:1-6.  Epub 2026 Sep 15&lt;br&gt;Authors: Hicks S, Fernandes Gomes B, Heslegrave A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42745552&quot;&gt;42745552&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/capillary-blood-sampling-neurodegenerative-diseases-future-screening-and-monitoring-brain#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/capillary-blood-sampling-neurodegenerative-diseases-future-screening-and-monitoring-brain#comments</comments>
</item>
<item>
 <title>Investigating oral blarcamesine for treatment of early Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/investigating-oral-blarcamesine-treatment-early-alzheimers-disease</link>
 <description>Expert Opin Pharmacother. 2026 Sep 15; Epub 2026 Sep 15&lt;br&gt;Authors: Chandrasekaran A, Paget-Blanc A, Decourt B, Sabbagh MN&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42745524&quot;&gt;42745524&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/investigating-oral-blarcamesine-treatment-early-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/investigating-oral-blarcamesine-treatment-early-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Molecular Binding in Supramolecular Fibrillar Biomolecules.</title>
 <link>https://www.alzforum.org/papers/molecular-binding-supramolecular-fibrillar-biomolecules</link>
 <description>Biophys J. 2026 Sep 15; Epub 2026 Sep 15&lt;br&gt;Authors: Umezaki U, Holladay C, Sonia He ZM, Chakraborty S, Martí AA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42745471&quot;&gt;42745471&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/molecular-binding-supramolecular-fibrillar-biomolecules#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/molecular-binding-supramolecular-fibrillar-biomolecules#comments</comments>
</item>
<item>
 <title>Bioinformatics-driven discovery and cross-cohort validation of a two-gene signature (RPH3A and HIGD1B) associated with Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/bioinformatics-driven-discovery-and-cross-cohort-validation-two-gene-signature-rph3a-and</link>
 <description>Comput Biol Chem. 2026 Sep 15;126(Pt 1):109417.  Epub 2026 Sep 15&lt;br&gt;Authors: Chen F&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42753521&quot;&gt;42753521&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/bioinformatics-driven-discovery-and-cross-cohort-validation-two-gene-signature-rph3a-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/bioinformatics-driven-discovery-and-cross-cohort-validation-two-gene-signature-rph3a-and#comments</comments>
</item>
<item>
 <title>Association of dietary choline intake with cognitive decline and related outcomes: a systematic review and dose-response meta-analysis of observational studies.</title>
 <link>https://www.alzforum.org/papers/association-dietary-choline-intake-cognitive-decline-and-related-outcomes-systematic-review</link>
 <description>Food Funct. 2026 Sep 14; Epub 2026 Sep 14&lt;br&gt;Authors: Feng S, An K, Wang Y, Cheng Z, Ma X, Zhao X, Chen X, Qiao J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42735059&quot;&gt;42735059&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/association-dietary-choline-intake-cognitive-decline-and-related-outcomes-systematic-review#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/association-dietary-choline-intake-cognitive-decline-and-related-outcomes-systematic-review#comments</comments>
</item>
<item>
 <title>Association between cerebrospinal fluid LRRK2 and incident orthostatic hypotension differs by genetic background in Parkinson&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/association-between-cerebrospinal-fluid-lrrk2-and-incident-orthostatic-hypotension-differs</link>
 <description>Acta Neurol Belg. 2026 Sep 14; Epub 2026 Sep 14&lt;br&gt;Authors: Kazemi E&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42734894&quot;&gt;42734894&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/association-between-cerebrospinal-fluid-lrrk2-and-incident-orthostatic-hypotension-differs#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/association-between-cerebrospinal-fluid-lrrk2-and-incident-orthostatic-hypotension-differs#comments</comments>
</item>
<item>
 <title>Optimization and characterization of lipid-based nanocarriers for intranasal delivery in amyotrophic lateral sclerosis.</title>
 <link>https://www.alzforum.org/papers/optimization-and-characterization-lipid-based-nanocarriers-intranasal-delivery-amyotrophic</link>
 <description>Naunyn Schmiedebergs Arch Pharmacol. 2026 Sep 14; Epub 2026 Sep 14&lt;br&gt;Authors: P Padhiyar D, Butani S, Patel RJ&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42734825&quot;&gt;42734825&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/optimization-and-characterization-lipid-based-nanocarriers-intranasal-delivery-amyotrophic#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/optimization-and-characterization-lipid-based-nanocarriers-intranasal-delivery-amyotrophic#comments</comments>
</item>
<item>
 <title>Astrocytes in Neurodegeneration: Spatial States, Crosstalk, and Emerging Therapies.</title>
 <link>https://www.alzforum.org/papers/astrocytes-neurodegeneration-spatial-states-crosstalk-and-emerging-therapies</link>
 <description>Mol Neurobiol. 2026 Sep 14;63(1)&lt;br&gt;Authors: Steger L, Rothhammer V, Zunke F&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42734724&quot;&gt;42734724&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/astrocytes-neurodegeneration-spatial-states-crosstalk-and-emerging-therapies#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/astrocytes-neurodegeneration-spatial-states-crosstalk-and-emerging-therapies#comments</comments>
</item>
<item>
 <title>Autoimmune processes and production of catalytically active antibodies-abzymes in prone to amyotrophic lateral sclerosis FUS(1-359) mice.</title>
 <link>https://www.alzforum.org/papers/autoimmune-processes-and-production-catalytically-active-antibodies-abzymes-prone-amyotrophic</link>
 <description>Inflamm Res. 2026 Sep 14;75(1)&lt;br&gt;Authors: Urusov AE, Gorobets MA, Aulova KS, Timofeeva AM, Toporkova LB, Orlovskaya IA, Ustyugov AA, Nevinsky GA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42734657&quot;&gt;42734657&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/autoimmune-processes-and-production-catalytically-active-antibodies-abzymes-prone-amyotrophic#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/autoimmune-processes-and-production-catalytically-active-antibodies-abzymes-prone-amyotrophic#comments</comments>
</item>
<item>
 <title>Correction to &quot;Molecular Mechanism of Beta-Amyloid Aggregation Inhibition by KLVFF&quot;.</title>
 <link>https://www.alzforum.org/papers/correction-molecular-mechanism-beta-amyloid-aggregation-inhibition-klvff</link>
 <description>J Chem Inf Model. 2026 Sep 14;66(17):11542. &lt;br&gt;Authors: Cobos-Montes K, Fuentes SE, Estuardo F, Cárdenas C, Guzmán F, Santana P, Gavilán J, Figueroa M, Fuentealba J, Jiménez VA, Ramírez D&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42734566&quot;&gt;42734566&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/correction-molecular-mechanism-beta-amyloid-aggregation-inhibition-klvff#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/correction-molecular-mechanism-beta-amyloid-aggregation-inhibition-klvff#comments</comments>
</item>
<item>
 <title>Structural Hierarchy and Maturation of Amyloid Fibrils Revealed by Interface Descriptor Analysis.</title>
 <link>https://www.alzforum.org/papers/structural-hierarchy-and-maturation-amyloid-fibrils-revealed-interface-descriptor-analysis</link>
 <description>J Chem Inf Model. 2026 Sep 14;66(17):11471-11490. &lt;br&gt;Authors: Sulyok-Eiler M, Harmat V, Perczel A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42734527&quot;&gt;42734527&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/structural-hierarchy-and-maturation-amyloid-fibrils-revealed-interface-descriptor-analysis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/structural-hierarchy-and-maturation-amyloid-fibrils-revealed-interface-descriptor-analysis#comments</comments>
</item>
<item>
 <title>Hyperactive KIF5A in Neurodegeneration.</title>
 <link>https://www.alzforum.org/papers/hyperactive-kif5a-neurodegeneration</link>
 <description>Cytoskeleton (Hoboken). 2026 Sep 14;:e70204.  Epub 2026 Sep 14&lt;br&gt;Authors: Villarroel-Campos D, Sleigh JN&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42734068&quot;&gt;42734068&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/hyperactive-kif5a-neurodegeneration#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/hyperactive-kif5a-neurodegeneration#comments</comments>
</item>
<item>
 <title>Medial Temporal Atrophy and Posterior Cingulate Structural Covariance in Mild Cognitive Impairment.</title>
 <link>https://www.alzforum.org/papers/medial-temporal-atrophy-and-posterior-cingulate-structural-covariance-mild-cognitive</link>
 <description>Int J Neurosci. 2026 Sep 14;:1-23.  Epub 2026 Sep 14&lt;br&gt;Authors: Yang X, Lyu J, Wang J, Quan Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42733346&quot;&gt;42733346&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/medial-temporal-atrophy-and-posterior-cingulate-structural-covariance-mild-cognitive#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/medial-temporal-atrophy-and-posterior-cingulate-structural-covariance-mild-cognitive#comments</comments>
</item>
<item>
 <title>Circulating Metabolite Signatures Associated With Amyloid Positivity, Cognitive Performance and Plasma P-tau181 Levels in Cognitively Unimpaired Older Adults.</title>
 <link>https://www.alzforum.org/papers/circulating-metabolite-signatures-associated-amyloid-positivity-cognitive-performance-and</link>
 <description>Mol Neurobiol. 2026 Sep 14;63(1)&lt;br&gt;Authors: Sharmin T, Doecke JD, Chatterjee P, Sohrabi HR, Zetterberg H, Ashton NJ, Garg ML, Blennow K, Martins RN&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42733048&quot;&gt;42733048&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/circulating-metabolite-signatures-associated-amyloid-positivity-cognitive-performance-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/circulating-metabolite-signatures-associated-amyloid-positivity-cognitive-performance-and#comments</comments>
</item>
<item>
 <title>Microglia Ablation and Downstream Effects in the Cerebrospinal Fluid Proteome.</title>
 <link>https://www.alzforum.org/papers/microglia-ablation-and-downstream-effects-cerebrospinal-fluid-proteome</link>
 <description>Proteomics. 2026 Sep 14;:e70178.  Epub 2026 Sep 14&lt;br&gt;Authors: Buchner S, Song S, Müller SA, Chen Y, Parhizkar S, Lichtenthaler SF, Holtzman DM, Jucker M, Kaeser SA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42740399&quot;&gt;42740399&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/microglia-ablation-and-downstream-effects-cerebrospinal-fluid-proteome#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/microglia-ablation-and-downstream-effects-cerebrospinal-fluid-proteome#comments</comments>
</item>
<item>
 <title>Cerebral perfusion correlates of domain-specific cognitive function in Alzheimer&#039;s disease and dementia with Lewy bodies.</title>
 <link>https://www.alzforum.org/papers/cerebral-perfusion-correlates-domain-specific-cognitive-function-alzheimers-disease-and</link>
 <description>J Alzheimers Dis. 2026 Sep 14;:13872877261482134.  Epub 2026 Sep 14&lt;br&gt;Authors: Koizumi Y, Nakano Y, Tamura M, Yamagishi K, Suzuki Y, Izumi M, Chishiki Y, Osawa K, Furukawa S, Ishikawa A, Kitayama Y, Horikoshi T, Uno T, Mori M, Kuwabara S, Hirano S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42736636&quot;&gt;42736636&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/cerebral-perfusion-correlates-domain-specific-cognitive-function-alzheimers-disease-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/cerebral-perfusion-correlates-domain-specific-cognitive-function-alzheimers-disease-and#comments</comments>
</item>
<item>
 <title>APOE:RAAS epistasis as a population specific risk factor for cognitive impairment and cardiovascular health.</title>
 <link>https://www.alzforum.org/papers/apoeraas-epistasis-population-specific-risk-factor-cognitive-impairment-and-cardiovascular</link>
 <description>J Alzheimers Dis. 2026 Sep 14;:13872877261484965.  Epub 2026 Sep 14&lt;br&gt;Authors: Tucker AE, Barber RC, Zhou Z, Jones HP, Phillips NR&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42736635&quot;&gt;42736635&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/apoeraas-epistasis-population-specific-risk-factor-cognitive-impairment-and-cardiovascular#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/apoeraas-epistasis-population-specific-risk-factor-cognitive-impairment-and-cardiovascular#comments</comments>
</item>
<item>
 <title>APOE-stratified genome-wide association analyses provide insights into the genetic etiology of Alzheimers&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/apoe-stratified-genome-wide-association-analyses-provide-insights-genetic-etiology</link>
 <description>Nat Genet. 2026 Sep 14; Epub 2026 Sep 14&lt;br&gt;Authors: Thomassen JQ, Leonard H, Ulms B, Grenier-Boley B, Heikkinen S, Garcia-González P, Castillo-Morales A, Kikuchi M, Gim J, Cao H, Küçükali F, Amin N, Yoon D, de Rojas I, Alvarez Jerez P, Alvarez V, Arosio B, Bellenguez C, Bergh S, Billingsley K, Blauwendraat C, Boada M, Borroni B, Bossù P, Bullido MJ, Daniele A, Carracedo Á, de Mendonça A, Cookson M, Deckert J, Dichgans M, Djurovic S, Dols-Icardo O, Dufouil C, Düzel E, Escott-Price V, Fladby T, Fratiglioni L, Fu AK, Galimberti D, García-Alberca JM, Giedraitis V, Garcia-Ribas G, Graff C, Grimmer T, Grünblatt E, Hanon O, Hausner L, Heilmann-Heimbach S, Hort J, Jessen F, Jensen K, Jonson C, Kim Y, Kuznetsov N, Leinonen V, Lipponen A, Luo J, Makarious M, Martiskainen H, Masullo C, Mecocci P, Mehrabian S, Mir P, Miyashita A, Moebus S, Mok KY, Molina Porcel L, Moreno F, Nacmias B, Parnetti L, Pastor P, Pérez-Tur J, Peters O, Pijnenburg YA, Piñol-Ripoll G, Popp J, Rainero I, Real LM, Riedel-Heller S, Rodriguez-Rodriguez E, Rongve A, Rossi G, Royo JL, Rujescu D, Saltvedt I, Sáez ME, Sánchez-Valle R, Sanchez-Garcia F, Sandau N, Scarmeas N, Scheffler K, Scherbaum N, Schneider A, Selbæk G, Seripa D, Solfrizzi V, Spallazzi M, Squassina A, Stordal E, Tesi N, Tremolizzo L, Tripathi KP, van der Flier WM, Williams J, Wiltfang J, Aarsland D, Singleton AB, Amouyel P, Debette S, Tsolaki M, Nicolas G, van der Lee S, Holstege H, Fernandez MV, Kehoe PG, Sleegers K, Ingelsson M, Ghidoni R, Andreassen OA, Holmans PA, Sánchez-Juan P, Sims R, Ip NY, Lee KH, Ikeuchi T, Ramirez A, Ruiz A, Hiltunen M, Lambert JC, van Duijn C, Nalls M, Frikke-Schmidt R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42736378&quot;&gt;42736378&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/apoe-stratified-genome-wide-association-analyses-provide-insights-genetic-etiology#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/apoe-stratified-genome-wide-association-analyses-provide-insights-genetic-etiology#comments</comments>
</item>
<item>
 <title>Triptolide preserves cognitive function and reduces hippocampal inflammation in a mouse model of Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/triptolide-preserves-cognitive-function-and-reduces-hippocampal-inflammation-mouse-model</link>
 <description>Mol Cell Neurosci. 2026 Sep 14;:104126.  Epub 2026 Sep 14&lt;br&gt;Authors: Ma X, Li W, Ma Y, Ma W, Han Z&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42735882&quot;&gt;42735882&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/triptolide-preserves-cognitive-function-and-reduces-hippocampal-inflammation-mouse-model#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/triptolide-preserves-cognitive-function-and-reduces-hippocampal-inflammation-mouse-model#comments</comments>
</item>
<item>
 <title>Gut microbiota dysregulation in dementia: Molecular mechanism linking the gut-brain axis to neurodegeneration.</title>
 <link>https://www.alzforum.org/papers/gut-microbiota-dysregulation-dementia-molecular-mechanism-linking-gut-brain-axis</link>
 <description>Ageing Res Rev. 2026 Sep 14;122:103373.  Epub 2026 Sep 14&lt;br&gt;Authors: Bhamare JS, Jha P, Chintamaneni M, Kaur G&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42735872&quot;&gt;42735872&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/gut-microbiota-dysregulation-dementia-molecular-mechanism-linking-gut-brain-axis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/gut-microbiota-dysregulation-dementia-molecular-mechanism-linking-gut-brain-axis#comments</comments>
</item>
<item>
 <title>Integrated proteomics and network pharmacology reveal autophagy-lysosomal regulation underlying sulforaphane-mediated neuroprotection in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/integrated-proteomics-and-network-pharmacology-reveal-autophagy-lysosomal-regulation</link>
 <description>Brain Res. 2026 Sep 14;1892:150549.  Epub 2026 Sep 14&lt;br&gt;Authors: Li Y, Lu C, Liu N, Wang X, Li S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42735792&quot;&gt;42735792&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/integrated-proteomics-and-network-pharmacology-reveal-autophagy-lysosomal-regulation#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/integrated-proteomics-and-network-pharmacology-reveal-autophagy-lysosomal-regulation#comments</comments>
</item>
<item>
 <title>DNA methylation changes associated with Parkinson&#039;s disease in SNCA.</title>
 <link>https://www.alzforum.org/papers/dna-methylation-changes-associated-parkinsons-disease-snca</link>
 <description>Neuroscience. 2026 Sep 14; Epub 2026 Sep 14&lt;br&gt;Authors: Ntuli A, Jughoo C, Mpofana T, Lazarus L&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42735781&quot;&gt;42735781&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/dna-methylation-changes-associated-parkinsons-disease-snca#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/dna-methylation-changes-associated-parkinsons-disease-snca#comments</comments>
</item>
<item>
 <title>N-of-1 investigational study of a novel antisense oligonucleotide drug in CHCHD10-related ALS shows early signs of efficacy.</title>
 <link>https://www.alzforum.org/papers/n-1-investigational-study-novel-antisense-oligonucleotide-drug-chchd10-related-als-shows</link>
 <description>Med. 2026 Sep 14;:101295.  Epub 2026 Sep 14&lt;br&gt;Authors: Cousin MA, Dagli AI, Mignon L, Shah JS, Prudencio M, Gendron TF, Jain A, Udine E, van Blitterswijk M, Middlebrooks EH, Donahue MH, Dagher JE, Watzlawik JO, Springer W, Parekh T, McEachin ZT, Petrucelli L, Oskarsson B&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42735682&quot;&gt;42735682&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/n-1-investigational-study-novel-antisense-oligonucleotide-drug-chchd10-related-als-shows#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/n-1-investigational-study-novel-antisense-oligonucleotide-drug-chchd10-related-als-shows#comments</comments>
</item>
<item>
 <title>Enhancing Alzheimer&#039;s disease diagnosis in primary care through targeted screening of people at risk of developing dementia - study design and feasibility assessment of the PREDEM primary care study.</title>
 <link>https://www.alzforum.org/papers/enhancing-alzheimers-disease-diagnosis-primary-care-through-targeted-screening-people-risk</link>
 <description>Alzheimers Res Ther. 2026 Sep 14;18(1)&lt;br&gt;Authors: Aye S, Åhrberg S, Carlsson AC, Hasselström J, Alshamani I, Wallen S, van den Hurk W, Lund L, Jejcic A, Broome ST, Duran Sidera A, Tjernberg L, Jönsson L, Schedin-Weiss S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42745326&quot;&gt;42745326&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/enhancing-alzheimers-disease-diagnosis-primary-care-through-targeted-screening-people-risk#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/enhancing-alzheimers-disease-diagnosis-primary-care-through-targeted-screening-people-risk#comments</comments>
</item>
<item>
 <title>Dysregulated TIE-2 expression in Alzheimer&#039;s disease: Further considerations on regional specificity and shedding evidence.</title>
 <link>https://www.alzforum.org/papers/dysregulated-tie-2-expression-alzheimers-disease-further-considerations-regional-specificity</link>
 <description>Brain Pathol. 2026 Sep 13;:e70151.  Epub 2026 Sep 13&lt;br&gt;Authors: Zhang SQ, Liu M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42733001&quot;&gt;42733001&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/dysregulated-tie-2-expression-alzheimers-disease-further-considerations-regional-specificity#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/dysregulated-tie-2-expression-alzheimers-disease-further-considerations-regional-specificity#comments</comments>
</item>
<item>
 <title>Hearing Loss Is Associated With Regional Brain Amyloid in a Late Middle-Aged Cohort.</title>
 <link>https://www.alzforum.org/papers/hearing-loss-associated-regional-brain-amyloid-late-middle-aged-cohort</link>
 <description>Laryngoscope. 2026 Sep 13; Epub 2026 Sep 13&lt;br&gt;Authors: Powell SD, Weinstein HN, Aziz F, Brickman AM, Lao PJ, Eckert MA, Luchsinger JA, Golub JS&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42732997&quot;&gt;42732997&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/hearing-loss-associated-regional-brain-amyloid-late-middle-aged-cohort#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/hearing-loss-associated-regional-brain-amyloid-late-middle-aged-cohort#comments</comments>
</item>
<item>
 <title>Matrix metalloproteinase-9 is associated with CX3CL1 on tau and amyloid biomarker pathways in APOE4 carriers.</title>
 <link>https://www.alzforum.org/papers/matrix-metalloproteinase-9-associated-cx3cl1-tau-and-amyloid-biomarker-pathways-apoe4</link>
 <description>Neurobiol Dis. 2026 Sep 13;229:107605.  Epub 2026 Sep 13&lt;br&gt;Authors: Johnson AK, Van Hulle CA, Zylstra H, Cronin K, Johnson K, Rivera-Rivera L, Chappell R, Wilson R, Kac PR, Gleason CE, Zetterberg H, Johnson SC, Auger AP, Carlsson CM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42732855&quot;&gt;42732855&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/matrix-metalloproteinase-9-associated-cx3cl1-tau-and-amyloid-biomarker-pathways-apoe4#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/matrix-metalloproteinase-9-associated-cx3cl1-tau-and-amyloid-biomarker-pathways-apoe4#comments</comments>
</item>
<item>
 <title>Nrf2 overexpression ameliorates cognitive deficits and neuronal damage in APP/PS1 mice via attenuation of Aβ deposition and neuronal ferroptosis.</title>
 <link>https://www.alzforum.org/papers/nrf2-overexpression-ameliorates-cognitive-deficits-and-neuronal-damage-appps1-mice</link>
 <description>Neurosci Lett. 2026 Sep 13;887:138733.  Epub 2026 Sep 13&lt;br&gt;Authors: Zhu X, Bo J, Qian Y, Diao F, Liang H, Fan L, Su Y, Li W&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42732850&quot;&gt;42732850&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/nrf2-overexpression-ameliorates-cognitive-deficits-and-neuronal-damage-appps1-mice#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/nrf2-overexpression-ameliorates-cognitive-deficits-and-neuronal-damage-appps1-mice#comments</comments>
</item>
<item>
 <title>Artificial Intelligence-Related Voice and Speech Biomarkers of Alzheimer&#039;s Disease: A Systematic Review.</title>
 <link>https://www.alzforum.org/papers/artificial-intelligence-related-voice-and-speech-biomarkers-alzheimers-disease-systematic</link>
 <description>J Voice. 2026 Sep 12; Epub 2026 Sep 12&lt;br&gt;Authors: Mairesse S, Briganti G, Lechien JR&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42731970&quot;&gt;42731970&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/artificial-intelligence-related-voice-and-speech-biomarkers-alzheimers-disease-systematic#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/artificial-intelligence-related-voice-and-speech-biomarkers-alzheimers-disease-systematic#comments</comments>
</item>
<item>
 <title>Clinical efficacy of non-pharmacological interventions on cognitive improvement in patients with mild to moderate Alzheimer&#039;s disease: A systematic review and Bayesian network meta-analysis.</title>
 <link>https://www.alzforum.org/papers/clinical-efficacy-non-pharmacological-interventions-cognitive-improvement-patients-mild</link>
 <description>J Alzheimers Dis. 2026 Sep 12;:13872877261485496.  Epub 2026 Sep 12&lt;br&gt;Authors: Cui T, Han X, Yao Q, Xu C, Shan A, Wang X, Li S, Luan H, Wen B, Chen R, Guo J, Lian Q, Li C, Sun Y, Lv S, Wei C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42731086&quot;&gt;42731086&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/clinical-efficacy-non-pharmacological-interventions-cognitive-improvement-patients-mild#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/clinical-efficacy-non-pharmacological-interventions-cognitive-improvement-patients-mild#comments</comments>
</item>
<item>
 <title>Exploring TIMP2 genetics and CSF levels in Parkinson&#039;s disease: biomarkers of neurodegeneration and ageing.</title>
 <link>https://www.alzforum.org/papers/exploring-timp2-genetics-and-csf-levels-parkinsons-disease-biomarkers-neurodegeneration-and</link>
 <description>Geroscience. 2026 Sep 12; Epub 2026 Sep 12&lt;br&gt;Authors: Zimmermann M, Fandrich M, Schulte C, Jakobi M, Wurster I, Lerche S, Zimmermann S, Deuschle C, Schneiderhan-Marra N, Joos TO, Gasser T, Brockmann K, Roeben B&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42730910&quot;&gt;42730910&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/exploring-timp2-genetics-and-csf-levels-parkinsons-disease-biomarkers-neurodegeneration-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/exploring-timp2-genetics-and-csf-levels-parkinsons-disease-biomarkers-neurodegeneration-and#comments</comments>
</item>
<item>
 <title>Correction to: Resveratrol and neuroprotection: an insight into prospective therapeutic approaches against Alzheimer&#039;s disease from bench to bedside.</title>
 <link>https://www.alzforum.org/papers/correction-resveratrol-and-neuroprotection-insight-prospective-therapeutic-approaches-against</link>
 <description>Mol Neurobiol. 2026 Sep 12;63(1)&lt;br&gt;Authors: Islam F, Nafady MH, Islam MR, Saha S, Rashid S, Akter A, Harun-Or-Rashid M, Akhtar MF, Perveen A, Ashraf GM, Rahman MH, Sweilam SH&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42730894&quot;&gt;42730894&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/correction-resveratrol-and-neuroprotection-insight-prospective-therapeutic-approaches-against#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/correction-resveratrol-and-neuroprotection-insight-prospective-therapeutic-approaches-against#comments</comments>
</item>
<item>
 <title>Dihydromyricetin ameliorates cognitive dysfunction in SAMP8 mice via autophagy-mediated degradation of the NLRP3 inflammasome.</title>
 <link>https://www.alzforum.org/papers/dihydromyricetin-ameliorates-cognitive-dysfunction-samp8-mice-autophagy-mediated-degradation</link>
 <description>Metab Brain Dis. 2026 Sep 12;41(1)&lt;br&gt;Authors: Liu XR, Zhang M, Chen DD, Chang JR, Kou XJ&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42730882&quot;&gt;42730882&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/dihydromyricetin-ameliorates-cognitive-dysfunction-samp8-mice-autophagy-mediated-degradation#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/dihydromyricetin-ameliorates-cognitive-dysfunction-samp8-mice-autophagy-mediated-degradation#comments</comments>
</item>
<item>
 <title>Genetics of α-Synuclein: The Prime Pathological Player of Parkinson&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/genetics-synuclein-prime-pathological-player-parkinsons-disease</link>
 <description>Neurotox Res. 2026 Sep 12;44(5)&lt;br&gt;Authors: Sarhadi TR, Joshi N, Raveendran A, Panse JS, Nagotu S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42730873&quot;&gt;42730873&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/genetics-synuclein-prime-pathological-player-parkinsons-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/genetics-synuclein-prime-pathological-player-parkinsons-disease#comments</comments>
</item>
<item>
 <title>Progressive micrographia in Parkinson&#039;s disease is associated with multidimensional cognitive and motor features.</title>
 <link>https://www.alzforum.org/papers/progressive-micrographia-parkinsons-disease-associated-multidimensional-cognitive-and-motor</link>
 <description>J Neural Transm (Vienna). 2026 Sep 12; Epub 2026 Sep 12&lt;br&gt;Authors: Hamada H, Mikami K, Itaguchi Y, Yoshida K, Yamashita A, An Q&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42730821&quot;&gt;42730821&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/progressive-micrographia-parkinsons-disease-associated-multidimensional-cognitive-and-motor#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/progressive-micrographia-parkinsons-disease-associated-multidimensional-cognitive-and-motor#comments</comments>
</item>
<item>
 <title>One-week changes on the Independent Living Scales in older adults: Proof of concept for quantifying subtle functional decline.</title>
 <link>https://www.alzforum.org/papers/one-week-changes-independent-living-scales-older-adults-proof-concept-quantifying-subtle</link>
 <description>Clin Neuropsychol. 2026 Sep 12;:1-15.  Epub 2026 Sep 12&lt;br&gt;Authors: Kannan L, Duff K&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42730711&quot;&gt;42730711&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/one-week-changes-independent-living-scales-older-adults-proof-concept-quantifying-subtle#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/one-week-changes-independent-living-scales-older-adults-proof-concept-quantifying-subtle#comments</comments>
</item>
<item>
 <title>Microbiome-gut-brain axis modulation for the management of Parkinson&#039;s disease: Emerging mechanisms and translational insights.</title>
 <link>https://www.alzforum.org/papers/microbiome-gut-brain-axis-modulation-management-parkinsons-disease-emerging-mechanisms-and</link>
 <description>J Neuroimmunol. 2026 Sep 12;421:579099.  Epub 2026 Sep 12&lt;br&gt;Authors: Porwal M, Malviya R, Chandra P, Sridhar SB, Shareef J, Wadhwa T, Tripathy DB, Arockiam D&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42732715&quot;&gt;42732715&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/microbiome-gut-brain-axis-modulation-management-parkinsons-disease-emerging-mechanisms-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/microbiome-gut-brain-axis-modulation-management-parkinsons-disease-emerging-mechanisms-and#comments</comments>
</item>
<item>
 <title>The method matters: free water imaging in Parkinson&#039;s disease is not a binary verdict.</title>
 <link>https://www.alzforum.org/papers/method-matters-free-water-imaging-parkinsons-disease-not-binary-verdict</link>
 <description>NPJ Parkinsons Dis. 2026 Sep 12;12(1)&lt;br&gt;Authors: Martinez-Nunez AE, Barmpoutis A, Okun MS, Vaillancourt D&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42731990&quot;&gt;42731990&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/method-matters-free-water-imaging-parkinsons-disease-not-binary-verdict#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/method-matters-free-water-imaging-parkinsons-disease-not-binary-verdict#comments</comments>
</item>
<item>
 <title>Reply to &#039;The method matters: free water imaging in Parkinson&#039;s disease is not a binary verdict&#039;.</title>
 <link>https://www.alzforum.org/papers/reply-method-matters-free-water-imaging-parkinsons-disease-not-binary-verdict</link>
 <description>NPJ Parkinsons Dis. 2026 Sep 12;12(1)&lt;br&gt;Authors: Roh YH, Youn J, Kim SY, Heo H, Song S, Sohn B&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42731984&quot;&gt;42731984&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/reply-method-matters-free-water-imaging-parkinsons-disease-not-binary-verdict#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/reply-method-matters-free-water-imaging-parkinsons-disease-not-binary-verdict#comments</comments>
</item>
<item>
 <title>[Effect of moxibustion-induced deqi on hippocampal autophagy function in APPswe/PSEN1dE9 transgenic Alzheimer&#039;s disease mice].</title>
 <link>https://www.alzforum.org/papers/effect-moxibustion-induced-deqi-hippocampal-autophagy-function-appswepsen1de9-transgenic</link>
 <description>Zhongguo Zhen Jiu. 2026 Sep 12;46(9):1465-1472.  Epub 2026 May 21&lt;br&gt;Authors: Lv Z, Xie D, Li H, Chen C, Chen R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42744633&quot;&gt;42744633&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/effect-moxibustion-induced-deqi-hippocampal-autophagy-function-appswepsen1de9-transgenic#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/effect-moxibustion-induced-deqi-hippocampal-autophagy-function-appswepsen1de9-transgenic#comments</comments>
</item>
<item>
 <title>The role of gender in informant reports of cognitive decline in the United States and Mexico.</title>
 <link>https://www.alzforum.org/papers/role-gender-informant-reports-cognitive-decline-united-states-and-mexico</link>
 <description>J Gerontol B Psychol Sci Soc Sci. 2026 Sep 12; Epub 2026 Sep 12&lt;br&gt;Authors: Cantu PA, Zhang Y, Saenz J, Wong R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42742165&quot;&gt;42742165&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/role-gender-informant-reports-cognitive-decline-united-states-and-mexico#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/role-gender-informant-reports-cognitive-decline-united-states-and-mexico#comments</comments>
</item>
<item>
 <title>Disrupted interhemispheric communication in primary progressive aphasia: a multimodal MRI study of homotopic connectivity.</title>
 <link>https://www.alzforum.org/papers/disrupted-interhemispheric-communication-primary-progressive-aphasia-multimodal-mri-study</link>
 <description>Neuroimage Clin. 2026 Sep 12;52:104061.  Epub 2026 Sep 12&lt;br&gt;Authors: Tao Y, Tsapkini K, Rapp B&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42753639&quot;&gt;42753639&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/disrupted-interhemispheric-communication-primary-progressive-aphasia-multimodal-mri-study#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/disrupted-interhemispheric-communication-primary-progressive-aphasia-multimodal-mri-study#comments</comments>
</item>
<item>
 <title>Exploring the toxicological impact of BDE-209 on neurodegenerative diseases through network toxicology, molecular docking, molecular dynamics simulation and in-vitro study.</title>
 <link>https://www.alzforum.org/papers/exploring-toxicological-impact-bde-209-neurodegenerative-diseases-through-network-toxicology</link>
 <description>Toxicol Appl Pharmacol. 2026 Sep 11;516:118034.  Epub 2026 Sep 11&lt;br&gt;Authors: Li X, Zhang S, Liu Y, Yu X, Han L, Liu Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42727824&quot;&gt;42727824&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/exploring-toxicological-impact-bde-209-neurodegenerative-diseases-through-network-toxicology#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/exploring-toxicological-impact-bde-209-neurodegenerative-diseases-through-network-toxicology#comments</comments>
</item>
<item>
 <title>Midbrain organoids as next-generation models for Parkinson&#039;s disease: From pathogenesis to therapeutic discovery.</title>
 <link>https://www.alzforum.org/papers/midbrain-organoids-next-generation-models-parkinsons-disease-pathogenesis-therapeutic</link>
 <description>Exp Neurol. 2026 Sep 11;407:116022.  Epub 2026 Sep 11&lt;br&gt;Authors: Jiang DY, Yao SY, Du MQ, Lin LX, Kang XH, Peng Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42727800&quot;&gt;42727800&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/midbrain-organoids-next-generation-models-parkinsons-disease-pathogenesis-therapeutic#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/midbrain-organoids-next-generation-models-parkinsons-disease-pathogenesis-therapeutic#comments</comments>
</item>
<item>
 <title>ROS-xCT metabolic coupling defines an astrocyte subtype that drives glutamate excitotoxicity during Alzheimer&#039;s disease progression.</title>
 <link>https://www.alzforum.org/papers/ros-xct-metabolic-coupling-defines-astrocyte-subtype-drives-glutamate-excitotoxicity-during</link>
 <description>Life Sci. 2026 Sep 11;405:124679.  Epub 2026 Sep 11&lt;br&gt;Authors: Xie X, Liu W, Chen L, Chen J, Jiang Y, Liu Q, Chen S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42727766&quot;&gt;42727766&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/ros-xct-metabolic-coupling-defines-astrocyte-subtype-drives-glutamate-excitotoxicity-during#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/ros-xct-metabolic-coupling-defines-astrocyte-subtype-drives-glutamate-excitotoxicity-during#comments</comments>
</item>
<item>
 <title>Selective neuroprotection in the ALS-FTD spectrum: Mechanisms of neuronal resilience and translational perspectives.</title>
 <link>https://www.alzforum.org/papers/selective-neuroprotection-als-ftd-spectrum-mechanisms-neuronal-resilience-and-translational</link>
 <description>Brain Res Bull. 2026 Sep 11;245:112111.  Epub 2026 Sep 11&lt;br&gt;Authors: Inoue Y, Tanaka M, Oguchi T, Sasaki A, Saito K, Inoue A, Otsuka N&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42727710&quot;&gt;42727710&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/selective-neuroprotection-als-ftd-spectrum-mechanisms-neuronal-resilience-and-translational#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/selective-neuroprotection-als-ftd-spectrum-mechanisms-neuronal-resilience-and-translational#comments</comments>
</item>
<item>
 <title>Olfactory bulb-initiated α-synucleinopathy induces visual abnormalities via remote occipital network dysfunction.</title>
 <link>https://www.alzforum.org/papers/olfactory-bulb-initiated-synucleinopathy-induces-visual-abnormalities-remote-occipital</link>
 <description>Neurosci Res. 2026 Sep 11;:105118.  Epub 2026 Sep 11&lt;br&gt;Authors: Amakusa Y, Takeuchi RF, Ito H, Iguchi Y, Ohba A, Kobayashi K, Yokoi S, Hamaguchi T, Hirunagi T, Sahashi K, Yamaguchi H, Osakada F, Katsuno M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42727708&quot;&gt;42727708&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/olfactory-bulb-initiated-synucleinopathy-induces-visual-abnormalities-remote-occipital#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/olfactory-bulb-initiated-synucleinopathy-induces-visual-abnormalities-remote-occipital#comments</comments>
</item>
<item>
 <title>Predicting conversion from mild cognitive impairment to Alzheimer&#039;s disease: A systematic review of deep learning models for early-stage disease classification.</title>
 <link>https://www.alzforum.org/papers/predicting-conversion-mild-cognitive-impairment-alzheimers-disease-systematic-review-deep</link>
 <description>Ageing Res Rev. 2026 Sep 11;122:103372.  Epub 2026 Sep 11&lt;br&gt;Authors: Ghasabi M, Aghdasi H, Feizi-Derakhshi MR&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42727648&quot;&gt;42727648&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/predicting-conversion-mild-cognitive-impairment-alzheimers-disease-systematic-review-deep#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/predicting-conversion-mild-cognitive-impairment-alzheimers-disease-systematic-review-deep#comments</comments>
</item>
<item>
 <title>Aerobic exercise and the gut-brain axis in Alzheimer&#039;s disease: Mechanistic perspectives, evidence appraisal, and future directions.</title>
 <link>https://www.alzforum.org/papers/aerobic-exercise-and-gut-brain-axis-alzheimers-disease-mechanistic-perspectives-evidence</link>
 <description>Ageing Res Rev. 2026 Sep 11;122:103347.  Epub 2026 Sep 11&lt;br&gt;Authors: Wu J, Zhong Z, Sun Z, Yuan S, Qiu L&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42727647&quot;&gt;42727647&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/aerobic-exercise-and-gut-brain-axis-alzheimers-disease-mechanistic-perspectives-evidence#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/aerobic-exercise-and-gut-brain-axis-alzheimers-disease-mechanistic-perspectives-evidence#comments</comments>
</item>
<item>
 <title>Evidence for similar enzymatic but different cellular generation of pE79-modified α-synuclein in PD and AD mouse models.</title>
 <link>https://www.alzforum.org/papers/evidence-similar-enzymatic-different-cellular-generation-pe79-modified-synuclein-pd-and-ad</link>
 <description>Neurochem Int. 2026 Sep 11;200:106260.  Epub 2026 Sep 11&lt;br&gt;Authors: Bluhm A, Großmann M, Minister C, Schrempel S, Joseph MA, Holzer M, Sauter C, Xiang W, Feja M, Schilling S, Schulze A, Richter F, Hartlage-Rübsamen M, Roßner S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42727643&quot;&gt;42727643&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/evidence-similar-enzymatic-different-cellular-generation-pe79-modified-synuclein-pd-and-ad#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/evidence-similar-enzymatic-different-cellular-generation-pe79-modified-synuclein-pd-and-ad#comments</comments>
</item>
<item>
 <title>The path to treating multiple-etiology dementia: Combining vascular risk control and disease-modifying neurodegenerative therapies.</title>
 <link>https://www.alzforum.org/papers/path-treating-multiple-etiology-dementia-combining-vascular-risk-control-and-disease</link>
 <description>Neurotherapeutics. 2026 Sep 11;23(6):e01068.  Epub 2026 Sep 11&lt;br&gt;Authors: de Havenon A, Sheth KN, Fredericks CA, Brickman AM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42727484&quot;&gt;42727484&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/path-treating-multiple-etiology-dementia-combining-vascular-risk-control-and-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/path-treating-multiple-etiology-dementia-combining-vascular-risk-control-and-disease#comments</comments>
</item>
<item>
 <title>Association of Herpes Simplex Virus Type-1 With Dementia Outcomes: Longitudinal Retrospective Cohort Study Using Real-World Electronic Health Record Data.</title>
 <link>https://www.alzforum.org/papers/association-herpes-simplex-virus-type-1-dementia-outcomes-longitudinal-retrospective-cohort</link>
 <description>JMIR Form Res. 2026 Sep 11;10:e83028. &lt;br&gt;Authors: Islam MM, Foraker R, Hossain MS, Arnold WD, Dandachi D, Mosa AS&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42727071&quot;&gt;42727071&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/association-herpes-simplex-virus-type-1-dementia-outcomes-longitudinal-retrospective-cohort#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/association-herpes-simplex-virus-type-1-dementia-outcomes-longitudinal-retrospective-cohort#comments</comments>
</item>
<item>
 <title>Treating depression predicts cognitive improvement in Mild Cognitive Impairment: a 1-year prospective cohort study.</title>
 <link>https://www.alzforum.org/papers/treating-depression-predicts-cognitive-improvement-mild-cognitive-impairment-1-year</link>
 <description>Aging Ment Health. 2026 Sep 11;:1-9.  Epub 2026 Sep 11&lt;br&gt;Authors: Baldini V, Martinelli G, De Ronchi D, Macchiarulo M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42726936&quot;&gt;42726936&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/treating-depression-predicts-cognitive-improvement-mild-cognitive-impairment-1-year#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/treating-depression-predicts-cognitive-improvement-mild-cognitive-impairment-1-year#comments</comments>
</item>
<item>
 <title>Limited Early-Life Sugar Intake Linked to Lower Dementia Risk.</title>
 <link>https://www.alzforum.org/papers/limited-early-life-sugar-intake-linked-lower-dementia-risk</link>
 <description>JAMA. 2026 Sep 11; Epub 2026 Sep 11&lt;br&gt;Authors: Bock A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42726499&quot;&gt;42726499&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/limited-early-life-sugar-intake-linked-lower-dementia-risk#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/limited-early-life-sugar-intake-linked-lower-dementia-risk#comments</comments>
</item>
<item>
 <title>Changes in sleep characteristics in Parkinson&#039;s disease: a prospective 5-year follow-up study.</title>
 <link>https://www.alzforum.org/papers/changes-sleep-characteristics-parkinsons-disease-prospective-5-year-follow-study</link>
 <description>J Clin Sleep Med. 2026 Sep 11;22(1)&lt;br&gt;Authors: Partinen E, Ylikoski A, Hublin C, Partinen M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42726411&quot;&gt;42726411&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/changes-sleep-characteristics-parkinsons-disease-prospective-5-year-follow-study#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/changes-sleep-characteristics-parkinsons-disease-prospective-5-year-follow-study#comments</comments>
</item>
<item>
 <title>The Senescent Phenotype of Cultured Hypothalamic Astrocytes from Rats with Streptozotocin-Induced Dementia.</title>
 <link>https://www.alzforum.org/papers/senescent-phenotype-cultured-hypothalamic-astrocytes-rats-streptozotocin-induced-dementia</link>
 <description>Neurochem Res. 2026 Sep 11;51(5)&lt;br&gt;Authors: Da Silva VF, da Costa DS, Gayger-Dias V, Sobottka TM, Da Silva AC, Biolchi BC, da Silva LF, Zasso N, Weber FB, Schimitz I, Machado DN, Netto CA, Leite MC, Bobermin LD, Quincozes-Santos A, Gonçalves CA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42726406&quot;&gt;42726406&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/senescent-phenotype-cultured-hypothalamic-astrocytes-rats-streptozotocin-induced-dementia#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/senescent-phenotype-cultured-hypothalamic-astrocytes-rats-streptozotocin-induced-dementia#comments</comments>
</item>
<item>
 <title>Chronic kidney disease and cognitive decline: choroid plexus remodeling, glymphatic dysfunction, and alzheimer biomarker interpretation.</title>
 <link>https://www.alzforum.org/papers/chronic-kidney-disease-and-cognitive-decline-choroid-plexus-remodeling-glymphatic-dysfunction</link>
 <description>Neurol Sci. 2026 Sep 11;47(10)&lt;br&gt;Authors: Corrêa LM, Oliveira da Silva R, Brandão LK, Delmiro Silva YR, da Silva ÉV, Tretow J, Gomes ED, Fernandes CC, Moreira GN, Zanella J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42726307&quot;&gt;42726307&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/chronic-kidney-disease-and-cognitive-decline-choroid-plexus-remodeling-glymphatic-dysfunction#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/chronic-kidney-disease-and-cognitive-decline-choroid-plexus-remodeling-glymphatic-dysfunction#comments</comments>
</item>
<item>
 <title>Molecular programs in human locus coeruleus link APOE and neuromelanin to Alzheimer&#039;s vulnerability.</title>
 <link>https://www.alzforum.org/papers/molecular-programs-human-locus-coeruleus-link-apoe-and-neuromelanin-alzheimers-vulnerability</link>
 <description>Acta Neuropathol. 2026 Sep 11;152(1)&lt;br&gt;Authors: Mulvey B, Divecha HR, Tippani M, Bach SV, Bharadwaj R, Del Rosario I, Maguire SE, Miller RA, Salisbury AJ, Chandra A, Oster BA, Montgomery KD, Kwon SH, Algrain HA, Papariello AR, Huuki-Myers LA, Kleinman JE, Collado-Torres L, Hyde TM, Han S, Hicks SC, Weinberger DR, Page SC, Maynard KR, Martinowich K&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42726290&quot;&gt;42726290&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/molecular-programs-human-locus-coeruleus-link-apoe-and-neuromelanin-alzheimers-vulnerability#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/molecular-programs-human-locus-coeruleus-link-apoe-and-neuromelanin-alzheimers-vulnerability#comments</comments>
</item>
<item>
 <title>Circ_0004801 promotes tau hyperphosphorylation and cognitive impairment in Alzheimer&#039;s disease through the miR-7688-5p/TTBK1 axis.</title>
 <link>https://www.alzforum.org/papers/circ0004801-promotes-tau-hyperphosphorylation-and-cognitive-impairment-alzheimers-disease</link>
 <description>J Alzheimers Dis. 2026 Sep 11;:13872877261487120.  Epub 2026 Sep 11&lt;br&gt;Authors: Li Q, Xiao J, Deng G, Zhong H, Li Y, Lin W, Zhou M, Lu Y, Huang C, Wang C, Xuan A, Yang Q&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42725992&quot;&gt;42725992&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/circ0004801-promotes-tau-hyperphosphorylation-and-cognitive-impairment-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/circ0004801-promotes-tau-hyperphosphorylation-and-cognitive-impairment-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Cadmium exposure and incidence of all-cause dementia and Alzheimer&#039;s disease in US adults.</title>
 <link>https://www.alzforum.org/papers/cadmium-exposure-and-incidence-all-cause-dementia-and-alzheimers-disease-us-adults-0</link>
 <description>J Alzheimers Dis. 2026 Sep 11;:13872877261487104.  Epub 2026 Sep 11&lt;br&gt;Authors: Walker E, Rodríguez-Carmona Y, Wang X, Mukherjee B, Arboleda-Merino L, Hao W, Dodge H, Albin RL, Paulson HL, Park SK, Bakulski KM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42725989&quot;&gt;42725989&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/cadmium-exposure-and-incidence-all-cause-dementia-and-alzheimers-disease-us-adults-0#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/cadmium-exposure-and-incidence-all-cause-dementia-and-alzheimers-disease-us-adults-0#comments</comments>
</item>
<item>
 <title>Revisiting the role of amyloid-β: A molecular and immunological perspective.</title>
 <link>https://www.alzforum.org/papers/revisiting-role-amyloid-v-molecular-and-immunological-perspective</link>
 <description>J Alzheimers Dis. 2026 Sep 11;:13872877261484863.  Epub 2026 Sep 11&lt;br&gt;Authors: Slama PS&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42725888&quot;&gt;42725888&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/revisiting-role-amyloid-v-molecular-and-immunological-perspective#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/revisiting-role-amyloid-v-molecular-and-immunological-perspective#comments</comments>
</item>
<item>
 <title>Implementation of a novel strategy to increase participation of Black and Hispanic people in parkinsonism research.</title>
 <link>https://www.alzforum.org/papers/implementation-novel-strategy-increase-participation-black-and-hispanic-people-parkinsonism</link>
 <description>J Parkinsons Dis. 2026 Sep 11;:1877718X261487914.  Epub 2026 Sep 11&lt;br&gt;Authors: Quintana Mora DF, McGoldrick AC, Mendez Y, Cervera A, Agarwal P, Crary JF, Walker RH, Nirenberg MJ&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42725877&quot;&gt;42725877&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/implementation-novel-strategy-increase-participation-black-and-hispanic-people-parkinsonism#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/implementation-novel-strategy-increase-participation-black-and-hispanic-people-parkinsonism#comments</comments>
</item>
<item>
 <title>Evaluation of the NIH Toolbox Odor Identification Test in African American older adults with and without amnestic mild cognitive impairment.</title>
 <link>https://www.alzforum.org/papers/evaluation-nih-toolbox-odor-identification-test-african-american-older-adults-and-without</link>
 <description>J Alzheimers Dis. 2026 Sep 11;:13872877261483176.  Epub 2026 Sep 11&lt;br&gt;Authors: Ece B, Giordani B, Goldstein F, Weintraub S, Manly J, Dalton P, Parma V, Gershon RC, Ho EH&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42725855&quot;&gt;42725855&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/evaluation-nih-toolbox-odor-identification-test-african-american-older-adults-and-without#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/evaluation-nih-toolbox-odor-identification-test-african-american-older-adults-and-without#comments</comments>
</item>
<item>
 <title>Down Syndrome and Alzheimer&#039;s Disease: A Qualitative Study Exploring Understanding and Perceptions of Dementia and Diagnostic Pathways Among People With Down Syndrome and Their Families.</title>
 <link>https://www.alzforum.org/papers/down-syndrome-and-alzheimers-disease-qualitative-study-exploring-understanding-and</link>
 <description>J Intellect Disabil Res. 2026 Sep 11; Epub 2026 Sep 11&lt;br&gt;Authors: Healy ML, Brodtmann A, Foster AM, Ayton D&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42725843&quot;&gt;42725843&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/down-syndrome-and-alzheimers-disease-qualitative-study-exploring-understanding-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/down-syndrome-and-alzheimers-disease-qualitative-study-exploring-understanding-and#comments</comments>
</item>
<item>
 <title>Cellular redox status is linked to olfactory alterations in cognitive decline.</title>
 <link>https://www.alzforum.org/papers/cellular-redox-status-linked-olfactory-alterations-cognitive-decline</link>
 <description>Redox Biol. 2026 Sep 11;97:104393.  Epub 2026 Sep 11&lt;br&gt;Authors: Lampinen R, Afonin AM, Mussalo L, Avesani S, Zavodna T, Feneberg E, Krejcik Z, Topinka J, Chew S, Löppönen H, Malm T, Giugno R, White AR, Koivisto AM, Penttilä E, Kanninen KM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42731289&quot;&gt;42731289&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/cellular-redox-status-linked-olfactory-alterations-cognitive-decline#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/cellular-redox-status-linked-olfactory-alterations-cognitive-decline#comments</comments>
</item>
<item>
 <title>Research Trends and Mechanistic Insights Into Natural Medicines for Alzheimer&#039;s Disease: A Bibliometric Analysis and Narrative Review.</title>
 <link>https://www.alzforum.org/papers/research-trends-and-mechanistic-insights-natural-medicines-alzheimers-disease-bibliometric</link>
 <description>Phytother Res. 2026 Sep 11; Epub 2026 Sep 11&lt;br&gt;Authors: Wang M, Zhang X, Yang H, Zhao J, Wei W, Zhao Q, Wang W, Hu Y, Fang J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42730515&quot;&gt;42730515&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/research-trends-and-mechanistic-insights-natural-medicines-alzheimers-disease-bibliometric#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/research-trends-and-mechanistic-insights-natural-medicines-alzheimers-disease-bibliometric#comments</comments>
</item>
<item>
 <title>Estrogen deprivation exacerbates Alzheimer&#039;s disease pathology through neuronal CTSS signaling.</title>
 <link>https://www.alzforum.org/papers/estrogen-deprivation-exacerbates-alzheimers-disease-pathology-through-neuronal-ctss-signaling</link>
 <description>J Neuroinflammation. 2026 Sep 11;23(1)&lt;br&gt;Authors: Yang R, Shao L, Huang F, He Y, Yuan M, Wu Q, Lin S, Guo K, Zhang H&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42728627&quot;&gt;42728627&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/estrogen-deprivation-exacerbates-alzheimers-disease-pathology-through-neuronal-ctss-signaling#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/estrogen-deprivation-exacerbates-alzheimers-disease-pathology-through-neuronal-ctss-signaling#comments</comments>
</item>
<item>
 <title>Joint impact of pathological burden and cognitive resilience on Alzheimer&#039;s disease risk.</title>
 <link>https://www.alzforum.org/papers/joint-impact-pathological-burden-and-cognitive-resilience-alzheimers-disease-risk</link>
 <description>Nat Med. 2026 Sep 11; Epub 2026 Sep 11&lt;br&gt;Authors: Wang Z, Wang S, Liang Y, Chen X, Wang S, Qin W, Wang Q, Li Y, Zhao T, Wang Y, Li F, Zhao G, Jia J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42728380&quot;&gt;42728380&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/joint-impact-pathological-burden-and-cognitive-resilience-alzheimers-disease-risk#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/joint-impact-pathological-burden-and-cognitive-resilience-alzheimers-disease-risk#comments</comments>
</item>
<item>
 <title>Intentional Repetitive Slapping (IRS): A Novel Agitation Phenotype in Behavioral-Variant Frontotemporal Dementia.</title>
 <link>https://www.alzforum.org/papers/intentional-repetitive-slapping-irs-novel-agitation-phenotype-behavioral-variant</link>
 <description>Ann Indian Acad Neurol. 2026 Sep 11; Epub 2026 Sep 11&lt;br&gt;Authors: Thampi AS, Thampi AS, Xavier T, Mathew R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42734470&quot;&gt;42734470&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/intentional-repetitive-slapping-irs-novel-agitation-phenotype-behavioral-variant#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/intentional-repetitive-slapping-irs-novel-agitation-phenotype-behavioral-variant#comments</comments>
</item>
<item>
 <title>Unraveling shared immunotoxicological mechanisms linking exposure to PPCPs with Alzheimer&#039;s disease and atherosclerosis: integrative multi-omics, network toxicology, and experimental validation.</title>
 <link>https://www.alzforum.org/papers/unraveling-shared-immunotoxicological-mechanisms-linking-exposure-ppcps-alzheimers-disease</link>
 <description>Environ Int. 2026 Sep 11;216:110518.  Epub 2026 Sep 11&lt;br&gt;Authors: Chen Z, Liu T, Wang J, Li P, Yuan H, Liu Z, Guo J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42743802&quot;&gt;42743802&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/unraveling-shared-immunotoxicological-mechanisms-linking-exposure-ppcps-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/unraveling-shared-immunotoxicological-mechanisms-linking-exposure-ppcps-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Correlation between MMP-3-1171 5A/6A polymorphism and the risk of Alzheimer&#039;s disease: A meta-analysis.</title>
 <link>https://www.alzforum.org/papers/correlation-between-mmp-3-1171-5a6a-polymorphism-and-risk-alzheimers-disease-meta-analysis</link>
 <description>Medicine (Baltimore). 2026 Sep 11;105(37):e50560. &lt;br&gt;Authors: Wang Y, Zhu S, Ma Y, Chen X, Zhou M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42742624&quot;&gt;42742624&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/correlation-between-mmp-3-1171-5a6a-polymorphism-and-risk-alzheimers-disease-meta-analysis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/correlation-between-mmp-3-1171-5a6a-polymorphism-and-risk-alzheimers-disease-meta-analysis#comments</comments>
</item>
<item>
 <title>Alzheimer&#039;s prevention drug trial: is a &quot;statin for the brain&quot; on the horizon?</title>
 <link>https://www.alzforum.org/papers/alzheimers-prevention-drug-trial-statin-brain-horizon</link>
 <description>BMJ. 2026 Sep 10;394:e100822. &lt;br&gt;Authors: Wise J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42727955&quot;&gt;42727955&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/alzheimers-prevention-drug-trial-statin-brain-horizon#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/alzheimers-prevention-drug-trial-statin-brain-horizon#comments</comments>
</item>
<item>
 <title>EXPRESS: Rapamycin increases cerebral blood flow and modulates metabolic, inflammatory, and microbiome profiles in healthy middle-aged APOE4 carriers: a pilot single-arm trial.</title>
 <link>https://www.alzforum.org/papers/express-rapamycin-increases-cerebral-blood-flow-and-modulates-metabolic-inflammatory-and</link>
 <description>J Cereb Blood Flow Metab. 2026 Sep 10;:271678X261490342.  Epub 2026 Sep 10&lt;br&gt;Authors: Aware C, Neher CM, Woods C, Khegai O, Dwivedi AK, Govindarajan M, Ivanich K, Kurt M, Beversdorf D, Cheng J, Bresette N, Cui T, Balchandani P, Gonzales MM, Ericsson AC, Altes T, Lin AL&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42723264&quot;&gt;42723264&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/express-rapamycin-increases-cerebral-blood-flow-and-modulates-metabolic-inflammatory-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/express-rapamycin-increases-cerebral-blood-flow-and-modulates-metabolic-inflammatory-and#comments</comments>
</item>
<item>
 <title>Diffuse MRI Edema Predicts Relapse in Cerebral Amyloid Angiopathy-Related Inflammation.</title>
 <link>https://www.alzforum.org/papers/diffuse-mri-edema-predicts-relapse-cerebral-amyloid-angiopathy-related-inflammation</link>
 <description>Ann Clin Transl Neurol. 2026 Sep 10; Epub 2026 Sep 10&lt;br&gt;Authors: Kharal GA, Yerneni G, Griffin KJ, Thompson N, Uchino K, Katzan I, Wisco D, Farrag A, Sundarajan J, Russman A, Hussain MS&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42723177&quot;&gt;42723177&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/diffuse-mri-edema-predicts-relapse-cerebral-amyloid-angiopathy-related-inflammation#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/diffuse-mri-edema-predicts-relapse-cerebral-amyloid-angiopathy-related-inflammation#comments</comments>
</item>
<item>
 <title>Retromer-targeted therapy for neurodegenerative diseases.</title>
 <link>https://www.alzforum.org/papers/retromer-targeted-therapy-neurodegenerative-diseases</link>
 <description>Mol Neurodegener. 2026 Sep 10;21(1)&lt;br&gt;Authors: Persico M, Tuithung S, Lorenzo A, Crawford D, Eleuteri S, Simon DK&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42723096&quot;&gt;42723096&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/retromer-targeted-therapy-neurodegenerative-diseases#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/retromer-targeted-therapy-neurodegenerative-diseases#comments</comments>
</item>
<item>
 <title>Emotional brain responses and pattern expressions in right temporal variant frontotemporal dementia.</title>
 <link>https://www.alzforum.org/papers/emotional-brain-responses-and-pattern-expressions-right-temporal-variant-frontotemporal</link>
 <description>J Neurol. 2026 Sep 10;273(10)&lt;br&gt;Authors: Adams J, Gundem D, Yargholi E, Luo Q, Sunaert S, Peeters R, De Winter FL, D Wager T, Vandenbulcke M, Van den Stock J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42722905&quot;&gt;42722905&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/emotional-brain-responses-and-pattern-expressions-right-temporal-variant-frontotemporal#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/emotional-brain-responses-and-pattern-expressions-right-temporal-variant-frontotemporal#comments</comments>
</item>
<item>
 <title>AI-guided discovery of a brain-penetrant LILRB4 inhibitor active in microglial and 5xFAD models of Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/ai-guided-discovery-brain-penetrant-lilrb4-inhibitor-active-microglial-and-5xfad-models</link>
 <description>Bioorg Chem. 2026 Sep 10;182:110508.  Epub 2026 Sep 10&lt;br&gt;Authors: Abdel-Rahman SA, Gabr MT&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42731186&quot;&gt;42731186&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/ai-guided-discovery-brain-penetrant-lilrb4-inhibitor-active-microglial-and-5xfad-models#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/ai-guided-discovery-brain-penetrant-lilrb4-inhibitor-active-microglial-and-5xfad-models#comments</comments>
</item>
<item>
 <title>Crystal Structure of the Sigma‑2 Receptor Complexed with Investigational Drug Zervimesine (CT1812).</title>
 <link>https://www.alzforum.org/papers/crystal-structure-sigma-2-receptor-complexed-investigational-drug-zervimesine-ct1812</link>
 <description>ACS Med Chem Lett. 2026 Sep 10;17(9):1925-1932.  Epub 2026 Aug 7&lt;br&gt;Authors: Look GC, Gilzer D, Preuss F, Wollenhaupt J, Nitsche J, Amaudrut J, Malancona S, Montalbetti CA, Caggiano AO, Hamby ME&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42741631&quot;&gt;42741631&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/crystal-structure-sigma-2-receptor-complexed-investigational-drug-zervimesine-ct1812#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/crystal-structure-sigma-2-receptor-complexed-investigational-drug-zervimesine-ct1812#comments</comments>
</item>
<item>
 <title>Differential aggregation and seeding of tau microtubule-binding region fragments in vitro.</title>
 <link>https://www.alzforum.org/papers/differential-aggregation-and-seeding-tau-microtubule-binding-region-fragments-vitro</link>
 <description>Biochem Biophys Res Commun. 2026 Sep 9;836:154575.  Epub 2026 Sep 9&lt;br&gt;Authors: Kim MS, Hwang SJ, Kim DH, Yoon SY&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42727478&quot;&gt;42727478&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/differential-aggregation-and-seeding-tau-microtubule-binding-region-fragments-vitro#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/differential-aggregation-and-seeding-tau-microtubule-binding-region-fragments-vitro#comments</comments>
</item>
<item>
 <title>Retinal and Choroidal Structure and Microvasculature in Dementia With Lewy Bodies and Alzheimer Disease.</title>
 <link>https://www.alzforum.org/papers/retinal-and-choroidal-structure-and-microvasculature-dementia-lewy-bodies-and-alzheimer</link>
 <description>J Vitreoretin Dis. 2026 Sep 9;:24741264261479309.  Epub 2026 Sep 9&lt;br&gt;Authors: Zhu M, Dasgupta A, Jotsinghani D, Hsu J, D&amp;#039;Cunha R, Choi A, Haystead A, Stinnett SS, Johnson KG, Grewal DS, Fekrat S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42723990&quot;&gt;42723990&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/retinal-and-choroidal-structure-and-microvasculature-dementia-lewy-bodies-and-alzheimer#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/retinal-and-choroidal-structure-and-microvasculature-dementia-lewy-bodies-and-alzheimer#comments</comments>
</item>
<item>
 <title>Emerging therapies expected to make a difference in Parkinson&#039;s disease management.</title>
 <link>https://www.alzforum.org/papers/emerging-therapies-expected-make-difference-parkinsons-disease-management</link>
 <description>Parkinsonism Relat Disord. 2026 Sep 9;:108962.  Epub 2026 Sep 9&lt;br&gt;Authors: An AY, Kalia LV&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42744685&quot;&gt;42744685&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/emerging-therapies-expected-make-difference-parkinsons-disease-management#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/emerging-therapies-expected-make-difference-parkinsons-disease-management#comments</comments>
</item>
<item>
 <title>Beyond the Single-Target Approach: Polypharmacology and Multi-Target Therapeutics in Alzheimer&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/beyond-single-target-approach-polypharmacology-and-multi-target-therapeutics-alzheimers</link>
 <description>Cent Nerv Syst Agents Med Chem. 2026 Sep 9; Epub 2026 Sep 9&lt;br&gt;Authors: Yadav R, Sinha J, Deeksha K&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42736653&quot;&gt;42736653&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/beyond-single-target-approach-polypharmacology-and-multi-target-therapeutics-alzheimers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/beyond-single-target-approach-polypharmacology-and-multi-target-therapeutics-alzheimers#comments</comments>
</item>
<item>
 <title>Novel Amyloid-β Aggregation Inhibitors Based on Phenylalanine Structure.</title>
 <link>https://www.alzforum.org/papers/novel-amyloid-v-aggregation-inhibitors-based-phenylalanine-structure</link>
 <description>Curr Alzheimer Res. 2026 Sep 7; Epub 2026 Sep 7&lt;br&gt;Authors: Xu M, Wang H, Li S, Ye J, Sun Y, Xu Y, Zhang H, Zhao W, Zhang J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42725603&quot;&gt;42725603&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/novel-amyloid-v-aggregation-inhibitors-based-phenylalanine-structure#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/novel-amyloid-v-aggregation-inhibitors-based-phenylalanine-structure#comments</comments>
</item>
<item>
 <title>The Gut-Brain Axis: Exploring the Role of Gut Microbiota in Alzheimer&#039;s Disease Pathogenesis and Therapeutics.</title>
 <link>https://www.alzforum.org/papers/gut-brain-axis-exploring-role-gut-microbiota-alzheimers-disease-pathogenesis-and-therapeutics</link>
 <description>CNS Neurol Disord Drug Targets. 2026 Sep 7; Epub 2026 Sep 7&lt;br&gt;Authors: Fatima J, Siddique YH&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42725602&quot;&gt;42725602&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/gut-brain-axis-exploring-role-gut-microbiota-alzheimers-disease-pathogenesis-and-therapeutics#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/gut-brain-axis-exploring-role-gut-microbiota-alzheimers-disease-pathogenesis-and-therapeutics#comments</comments>
</item>
<item>
 <title>Altered neuronal start codon stringency favors cap-independent repeat-associated non-AUG translation.</title>
 <link>https://www.alzforum.org/papers/altered-neuronal-start-codon-stringency-favors-cap-independent-repeat-associated-non-aug-0</link>
 <description>Nucleic Acids Res. 2026 Sep 7;54(17)&lt;br&gt;Authors: Wieland CM, Wright SE, Willey S, Purwar I, Grudzien SJ, Krans A, Laimon EL, Asher MJ, Isaacs AM, Garner AL, Todd PK&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42725432&quot;&gt;42725432&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/altered-neuronal-start-codon-stringency-favors-cap-independent-repeat-associated-non-aug-0#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/altered-neuronal-start-codon-stringency-favors-cap-independent-repeat-associated-non-aug-0#comments</comments>
</item>
<item>
 <title>Cognitive and Behavioural Profile of SOD1-ALS Across the ALS-FTD Spectrum: A Systematic Review.</title>
 <link>https://www.alzforum.org/papers/cognitive-and-behavioural-profile-sod1-als-across-als-ftd-spectrum-systematic-review</link>
 <description>Int J Mol Sci. 2026 Sep 7;27(17)&lt;br&gt;Authors: Ginanni F, Nicoletti F, Meoni C, Becattini L, Mancuso M, Carlesi C, Bianchi F&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42737854&quot;&gt;42737854&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/cognitive-and-behavioural-profile-sod1-als-across-als-ftd-spectrum-systematic-review#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/cognitive-and-behavioural-profile-sod1-als-across-als-ftd-spectrum-systematic-review#comments</comments>
</item>
<item>
 <title>Quantitative Analysis of Axonal Degeneration and TDP-43 Aggregation in Compartmentalized Human iPSC-Derived Motor Neuron-Myotube Co-cultures.</title>
 <link>https://www.alzforum.org/papers/quantitative-analysis-axonal-degeneration-and-tdp-43-aggregation-compartmentalized-human-ipsc</link>
 <description>Bio Protoc. 2026 Sep 5;16(17):e5801.  Epub 2026 Sep 5&lt;br&gt;Authors: Subramaniam AG, de Andrade Gensas LK, Gradus-Pery T, Perlson E&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42729071&quot;&gt;42729071&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/quantitative-analysis-axonal-degeneration-and-tdp-43-aggregation-compartmentalized-human-ipsc#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/quantitative-analysis-axonal-degeneration-and-tdp-43-aggregation-compartmentalized-human-ipsc#comments</comments>
</item>
<item>
 <title>Presymptomatic Amyotrophic Lateral Sclerosis: From Early Biomarker Detection to Phenoconversion Prediction.</title>
 <link>https://www.alzforum.org/papers/presymptomatic-amyotrophic-lateral-sclerosis-early-biomarker-detection-phenoconversion</link>
 <description>Diagnostics (Basel). 2026 Sep 5;16(17)&lt;br&gt;Authors: Chen M, Li H, Jin Q&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42739287&quot;&gt;42739287&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/presymptomatic-amyotrophic-lateral-sclerosis-early-biomarker-detection-phenoconversion#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/presymptomatic-amyotrophic-lateral-sclerosis-early-biomarker-detection-phenoconversion#comments</comments>
</item>
<item>
 <title>Hydroxytyrosol as a Multitarget Neuroprotective Agent: Molecular Mechanisms, Pharmacokinetics and Therapeutic Potential in Neurodegenerative Diseases.</title>
 <link>https://www.alzforum.org/papers/hydroxytyrosol-multitarget-neuroprotective-agent-molecular-mechanisms-pharmacokinetics-and</link>
 <description>Molecules. 2026 Sep 5;31(17)&lt;br&gt;Authors: Ballester-Navarro P, García-Muñoz AM, Victoria-Montesinos D, Zafrilla P&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42738773&quot;&gt;42738773&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/hydroxytyrosol-multitarget-neuroprotective-agent-molecular-mechanisms-pharmacokinetics-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/hydroxytyrosol-multitarget-neuroprotective-agent-molecular-mechanisms-pharmacokinetics-and#comments</comments>
</item>
<item>
 <title>Altered Epoxyeicosatrienoic Acid Signaling in Advanced-Stage Alzheimer&#039;s Disease (Investigation of Epoxyeicosatrienoic Acid Levels in Patients with Advanced Alzheimer&#039;s Disease).</title>
 <link>https://www.alzforum.org/papers/altered-epoxyeicosatrienoic-acid-signaling-advanced-stage-alzheimers-disease-investigation</link>
 <description>Curr Alzheimer Res. 2026 Sep 4; Epub 2026 Sep 4&lt;br&gt;Authors: Erşan S, Özmen E, Sari İ, Erşan EE&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42725525&quot;&gt;42725525&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/altered-epoxyeicosatrienoic-acid-signaling-advanced-stage-alzheimers-disease-investigation#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/altered-epoxyeicosatrienoic-acid-signaling-advanced-stage-alzheimers-disease-investigation#comments</comments>
</item>
<item>
 <title>Circadian Rhythm Disruption in Alzheimer&#039;s Disease: Mechanistic Insights, Diagnostic Implications, and Emerging Chronotherapeutic Strategies: A Narrative Review.</title>
 <link>https://www.alzforum.org/papers/circadian-rhythm-disruption-alzheimers-disease-mechanistic-insights-diagnostic-implications</link>
 <description>CNS Neurol Disord Drug Targets. 2026 Sep 4; Epub 2026 Sep 4&lt;br&gt;Authors: Kaur J, Kainth R, Mittal R, Kaur A, Kushwah AS&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42725517&quot;&gt;42725517&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/circadian-rhythm-disruption-alzheimers-disease-mechanistic-insights-diagnostic-implications#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/circadian-rhythm-disruption-alzheimers-disease-mechanistic-insights-diagnostic-implications#comments</comments>
</item>
<item>
 <title>Cardiometabolic medication exposures and cognitive outcomes in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/cardiometabolic-medication-exposures-and-cognitive-outcomes-alzheimers-disease</link>
 <description>Age Ageing. 2026 Sep 4;55(9)&lt;br&gt;Authors: Wang Y, Goudey B, Masters CL, Jin L, Pan Y, Health and Aging Brain Study (HABS-HD) Study Team&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42735389&quot;&gt;42735389&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/cardiometabolic-medication-exposures-and-cognitive-outcomes-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/cardiometabolic-medication-exposures-and-cognitive-outcomes-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Effects and mechanisms of Stauntonia brachyanthera Hand.-Mazz against Alzheimer&#039;s disease through network pharmacology and experimental validation.</title>
 <link>https://www.alzforum.org/papers/effects-and-mechanisms-stauntonia-brachyanthera-hand-mazz-against-alzheimers-disease-through</link>
 <description>Biochem Biophys Res Commun. 2026 Sep 3;836:154546.  Epub 2026 Sep 3&lt;br&gt;Authors: Wang J, Pu H, Peng L, Cai S, Ding Q, Chen X, Liu Y, Xiong W, Liao Y, Tang G&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42727480&quot;&gt;42727480&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/effects-and-mechanisms-stauntonia-brachyanthera-hand-mazz-against-alzheimers-disease-through#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/effects-and-mechanisms-stauntonia-brachyanthera-hand-mazz-against-alzheimers-disease-through#comments</comments>
</item>
<item>
 <title>Artemisinin Activates AMPK to Rescue Neuronal Cells and 3xTg Mice from Aβ1-42 Neurotoxicity.</title>
 <link>https://www.alzforum.org/papers/artemisinin-activates-ampk-rescue-neuronal-cells-and-3xtg-mice-av1-42-neurotoxicity</link>
 <description>Curr Neuropharmacol. 2026 Sep 3; Epub 2026 Sep 3&lt;br&gt;Authors: Chen Y, Xiong W, Ge L, Zheng W&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42725510&quot;&gt;42725510&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/artemisinin-activates-ampk-rescue-neuronal-cells-and-3xtg-mice-av1-42-neurotoxicity#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/artemisinin-activates-ampk-rescue-neuronal-cells-and-3xtg-mice-av1-42-neurotoxicity#comments</comments>
</item>
<item>
 <title>Alzheimer&#039;s Disease in the Era of Geroscience: Mechanisms, Biomarkers, and Therapeutic Prospects.</title>
 <link>https://www.alzforum.org/papers/alzheimers-disease-era-geroscience-mechanisms-biomarkers-and-therapeutic-prospects</link>
 <description>Cells. 2026 Sep 2;15(17)&lt;br&gt;Authors: Chmielewski PP&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42738893&quot;&gt;42738893&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/alzheimers-disease-era-geroscience-mechanisms-biomarkers-and-therapeutic-prospects#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/alzheimers-disease-era-geroscience-mechanisms-biomarkers-and-therapeutic-prospects#comments</comments>
</item>
<item>
 <title>Efficacy of Low Dose of Dihydroquercetin (DHQ) in Two Genetic Models of Neurodegeneration: Insights from FUS[1-359]-Tg and APPswe/PS1dE9 Paradigms.</title>
 <link>https://www.alzforum.org/papers/efficacy-low-dose-dihydroquercetin-dhq-two-genetic-models-neurodegeneration-insights-fus1-359</link>
 <description>Cells. 2026 Sep 2;15(17)&lt;br&gt;Authors: Lysikova E, Sitdikova K, Makhambetova A, Chaprov K, Gorlova A, Kostin A, Novikova P, Lyundup A, Askarova S, Kukharsky MS, Deykin A, Strekalova T&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42738892&quot;&gt;42738892&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/efficacy-low-dose-dihydroquercetin-dhq-two-genetic-models-neurodegeneration-insights-fus1-359#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/efficacy-low-dose-dihydroquercetin-dhq-two-genetic-models-neurodegeneration-insights-fus1-359#comments</comments>
</item>
<item>
 <title>The Paradox of Tau and RNA-Binding Proteins: How Adaptive Stress Granule Regulation Becomes Pathological with Aging.</title>
 <link>https://www.alzforum.org/papers/paradox-tau-and-rna-binding-proteins-how-adaptive-stress-granule-regulation-becomes</link>
 <description>Cells. 2026 Sep 2;15(17)&lt;br&gt;Authors: Wolozin B, Best M, Ellini M, Ma Y, Bok S, Hwang D, Filipponi C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42738890&quot;&gt;42738890&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/paradox-tau-and-rna-binding-proteins-how-adaptive-stress-granule-regulation-becomes#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/paradox-tau-and-rna-binding-proteins-how-adaptive-stress-granule-regulation-becomes#comments</comments>
</item>
<item>
 <title>Modeling Tau-Mediated Pathology in Monkey Brain Slices.</title>
 <link>https://www.alzforum.org/papers/modeling-tau-mediated-pathology-monkey-brain-slices</link>
 <description>Biology (Basel). 2026 Sep 2;15(17)&lt;br&gt;Authors: Pan M, Guo Q, Huang P, Han X, Yang S, Sun F, Zhang J, Chen L, Li B, He D, Li S, Li XJ, Guo X&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42737927&quot;&gt;42737927&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/modeling-tau-mediated-pathology-monkey-brain-slices#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/modeling-tau-mediated-pathology-monkey-brain-slices#comments</comments>
</item>
<item>
 <title>Older adult APOE4 mice exhibit modest immunometabolic adaptation following microglial APOE2 replacement.</title>
 <link>https://www.alzforum.org/papers/older-adult-apoe4-mice-exhibit-modest-immunometabolic-adaptation-following-microglial-apoe2</link>
 <description>Neurobiol Aging. 2026 Sep 2;169:13-26.  Epub 2026 Sep 2&lt;br&gt;Authors: Nolt GL, MacLean SM, Golden LR, Thorpe SP, Stephens IO, Funnell JL, Brock CR, Lucido CC, Smith L, Hernandez G, Arbones-Mainar JM, Wood C, Morganti JM, Johnson LA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42748650&quot;&gt;42748650&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/older-adult-apoe4-mice-exhibit-modest-immunometabolic-adaptation-following-microglial-apoe2#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/older-adult-apoe4-mice-exhibit-modest-immunometabolic-adaptation-following-microglial-apoe2#comments</comments>
</item>
<item>
 <title>[Alzheimer&#039;s disease: scientific advances, diagnostic challenges and therapeutic perspectives].</title>
 <link>https://www.alzforum.org/papers/alzheimers-disease-scientific-advances-diagnostic-challenges-and-therapeutic-perspectives</link>
 <description>Soins. 2026 Sep;71(908):14-19.  Epub 2026 Aug 27&lt;br&gt;Authors: Chenault C, Tchalla A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42727999&quot;&gt;42727999&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/alzheimers-disease-scientific-advances-diagnostic-challenges-and-therapeutic-perspectives#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/alzheimers-disease-scientific-advances-diagnostic-challenges-and-therapeutic-perspectives#comments</comments>
</item>
<item>
 <title>[4-Repeat Tauopathies: Progressive Supranuclear Palsy and Corticobasal Degeneration].</title>
 <link>https://www.alzforum.org/papers/4-repeat-tauopathies-progressive-supranuclear-palsy-and-corticobasal-degeneration</link>
 <description>Fortschr Neurol Psychiatr. 2026 Sep;94(9):389-399.  Epub 2026 Sep 11&lt;br&gt;Authors: Palleis CT, Bernhardt A, Höglinger G&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42727959&quot;&gt;42727959&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/4-repeat-tauopathies-progressive-supranuclear-palsy-and-corticobasal-degeneration#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/4-repeat-tauopathies-progressive-supranuclear-palsy-and-corticobasal-degeneration#comments</comments>
</item>
<item>
 <title>ENT1 inhibition links oligodendrocyte lipid metabolism to connectivity in tauopathy.</title>
 <link>https://www.alzforum.org/papers/ent1-inhibition-links-oligodendrocyte-lipid-metabolism-connectivity-tauopathy</link>
 <description>Alzheimers Dement. 2026 Sep;22(9):e71789. &lt;br&gt;Authors: Chang CP, Chang CW, Wu CW, Siew JJ, Blum D, Jin LW, Chen YY, Chern Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42725558&quot;&gt;42725558&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/ent1-inhibition-links-oligodendrocyte-lipid-metabolism-connectivity-tauopathy#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/ent1-inhibition-links-oligodendrocyte-lipid-metabolism-connectivity-tauopathy#comments</comments>
</item>
<item>
 <title>Microvascular damage in diabetic nephropathy and the subsequent risk of Alzheimer&#039;s disease: a systematic review.</title>
 <link>https://www.alzforum.org/papers/microvascular-damage-diabetic-nephropathy-and-subsequent-risk-alzheimers-disease-systematic</link>
 <description>Ann Med Surg (Lond). 2026 Sep;88(9):5922-5929.  Epub 2026 Aug 21&lt;br&gt;Authors: Mohammed N, Alyazan Khalil Taher Al-Jabali T, Yassien N, Osman Abufatima I, Omer Ibrahim Ahmed F, El Yazal S, Satti W, Alalamat N, Aamer Abkar Ibrahim M, Tirelbar B, Paudel L, Abdalla Abdelsadig Mahmoud I, Humdi L, Ali H, Hammad Jaber Amin M, Abdelrahman N&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42724815&quot;&gt;42724815&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/microvascular-damage-diabetic-nephropathy-and-subsequent-risk-alzheimers-disease-systematic#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/microvascular-damage-diabetic-nephropathy-and-subsequent-risk-alzheimers-disease-systematic#comments</comments>
</item>
<item>
 <title>Advances in Targeting Central Cholinergic Dysfunction for Neurodegenerative Diseases: From Pharmacotherapy to Neuromodulation.</title>
 <link>https://www.alzforum.org/papers/advances-targeting-central-cholinergic-dysfunction-neurodegenerative-diseases-pharmacotherapy</link>
 <description>CNS Neurosci Ther. 2026 Sep;32(9):e71151. &lt;br&gt;Authors: Lei L, Hu X, Lu R, Yang JJ, Meng Q&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42723527&quot;&gt;42723527&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/advances-targeting-central-cholinergic-dysfunction-neurodegenerative-diseases-pharmacotherapy#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/advances-targeting-central-cholinergic-dysfunction-neurodegenerative-diseases-pharmacotherapy#comments</comments>
</item>
<item>
 <title>Assessing the Clinical Relevance of Blood Soluble Triggering Receptor Expressed on Myeloid Cells 2 in Neurological Diseases.</title>
 <link>https://www.alzforum.org/papers/assessing-clinical-relevance-blood-soluble-triggering-receptor-expressed-myeloid-cells-2</link>
 <description>Eur J Neurosci. 2026 Sep;64(5):e70690. &lt;br&gt;Authors: Agnello L, Gambino CM, Salemi G, Di Stefano V, Piccoli T, Masucci A, Novara S, Ciaccio AM, Del Ben F, Capello D, Ciaccio M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42723297&quot;&gt;42723297&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/assessing-clinical-relevance-blood-soluble-triggering-receptor-expressed-myeloid-cells-2#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/assessing-clinical-relevance-blood-soluble-triggering-receptor-expressed-myeloid-cells-2#comments</comments>
</item>
<item>
 <title>Rethinking Senescence Hallmarks in the Brain: Lessons From Peripheral Tissues and Challenges in Defining Neuronal Senescence.</title>
 <link>https://www.alzforum.org/papers/rethinking-senescence-hallmarks-brain-lessons-peripheral-tissues-and-challenges-defining</link>
 <description>Aging Cell. 2026 Sep;25(9):e70719. &lt;br&gt;Authors: Momand MU, Macova K, Fricova D&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42730505&quot;&gt;42730505&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/rethinking-senescence-hallmarks-brain-lessons-peripheral-tissues-and-challenges-defining#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/rethinking-senescence-hallmarks-brain-lessons-peripheral-tissues-and-challenges-defining#comments</comments>
</item>
<item>
 <title>Recent Advancements in Drug Delivery Across the Blood-Brain Barrier in Amyotrophic Lateral Sclerosis (ALS).</title>
 <link>https://www.alzforum.org/papers/recent-advancements-drug-delivery-across-blood-brain-barrier-amyotrophic-lateral-sclerosis</link>
 <description>CNS Neurosci Ther. 2026 Sep;32(9):e71078. &lt;br&gt;Authors: Sanghai N, Pierce K, Sharma N, Leggett S, Yadav TC, Masrori P, Atukorallaya D, Palaniyandi S, Marcogliese PC, Tranmer GK&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42728797&quot;&gt;42728797&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/recent-advancements-drug-delivery-across-blood-brain-barrier-amyotrophic-lateral-sclerosis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/recent-advancements-drug-delivery-across-blood-brain-barrier-amyotrophic-lateral-sclerosis#comments</comments>
</item>
<item>
 <title>Integrative analysis of single-cell multi-omics reveals heterogeneity in piriform cortex principal neurons and their selective vulnerability in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/integrative-analysis-single-cell-multi-omics-reveals-heterogeneity-piriform-cortex-principal</link>
 <description>Clin Transl Med. 2026 Sep;16(9):e70781. &lt;br&gt;Authors: Meng J, Zhang M, Chen Y, Han M, Cheng N, Cao R, He Q, Zhao Y, Yuan L, Zhang G&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42728785&quot;&gt;42728785&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/integrative-analysis-single-cell-multi-omics-reveals-heterogeneity-piriform-cortex-principal#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/integrative-analysis-single-cell-multi-omics-reveals-heterogeneity-piriform-cortex-principal#comments</comments>
</item>
<item>
 <title>SynthPET: A 3D generative AI approach for FDG-PET image synthesis from T1-weighted MRI and ASL CBF in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/synthpet-3d-generative-ai-approach-fdg-pet-image-synthesis-t1-weighted-mri-and-asl-cbf</link>
 <description>Alzheimers Dement. 2026 Sep;22(9):e71822. &lt;br&gt;Authors: Beltran-Urbano X, Jobson KR, Nasrallah IM, Kumar A, Taso M, Das SR, Brown CA, Li S, Xie L, McMillan CT, Yushkevich PA, Wolk DA, Zaharchuk G, Dolui S, Detre JA, Alzheimer&amp;#039;s Disease Neuroimaging Initiative&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42728741&quot;&gt;42728741&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/synthpet-3d-generative-ai-approach-fdg-pet-image-synthesis-t1-weighted-mri-and-asl-cbf#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/synthpet-3d-generative-ai-approach-fdg-pet-image-synthesis-t1-weighted-mri-and-asl-cbf#comments</comments>
</item>
<item>
 <title>Cellular transcriptomic signatures underpinning the heterogeneity of depression in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/cellular-transcriptomic-signatures-underpinning-heterogeneity-depression-alzheimers-disease</link>
 <description>Alzheimers Dement. 2026 Sep;22(9):e71823. &lt;br&gt;Authors: Lutz MW, Man Z, Chiba-Falek O&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42728740&quot;&gt;42728740&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/cellular-transcriptomic-signatures-underpinning-heterogeneity-depression-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/cellular-transcriptomic-signatures-underpinning-heterogeneity-depression-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Fibronectin mediates APOE4-driven blood-brain barrier dysfunction in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/fibronectin-mediates-apoe4-driven-blood-brain-barrier-dysfunction-alzheimers-disease</link>
 <description>Nat Aging. 2026 Sep;6(9):1901-1927.  Epub 2026 Sep 11&lt;br&gt;Authors: Bhattarai P, Yilmaz E, Cakir EÖ, Tayran H, Haq I, Murphy D, Keller JN, Le Grand Q, Eschbach JO, Celikkaya H, Cosacak MI, Yüceer Korkmaz H, Lee AJ, Haage V, Ma Y, Wang X, Nelson N, Lin W, Zhang Y, Turgutalp B, de Leeuw SM, Patel R, Jülich D, İş Ö, Holley SA, De Jager PL, Freudenberg U, Werner C, St George-Hyslop P, Ertekin-Taner N, Debette S, Elahi FM, Fisher ES, Phatnani H, Teich AF, Tubbesing K, Bertucci T, Temple S, Nuriel T, Vardarajan BN, Mayeux R, Kizil C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42728404&quot;&gt;42728404&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/fibronectin-mediates-apoe4-driven-blood-brain-barrier-dysfunction-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/fibronectin-mediates-apoe4-driven-blood-brain-barrier-dysfunction-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Associations between serum estradiol and estrone and Alzheimer&#039;s disease biomarkers: An analysis in female participants from the European Prevention of Alzheimer&#039;s Dementia Longitudinal Cohort Study (EPAD LCS).</title>
 <link>https://www.alzforum.org/papers/associations-between-serum-estradiol-and-estrone-and-alzheimers-disease-biomarkers-analysis</link>
 <description>Alzheimers Dement. 2026 Sep;22(9):e71826. &lt;br&gt;Authors: Shin J, Muniz-Terrera G, Ritchie CW, Manson J, Plachecki S, Kirschbaum C, Gregory S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42733033&quot;&gt;42733033&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/associations-between-serum-estradiol-and-estrone-and-alzheimers-disease-biomarkers-analysis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/associations-between-serum-estradiol-and-estrone-and-alzheimers-disease-biomarkers-analysis#comments</comments>
</item>
<item>
 <title>Machine Learning for Noninvasive Diagnosis of Neurodegenerative Diseases Using Retinal and Optic Nerve Imaging: A Comprehensive Review.</title>
 <link>https://www.alzforum.org/papers/machine-learning-noninvasive-diagnosis-neurodegenerative-diseases-using-retinal-and-optic</link>
 <description>Annu Rev Vis Sci. 2026 Sep;12(1):155-186. &lt;br&gt;Authors: Aghababaei A, Etemadifar M, Atapour-Abarghouei A, Innes W, Fard MA, Paul F, Rabbani H, Kafieh R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42744757&quot;&gt;42744757&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/machine-learning-noninvasive-diagnosis-neurodegenerative-diseases-using-retinal-and-optic#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/machine-learning-noninvasive-diagnosis-neurodegenerative-diseases-using-retinal-and-optic#comments</comments>
</item>
<item>
 <title>Reliable detection and continuous monitoring of memory dysfunction in mild cognitive impairment and healthy aging through adaptive computational phenotyping.</title>
 <link>https://www.alzforum.org/papers/reliable-detection-and-continuous-monitoring-memory-dysfunction-mild-cognitive-impairment-and</link>
 <description>PLOS Digit Health. 2026 Sep;5(9):e0001686.  Epub 2026 Sep 15&lt;br&gt;Authors: Hake HS, van der Velde M, Grabowski TJ, van Rijn H, Stocco A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42743227&quot;&gt;42743227&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/reliable-detection-and-continuous-monitoring-memory-dysfunction-mild-cognitive-impairment-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/reliable-detection-and-continuous-monitoring-memory-dysfunction-mild-cognitive-impairment-and#comments</comments>
</item>
<item>
 <title>Neural Stem Cell-Derived Extracellular Vesicles Improve CNS Delivery and Therapeutic Efficacy of Antisense Oligonucleotide in Amyotrophic Lateral Sclerosis.</title>
 <link>https://www.alzforum.org/papers/neural-stem-cell-derived-extracellular-vesicles-improve-cns-delivery-and-therapeutic-efficacy</link>
 <description>J Extracell Vesicles. 2026 Sep;15(9):e70370. &lt;br&gt;Authors: Zheng Y, Ellison TJ, Garrard R, Gao J, Lai X, Lan L, Xie J, Jiang J, Yao Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42742464&quot;&gt;42742464&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/neural-stem-cell-derived-extracellular-vesicles-improve-cns-delivery-and-therapeutic-efficacy#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/neural-stem-cell-derived-extracellular-vesicles-improve-cns-delivery-and-therapeutic-efficacy#comments</comments>
</item>
<item>
 <title>Incidence of dementia and mild cognitive impairment in two Indigenous Bolivian cohorts.</title>
 <link>https://www.alzforum.org/papers/incidence-dementia-and-mild-cognitive-impairment-two-indigenous-bolivian-cohorts</link>
 <description>Alzheimers Dement. 2026 Sep;22(9):e71750. &lt;br&gt;Authors: Gatz M, Mack WJ, Eid Rodriguez D, Quispe Gutierrez R, Bani Cuata J, Chui HC, Walters EE, Cummings DK, Hooper PL, Zetterberg H, Finch CE, Trumble BC, Stieglitz J, Gurven MD, Thompson RC, Thomas GS, HORUS Team, Tsimane Health and Life History Project, Kaplan HS&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42742085&quot;&gt;42742085&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/incidence-dementia-and-mild-cognitive-impairment-two-indigenous-bolivian-cohorts#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/incidence-dementia-and-mild-cognitive-impairment-two-indigenous-bolivian-cohorts#comments</comments>
</item>
<item>
 <title>Genetic and molecular evidence linking CTSH to Alzheimer&#039;s disease pathophysiology.</title>
 <link>https://www.alzforum.org/papers/genetic-and-molecular-evidence-linking-ctsh-alzheimers-disease-pathophysiology</link>
 <description>Alzheimers Dement. 2026 Sep;22(9):e71833. &lt;br&gt;Authors: Picard C, Aumont-Rodrigue G, Sarty I, Loncke J, Savard M, Maligne-Bruneau L, Poirier J, PREVENT‐AD research group&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42741981&quot;&gt;42741981&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/genetic-and-molecular-evidence-linking-ctsh-alzheimers-disease-pathophysiology#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/genetic-and-molecular-evidence-linking-ctsh-alzheimers-disease-pathophysiology#comments</comments>
</item>
<item>
 <title>Digital cognitive phenotyping enhances risk stratification in preclinical Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/digital-cognitive-phenotyping-enhances-risk-stratification-preclinical-alzheimers-disease</link>
 <description>Alzheimers Dement. 2026 Sep;22(9):e71834. &lt;br&gt;Authors: Vanderlip CR, Stark CE&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42741980&quot;&gt;42741980&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/digital-cognitive-phenotyping-enhances-risk-stratification-preclinical-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/digital-cognitive-phenotyping-enhances-risk-stratification-preclinical-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Incidence and risk factors for AD/ADRD among American Indian and Alaska Native US Veterans.</title>
 <link>https://www.alzforum.org/papers/incidence-and-risk-factors-adadrd-among-american-indian-and-alaska-native-us-veterans</link>
 <description>Alzheimers Dement. 2026 Sep;22(9):e71856. &lt;br&gt;Authors: Dintica CS, Bahorik A, Xia F, Boscardin J, Parko K, Yaffe K&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42740335&quot;&gt;42740335&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/incidence-and-risk-factors-adadrd-among-american-indian-and-alaska-native-us-veterans#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/incidence-and-risk-factors-adadrd-among-american-indian-and-alaska-native-us-veterans#comments</comments>
</item>
<item>
 <title>Anti-Amyloid Antibodies in the Treatment of Alzheimer&#039;s Disease: An Umbrella Review.</title>
 <link>https://www.alzforum.org/papers/anti-amyloid-antibodies-treatment-alzheimers-disease-umbrella-review</link>
 <description>J Clin Med. 2026 Sep 1;15(17)&lt;br&gt;Authors: Kalampokini S, Keramidiotis I, Frontistis A, Zuchi F, Michmizos D, Papaliagkas V, Koutsouraki E&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42739787&quot;&gt;42739787&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/anti-amyloid-antibodies-treatment-alzheimers-disease-umbrella-review#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/anti-amyloid-antibodies-treatment-alzheimers-disease-umbrella-review#comments</comments>
</item>
<item>
 <title>The Ocular Microbiome and Alzheimer&#039;s Disease: Emerging Insights.</title>
 <link>https://www.alzforum.org/papers/ocular-microbiome-and-alzheimers-disease-emerging-insights</link>
 <description>Cells. 2026 Sep 1;15(17)&lt;br&gt;Authors: Mishra SK, Ozkan J, Su F, Kim WS, Willcox M, Fu Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42738884&quot;&gt;42738884&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/ocular-microbiome-and-alzheimers-disease-emerging-insights#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/ocular-microbiome-and-alzheimers-disease-emerging-insights#comments</comments>
</item>
<item>
 <title>Photobiomodulation with 808 nm Laser Light Repairs Mitochondrial Integrity and Normalizes ROS, ATP, and Membrane Depolarization in Aβ-Exposed Primary Neurons in Alzheimer&#039;s Disease Model.</title>
 <link>https://www.alzforum.org/papers/photobiomodulation-808-nm-laser-light-repairs-mitochondrial-integrity-and-normalizes-ros-atp</link>
 <description>Int J Mol Sci. 2026 Sep 1;27(17)&lt;br&gt;Authors: Golovynska I, Li B, Chen Q, Golovynskyi S, Xu H, Stepanov YV, Stepanova LI, Lin F, Qu J, Ohulchanskyy TY&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42737733&quot;&gt;42737733&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/photobiomodulation-808-nm-laser-light-repairs-mitochondrial-integrity-and-normalizes-ros-atp#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/photobiomodulation-808-nm-laser-light-repairs-mitochondrial-integrity-and-normalizes-ros-atp#comments</comments>
</item>
<item>
 <title>Caenorhabditis elegans as a Model for Studying Nrf2/SKN-1 Activation in Alzheimer&#039;s Disease: Plant Bioactive Compounds and Therapeutic Translation.</title>
 <link>https://www.alzforum.org/papers/caenorhabditis-elegans-model-studying-nrf2skn-1-activation-alzheimers-disease-plant-bioactive</link>
 <description>Int J Mol Sci. 2026 Sep 1;27(17)&lt;br&gt;Authors: Bellver-Sanchis A, Ralchev NR, Romanska PR, Dyakova NK, Ivanova KI, Griñán-Ferré C, Marchev AS&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42737730&quot;&gt;42737730&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/caenorhabditis-elegans-model-studying-nrf2skn-1-activation-alzheimers-disease-plant-bioactive#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/caenorhabditis-elegans-model-studying-nrf2skn-1-activation-alzheimers-disease-plant-bioactive#comments</comments>
</item>
<item>
 <title>Genetic susceptibility of Alzheimer&#039;s disease associated with APOE polymorphism: systematic review and bibliometric study.</title>
 <link>https://www.alzforum.org/papers/genetic-susceptibility-alzheimers-disease-associated-apoe-polymorphism-systematic-review-and</link>
 <description>J Genet Eng Biotechnol. 2026 Sep;24(3):100785.  Epub 2026 Aug 4&lt;br&gt;Authors: Amukti DP, Kusumawardani N, Pratami RI, Purwanto BD, Rukhama RA, Akbar I, Sarwadhamana RJ, Aditya RA, Yuliani S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42749454&quot;&gt;42749454&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/genetic-susceptibility-alzheimers-disease-associated-apoe-polymorphism-systematic-review-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/genetic-susceptibility-alzheimers-disease-associated-apoe-polymorphism-systematic-review-and#comments</comments>
</item>
<item>
 <title>Computational identification of Ginkgo biloba phytochemicals as dual inhibitors of herpes simplex virus type 1 glycoproteins gB and gD targeting its entry and Alzheimer&#039;s disease pathogenesis.</title>
 <link>https://www.alzforum.org/papers/computational-identification-ginkgo-biloba-phytochemicals-dual-inhibitors-herpes-simplex</link>
 <description>J Genet Eng Biotechnol. 2026 Sep;24(3):100728.  Epub 2026 Jun 22&lt;br&gt;Authors: Hossain MM, Shammi SS, Sarwar G, Ahmed S, Fardous J, Morshed MM, Sarker MA, Asaduzzaman M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42749410&quot;&gt;42749410&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/computational-identification-ginkgo-biloba-phytochemicals-dual-inhibitors-herpes-simplex#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/computational-identification-ginkgo-biloba-phytochemicals-dual-inhibitors-herpes-simplex#comments</comments>
</item>
<item>
 <title>Efficacy and Effectiveness of the Recombinant Zoster Vaccine Against Herpes Zoster, Herpes Zoster Ophthalmicus, Postherpetic Neuralgia and Dementia: A Systematic Review and Meta-Analysis.</title>
 <link>https://www.alzforum.org/papers/efficacy-and-effectiveness-recombinant-zoster-vaccine-against-herpes-zoster-herpes-zoster</link>
 <description>Rev Med Virol. 2026 Sep;36(5):e70203. &lt;br&gt;Authors: Heen E, Øverbø J, Tveteraas IH, Solberg SL, Nøkleby H, Midtbø JE, Di Rusco F, Kasteng F, Ersson A, Andersson S, Johansen K, Juvet LK&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42748460&quot;&gt;42748460&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/efficacy-and-effectiveness-recombinant-zoster-vaccine-against-herpes-zoster-herpes-zoster#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/efficacy-and-effectiveness-recombinant-zoster-vaccine-against-herpes-zoster-herpes-zoster#comments</comments>
</item>
<item>
 <title>Unlocking the Potential of Isatin Scaffolds in Acetylcholinesterase Inhibition.</title>
 <link>https://www.alzforum.org/papers/unlocking-potential-isatin-scaffolds-acetylcholinesterase-inhibition</link>
 <description>Arch Pharm (Weinheim). 2026 Sep;359(9):e70336. &lt;br&gt;Authors: Tharwat T, El-Nassan HB, Adly ME, Kamel MM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42748401&quot;&gt;42748401&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/unlocking-potential-isatin-scaffolds-acetylcholinesterase-inhibition#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/unlocking-potential-isatin-scaffolds-acetylcholinesterase-inhibition#comments</comments>
</item>
<item>
 <title>A two-step processing method is recommended to inactivate human sporadic M1 and V2 prions.</title>
 <link>https://www.alzforum.org/papers/two-step-processing-method-recommended-inactivate-human-sporadic-m1-and-v2-prions</link>
 <description>J Gen Virol. 2026 Sep;107(9)&lt;br&gt;Authors: Mohri S, Matsuura Y, Parchi P, Kitamoto T&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42747978&quot;&gt;42747978&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/two-step-processing-method-recommended-inactivate-human-sporadic-m1-and-v2-prions#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/two-step-processing-method-recommended-inactivate-human-sporadic-m1-and-v2-prions#comments</comments>
</item>
<item>
 <title>A Pilot Study Evaluating the Effect of Artesunate on Glymphatic-Related Fluid Transport in Parkinson&#039;s Disease Mouse Models In Vivo and Ex Vivo.</title>
 <link>https://www.alzforum.org/papers/pilot-study-evaluating-effect-artesunate-glymphatic-related-fluid-transport-parkinsons</link>
 <description>CNS Neurosci Ther. 2026 Sep;32(9):e71145. &lt;br&gt;Authors: Han WT, Lu WH, Xu H, Xie GH, Cao Y, Wu XY, Qiu F, Fu T&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42747247&quot;&gt;42747247&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/pilot-study-evaluating-effect-artesunate-glymphatic-related-fluid-transport-parkinsons#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/pilot-study-evaluating-effect-artesunate-glymphatic-related-fluid-transport-parkinsons#comments</comments>
</item>
<item>
 <title>Clinical Practice Outcomes With Lecanemab for Alzheimer Disease.</title>
 <link>https://www.alzforum.org/papers/clinical-practice-outcomes-lecanemab-alzheimer-disease</link>
 <description>Neurol Open Access. 2026 Sep;2(3):e000121.  Epub 2026 Aug 7&lt;br&gt;Authors: Liu AJ, Moghadam AA, Alam MS, Lutz MW, Navarra A, Luo S, Wang LA, Petrella JR, Whitson H, O&amp;#039;Brien RJ, Johnson KG, Parker D, Beam C, Sanfilippo M, Al-Sahlani H, Cobb S, Liu MY, Doraiswamy PM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42746606&quot;&gt;42746606&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/clinical-practice-outcomes-lecanemab-alzheimer-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/clinical-practice-outcomes-lecanemab-alzheimer-disease#comments</comments>
</item>
<item>
 <title>[How to Proceed with Diagnosing Memory Loss].</title>
 <link>https://www.alzforum.org/papers/how-proceed-diagnosing-memory-loss</link>
 <description>Brain Nerve. 2026 Sep;78(9):1003-1014. &lt;br&gt;Authors: Ikeda M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42745714&quot;&gt;42745714&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/how-proceed-diagnosing-memory-loss#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/how-proceed-diagnosing-memory-loss#comments</comments>
</item>
<item>
 <title>Rethinking γ-Secretase Dysfunction in Alzheimer&#039;s Disease: From APP Processing to Network Perturbation.</title>
 <link>https://www.alzforum.org/papers/rethinking-g-secretase-dysfunction-alzheimers-disease-app-processing-network-perturbation</link>
 <description>J Neurochem. 2026 Sep;170(9):e70550. &lt;br&gt;Authors: Passarella D, Russo C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42745407&quot;&gt;42745407&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/rethinking-g-secretase-dysfunction-alzheimers-disease-app-processing-network-perturbation#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/rethinking-g-secretase-dysfunction-alzheimers-disease-app-processing-network-perturbation#comments</comments>
</item>
<item>
 <title>Evaluating the 8-Year Association Between Cognition and Beta Amyloid in the Dallas Lifespan Brain Study Cohort.</title>
 <link>https://www.alzforum.org/papers/evaluating-8-year-association-between-cognition-and-beta-amyloid-dallas-lifespan-brain-study</link>
 <description>Brain Behav. 2026 Sep;16(9):e71684. &lt;br&gt;Authors: David J, Torres I, Smith E, Pongpipat E, Park D&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42745402&quot;&gt;42745402&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/evaluating-8-year-association-between-cognition-and-beta-amyloid-dallas-lifespan-brain-study#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/evaluating-8-year-association-between-cognition-and-beta-amyloid-dallas-lifespan-brain-study#comments</comments>
</item>
<item>
 <title>MARBLE: An in vivo MRI marker of limbic-predominant age-related TDP-43 encephalopathy neuropathologic change (LATE-NC).</title>
 <link>https://www.alzforum.org/papers/marble-vivo-mri-marker-limbic-predominant-age-related-tdp-43-encephalopathy-neuropathologic</link>
 <description>Alzheimers Dement. 2026 Sep;22(9):e71832. &lt;br&gt;Authors: Tazwar M, Evia AM, Ridwan AR, Leurgans SE, Wagner M, Alzheimer&amp;#039;s Disease Neuroimaging Initiative, Bennett DA, Schneider JA, Arfanakis K&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42745216&quot;&gt;42745216&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/marble-vivo-mri-marker-limbic-predominant-age-related-tdp-43-encephalopathy-neuropathologic#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/marble-vivo-mri-marker-limbic-predominant-age-related-tdp-43-encephalopathy-neuropathologic#comments</comments>
</item>
<item>
 <title>Rethinking tau-targeted therapy in Alzheimer&#039;s disease: Toward a dual biomarker strategy.</title>
 <link>https://www.alzforum.org/papers/rethinking-tau-targeted-therapy-alzheimers-disease-toward-dual-biomarker-strategy</link>
 <description>Alzheimers Dement. 2026 Sep;22(9):e71867. &lt;br&gt;Authors: Teunissen CE, Pini L, Imbimbo BP&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42750203&quot;&gt;42750203&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/rethinking-tau-targeted-therapy-alzheimers-disease-toward-dual-biomarker-strategy#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/rethinking-tau-targeted-therapy-alzheimers-disease-toward-dual-biomarker-strategy#comments</comments>
</item>
<item>
 <title>Operationalizing Alzheimer&#039;s disease trials in the era of targeted therapies.</title>
 <link>https://www.alzforum.org/papers/operationalizing-alzheimers-disease-trials-era-targeted-therapies</link>
 <description>Alzheimers Dement. 2026 Sep;22(9):e71829. &lt;br&gt;Authors: Pillai JA, Alladi S, Appleby BS, Brosch JR, Frederiksen KS, Galasko D, Lopez OL, Leverenz JB, Saykin AJ, Schott JM, Seshadri S, Tousi B, Wolk DA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42750195&quot;&gt;42750195&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/operationalizing-alzheimers-disease-trials-era-targeted-therapies#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/operationalizing-alzheimers-disease-trials-era-targeted-therapies#comments</comments>
</item>
<item>
 <title>Hippocampal snRNA-seq in Collaborative Cross reveals molecular signatures of cognitive resilience independent of chronological aging.</title>
 <link>https://www.alzforum.org/papers/hippocampal-snrna-seq-collaborative-cross-reveals-molecular-signatures-cognitive-resilience</link>
 <description>Alzheimers Dement. 2026 Sep;22(9):e71825. &lt;br&gt;Authors: Chen Y, Ouellette AR, Cao Y, Zhang J, Kaczorowski CC&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42750154&quot;&gt;42750154&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/hippocampal-snrna-seq-collaborative-cross-reveals-molecular-signatures-cognitive-resilience#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/hippocampal-snrna-seq-collaborative-cross-reveals-molecular-signatures-cognitive-resilience#comments</comments>
</item>
<item>
 <title>[Lymphatic supermicrosurgery in neurodegenerative disorders].</title>
 <link>https://www.alzforum.org/papers/lymphatic-supermicrosurgery-neurodegenerative-disorders</link>
 <description>Ugeskr Laeger. 2026 Aug 31;188(36)&lt;br&gt;Authors: Salim D, Dalaei F, Beier D, Sørensen JA, Hölmich LR, Thomsen JB&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42740552&quot;&gt;42740552&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/lymphatic-supermicrosurgery-neurodegenerative-disorders#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/lymphatic-supermicrosurgery-neurodegenerative-disorders#comments</comments>
</item>
<item>
 <title>Spectral and Directed Connectivity EEG Markers for Classifying Alzheimer&#039;s Disease, Frontotemporal Dementia, and Healthy Controls with Exploratory Photobiomodulation Case-Study Projection.</title>
 <link>https://www.alzforum.org/papers/spectral-and-directed-connectivity-eeg-markers-classifying-alzheimers-disease-frontotemporal</link>
 <description>Sensors (Basel). 2026 Aug 31;26(17)&lt;br&gt;Authors: Šverko Z, Vlahinić S, Vrankić M, Stojković N&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42740150&quot;&gt;42740150&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/spectral-and-directed-connectivity-eeg-markers-classifying-alzheimers-disease-frontotemporal#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/spectral-and-directed-connectivity-eeg-markers-classifying-alzheimers-disease-frontotemporal#comments</comments>
</item>
<item>
 <title>HIF-2α Depletion and HIF-1α Overexpression in Vulnerable Brain Regions Distinguish Alzheimer&#039;s Disease with Cerebral Amyloid Angiopathy.</title>
 <link>https://www.alzforum.org/papers/hif-2a-depletion-and-hif-1a-overexpression-vulnerable-brain-regions-distinguish-alzheimers</link>
 <description>Int J Mol Sci. 2026 Aug 31;27(17)&lt;br&gt;Authors: Sukhorukov VS, Baranich TI, Velts OV, Okulova KM, Voronkov DN, Shcherbak EV, Egorova AV, Mudzhiri NM, Lazarev DS, Raksha AP, Yatskovskiy AN, Glinkina VV, Piradov MA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42737681&quot;&gt;42737681&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/hif-2a-depletion-and-hif-1a-overexpression-vulnerable-brain-regions-distinguish-alzheimers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/hif-2a-depletion-and-hif-1a-overexpression-vulnerable-brain-regions-distinguish-alzheimers#comments</comments>
</item>
<item>
 <title>Polyamine metabolic enzyme SAT1 remodels the neuronal transcriptome and rescues α-synuclein toxicity in Drosophila.</title>
 <link>https://www.alzforum.org/papers/polyamine-metabolic-enzyme-sat1-remodels-neuronal-transcriptome-and-rescues-synuclein-0</link>
 <description>Amino Acids. 2026 Aug 30;58(1)&lt;br&gt;Authors: Bangash ZR, Matsui H, Ranxhi B, Todi SV, LeWitt PA, Tsou WL&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42734829&quot;&gt;42734829&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/polyamine-metabolic-enzyme-sat1-remodels-neuronal-transcriptome-and-rescues-synuclein-0#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/polyamine-metabolic-enzyme-sat1-remodels-neuronal-transcriptome-and-rescues-synuclein-0#comments</comments>
</item>
<item>
 <title>Trajectories of Self-Awareness Across the Alzheimer&#039;s Disease Spectrum: A Systematic Review of Its Potential Contribution to Early Diagnosis.</title>
 <link>https://www.alzforum.org/papers/trajectories-self-awareness-across-alzheimers-disease-spectrum-systematic-review-its</link>
 <description>Diagnostics (Basel). 2026 Aug 30;16(17)&lt;br&gt;Authors: Tsouvala A, Moraitou D, Metallidou P, Tsentidou G, Katsouri IG, Papantoniou G, Sofologi M, Tsolaki M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42739221&quot;&gt;42739221&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/trajectories-self-awareness-across-alzheimers-disease-spectrum-systematic-review-its#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/trajectories-self-awareness-across-alzheimers-disease-spectrum-systematic-review-its#comments</comments>
</item>
<item>
 <title>From Single-Modal to Multi-Modal Artificial Intelligence in Alzheimer&#039;s Disease: A Systematic Review of Databases, Modalities, Diagnostic Performance, and Clinical Translation Challenges.</title>
 <link>https://www.alzforum.org/papers/single-modal-multi-modal-artificial-intelligence-alzheimers-disease-systematic-review</link>
 <description>Sensors (Basel). 2026 Aug 29;26(17)&lt;br&gt;Authors: Menezes J, Barbosa MI, Rodrigues PM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42740109&quot;&gt;42740109&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/single-modal-multi-modal-artificial-intelligence-alzheimers-disease-systematic-review#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/single-modal-multi-modal-artificial-intelligence-alzheimers-disease-systematic-review#comments</comments>
</item>
<item>
 <title>Lactate Metabolism and Signaling in Amyotrophic Lateral Sclerosis.</title>
 <link>https://www.alzforum.org/papers/lactate-metabolism-and-signaling-amyotrophic-lateral-sclerosis</link>
 <description>Cells. 2026 Aug 29;15(17)&lt;br&gt;Authors: Ma X, Liu J, Guan Y, Xu C, Li M, Zhang X, Li Z, Zhang L, Wang X, Zhang H, Chen Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42738864&quot;&gt;42738864&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/lactate-metabolism-and-signaling-amyotrophic-lateral-sclerosis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/lactate-metabolism-and-signaling-amyotrophic-lateral-sclerosis#comments</comments>
</item>
<item>
 <title>Apolipoprotein E Alleles Across the Spectrum of Frontotemporal Lobar Degeneration: A Systematic Review and Meta-Analysis.</title>
 <link>https://www.alzforum.org/papers/apolipoprotein-e-alleles-across-spectrum-frontotemporal-lobar-degeneration-systematic-review</link>
 <description>Int J Mol Sci. 2026 Aug 29;27(17)&lt;br&gt;Authors: Liampas I, Polyviou A, Demiri S, Malataras G, Oikonomakis V, Siokas V, Kargiotis O, Kefalopoulou ZM, Chroni E, Dardiotis E&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42737648&quot;&gt;42737648&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/apolipoprotein-e-alleles-across-spectrum-frontotemporal-lobar-degeneration-systematic-review#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/apolipoprotein-e-alleles-across-spectrum-frontotemporal-lobar-degeneration-systematic-review#comments</comments>
</item>
<item>
 <title>Visual and Semiquantitative Assessment of 123I-Ioflupane SPECT in Probable Dementia with Lewy Bodies and Its Association with Autonomic Dysfunction: A Retrospective Study.</title>
 <link>https://www.alzforum.org/papers/visual-and-semiquantitative-assessment-123i-ioflupane-spect-probable-dementia-lewy-bodies-and</link>
 <description>J Clin Med. 2026 Aug 28;15(17)&lt;br&gt;Authors: Arslan T, Bekiş R, Ontan MS, Isik AT&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42739651&quot;&gt;42739651&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/visual-and-semiquantitative-assessment-123i-ioflupane-spect-probable-dementia-lewy-bodies-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/visual-and-semiquantitative-assessment-123i-ioflupane-spect-probable-dementia-lewy-bodies-and#comments</comments>
</item>
<item>
 <title>Plasma Glial Fibrillary Acidic Protein and Neurofilament Light Chain Concentrations Are Inversely Associated with Retinal Microvascular Perfusion and Vessel Density in Cognitively Normal Individuals with Familial or Genetic Risk Factors for Alzheimer&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/plasma-glial-fibrillary-acidic-protein-and-neurofilament-light-chain-concentrations-are</link>
 <description>Diagnostics (Basel). 2026 Aug 28;16(17)&lt;br&gt;Authors: Zhao W, Zhu MY, Patel H, Whitson HE, Johnson KG, Grewal DS, Fekrat S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42739194&quot;&gt;42739194&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/plasma-glial-fibrillary-acidic-protein-and-neurofilament-light-chain-concentrations-are#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/plasma-glial-fibrillary-acidic-protein-and-neurofilament-light-chain-concentrations-are#comments</comments>
</item>
<item>
 <title>Beneficial Effects of Putative Hydrogen Sulfide (H2S) Donor POM16 in a Genetic Model of Amyotrophic Lateral Sclerosis, FUS [1-359]-Transgenic Mice.</title>
 <link>https://www.alzforum.org/papers/beneficial-effects-putative-hydrogen-sulfide-h2s-donor-pom16-genetic-model-amyotrophic</link>
 <description>Molecules. 2026 Aug 28;31(17)&lt;br&gt;Authors: Strekalova T, Gorlova A, Munter JP, Chervinskaya M, Deykin A, Aladysheva Z, Grigorieva E, Lyundup A, Askarova S, Kostin A, Pomytkin I&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42738680&quot;&gt;42738680&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/beneficial-effects-putative-hydrogen-sulfide-h2s-donor-pom16-genetic-model-amyotrophic#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/beneficial-effects-putative-hydrogen-sulfide-h2s-donor-pom16-genetic-model-amyotrophic#comments</comments>
</item>
<item>
 <title>Cox7a2l Variation Influences Complex III and Mitochondrial Supercomplex Differences in 3xTG-AD Mixed-Background Mice.</title>
 <link>https://www.alzforum.org/papers/cox7a2l-variation-influences-complex-iii-and-mitochondrial-supercomplex-differences-3xtg-ad</link>
 <description>Int J Mol Sci. 2026 Aug 28;27(17)&lt;br&gt;Authors: Ma W, Cavarsan C, Bazinet LF, Silvia SM, Owusu-Sarfo J, Atoyan J, Davis J, Van Nostrand WE, Robinson JK, Clements RT&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42737607&quot;&gt;42737607&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/cox7a2l-variation-influences-complex-iii-and-mitochondrial-supercomplex-differences-3xtg-ad#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/cox7a2l-variation-influences-complex-iii-and-mitochondrial-supercomplex-differences-3xtg-ad#comments</comments>
</item>
<item>
 <title>Electrodermal Activity as a Potential Diagnostic Biomarker for Alzheimer&#039;s Disease: A Pilot Study.</title>
 <link>https://www.alzforum.org/papers/electrodermal-activity-potential-diagnostic-biomarker-alzheimers-disease-pilot-study</link>
 <description>Sensors (Basel). 2026 Aug 27;26(17)&lt;br&gt;Authors: Pandian S, Mercado-Diaz LR, Ruiz-Trivino J, Aguillon D, Posada-Quintero H&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42740027&quot;&gt;42740027&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/electrodermal-activity-potential-diagnostic-biomarker-alzheimers-disease-pilot-study#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/electrodermal-activity-potential-diagnostic-biomarker-alzheimers-disease-pilot-study#comments</comments>
</item>
<item>
 <title>LncRNA Gas5, a Target of the Nonsense-Mediated Decay Pathway in the Brain, Regulates Neuroinflammation and Neurodegenerative Disease Pathways in a Tauopathy Mouse Model.</title>
 <link>https://www.alzforum.org/papers/lncrna-gas5-target-nonsense-mediated-decay-pathway-brain-regulates-neuroinflammation-and</link>
 <description>Int J Mol Sci. 2026 Aug 27;27(17)&lt;br&gt;Authors: Krause-Hauch M, Wang B, Patel RS, Verdina L, Hedrick A, Blair LJ, Dharap A, Cai J, Patel NA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42737576&quot;&gt;42737576&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/lncrna-gas5-target-nonsense-mediated-decay-pathway-brain-regulates-neuroinflammation-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/lncrna-gas5-target-nonsense-mediated-decay-pathway-brain-regulates-neuroinflammation-and#comments</comments>
</item>
<item>
 <title>The Innate Immune Memory That Bites Back: How Periodontitis May Train Neuroinflammation in Alzheimer&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/innate-immune-memory-bites-back-how-periodontitis-may-train-neuroinflammation-alzheimers</link>
 <description>Int J Mol Sci. 2026 Aug 27;27(17)&lt;br&gt;Authors: Valladares KN, Fields JL, Katz J, Michalek S, Zhang P&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42737563&quot;&gt;42737563&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/innate-immune-memory-bites-back-how-periodontitis-may-train-neuroinflammation-alzheimers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/innate-immune-memory-bites-back-how-periodontitis-may-train-neuroinflammation-alzheimers#comments</comments>
</item>
<item>
 <title>Application of Mesenchymal Stromal Cells and Their Exosomes in Neurodegenerative Diseases and Lysosomal Storage Diseases.</title>
 <link>https://www.alzforum.org/papers/application-mesenchymal-stromal-cells-and-their-exosomes-neurodegenerative-diseases-and</link>
 <description>Cells. 2026 Aug 26;15(17)&lt;br&gt;Authors: Ayupova AI, Sidorova AS, Luzina EA, Sufianov AA, Sufianova GZ, Zaynutdinov AM, Rizvanov AA, Solovyeva VV&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42738833&quot;&gt;42738833&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/application-mesenchymal-stromal-cells-and-their-exosomes-neurodegenerative-diseases-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/application-mesenchymal-stromal-cells-and-their-exosomes-neurodegenerative-diseases-and#comments</comments>
</item>
<item>
 <title>Sigma-1 Receptor Stimulation Rescues FTD/ALS Mutant TDP43-Induced Disruption of the VAPB-PTPIP51 ER-Mitochondria Tethering Proteins via Inhibition of GSK3β.</title>
 <link>https://www.alzforum.org/papers/sigma-1-receptor-stimulation-rescues-ftdals-mutant-tdp43-induced-disruption-vapb-ptpip51-er</link>
 <description>Cells. 2026 Aug 26;15(17)&lt;br&gt;Authors: Blair K, Gosset P, Martinez-Serra R, Mórotz GM, Martín-Guerrero SM, Gomez-Suaga P, Atherton J, Mitchell JC, Noble W, Miller CC, Markovinovic A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42738830&quot;&gt;42738830&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/sigma-1-receptor-stimulation-rescues-ftdals-mutant-tdp43-induced-disruption-vapb-ptpip51-er#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/sigma-1-receptor-stimulation-rescues-ftdals-mutant-tdp43-induced-disruption-vapb-ptpip51-er#comments</comments>
</item>
<item>
 <title>Rare Variants May Influence Disease Risk and Clinical Features in Sporadic Late-Onset Chinese Parkinson&#039;s Disease Patients.</title>
 <link>https://www.alzforum.org/papers/rare-variants-may-influence-disease-risk-and-clinical-features-sporadic-late-onset-chinese</link>
 <description>Int J Mol Sci. 2026 Aug 26;27(17)&lt;br&gt;Authors: Ho RW, Xiong Z, Lo RC, Liu H, Ho PW, Sham PC, Ho SL, Pang SY&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42737551&quot;&gt;42737551&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/rare-variants-may-influence-disease-risk-and-clinical-features-sporadic-late-onset-chinese#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/rare-variants-may-influence-disease-risk-and-clinical-features-sporadic-late-onset-chinese#comments</comments>
</item>
<item>
 <title>Effects of a Combined Vitamin D3 and Docosahexaenoic Acid Intervention on Cognitive Function and Blood Pyroptotic Biomarkers in Older Adults with Mild Cognitive Impairment: A 12-Month Randomized, Double-Blind, Placebo-Controlled Trial.</title>
 <link>https://www.alzforum.org/papers/effects-combined-vitamin-d3-and-docosahexaenoic-acid-intervention-cognitive-function-and</link>
 <description>Nutrients. 2026 Aug 25;18(17)&lt;br&gt;Authors: Yuan J, Yang R, Chen H, Zhao H, Chen X, Lou Z, Han X, Ma F&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42738950&quot;&gt;42738950&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/effects-combined-vitamin-d3-and-docosahexaenoic-acid-intervention-cognitive-function-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/effects-combined-vitamin-d3-and-docosahexaenoic-acid-intervention-cognitive-function-and#comments</comments>
</item>
<item>
 <title>LRRK2: Molecular Mechanisms in Parkinson&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/lrrk2-molecular-mechanisms-parkinsons-disease</link>
 <description>Int J Mol Sci. 2026 Aug 25;27(17)&lt;br&gt;Authors: Arias-Carrión O, Guerra-Crespo M, Ortuño-Sahagún D, Ortega-Robles E&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42737506&quot;&gt;42737506&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/lrrk2-molecular-mechanisms-parkinsons-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/lrrk2-molecular-mechanisms-parkinsons-disease#comments</comments>
</item>
<item>
 <title>Plasma p-Tau217 and SPECT-Based eZIS in Mild Cognitive Impairment: Concordance Analysis with Validation in an Amyloid PET Sub-Cohort.</title>
 <link>https://www.alzforum.org/papers/plasma-p-tau217-and-spect-based-ezis-mild-cognitive-impairment-concordance-analysis</link>
 <description>Diagnostics (Basel). 2026 Aug 24;16(17)&lt;br&gt;Authors: Huang IL, Matsuda H, Pai YT, Pai MC&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42739134&quot;&gt;42739134&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/plasma-p-tau217-and-spect-based-ezis-mild-cognitive-impairment-concordance-analysis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/plasma-p-tau217-and-spect-based-ezis-mild-cognitive-impairment-concordance-analysis#comments</comments>
</item>
<item>
 <title>Assessment of the Association of Periodontitis and Diabetes Mellitus with Alzheimer&#039;s Disease in a Mouse Model.</title>
 <link>https://www.alzforum.org/papers/assessment-association-periodontitis-and-diabetes-mellitus-alzheimers-disease-mouse-model</link>
 <description>Int J Mol Sci. 2026 Aug 23;27(17)&lt;br&gt;Authors: Nakahara M, Kataoka K, Maruyama T, Nurhamim M, Zhang Y, Fukuhara D, Uchida-Fukuhara Y, Islam MM, Morita M, Saito T, Ekuni D&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42737444&quot;&gt;42737444&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/assessment-association-periodontitis-and-diabetes-mellitus-alzheimers-disease-mouse-model#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/assessment-association-periodontitis-and-diabetes-mellitus-alzheimers-disease-mouse-model#comments</comments>
</item>
<item>
 <title>APOE genotypes differentially remodel the astrocytic lipid droplet proteome to shape lipid droplet dynamics.</title>
 <link>https://www.alzforum.org/papers/apoe-genotypes-differentially-remodel-astrocytic-lipid-droplet-proteome-shape-lipid-droplet</link>
 <description>Nat Commun. 2026 Aug 19;17(1)&lt;br&gt;Authors: Cuní-López C, Root JT, Hao Y, Blomberg N, Koppes-den Hertog SJ, Sacks D, Trujillo AE, Ghirlando R, Kowal I, Epstein J, Yang LG, Cookson MR, Marsan E, van der Kant R, Giera M, Qi YA, Narayan PS&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42749735&quot;&gt;42749735&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/apoe-genotypes-differentially-remodel-astrocytic-lipid-droplet-proteome-shape-lipid-droplet#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/apoe-genotypes-differentially-remodel-astrocytic-lipid-droplet-proteome-shape-lipid-droplet#comments</comments>
</item>
<item>
 <title>Microglia deploy TAM receptors to kill motor neurons in a mouse model of amyotrophic lateral sclerosis.</title>
 <link>https://www.alzforum.org/papers/microglia-deploy-tam-receptors-kill-motor-neurons-mouse-model-amyotrophic-lateral-sclerosis</link>
 <description>Nat Commun. 2026 Aug 15;17(1)&lt;br&gt;Authors: Huang Y, Mavinkurve A, Sabikunnahar B, Stevens B, Lemke G&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42744804&quot;&gt;42744804&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/microglia-deploy-tam-receptors-kill-motor-neurons-mouse-model-amyotrophic-lateral-sclerosis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/microglia-deploy-tam-receptors-kill-motor-neurons-mouse-model-amyotrophic-lateral-sclerosis#comments</comments>
</item>
<item>
 <title>TogoPhosTAC as a delivery-ready platform for targeted protein dephosphorylation.</title>
 <link>https://www.alzforum.org/papers/togophostac-delivery-ready-platform-targeted-protein-dephosphorylation</link>
 <description>Nat Commun. 2026 Aug 14;17(1)&lt;br&gt;Authors: Chen YY, Ke DT, Lee YC, Chen HR, Lin HY, Yeh CH, Ko YC, Tu MH, Yu CH, Hu Z, Chen PH&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42733006&quot;&gt;42733006&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/togophostac-delivery-ready-platform-targeted-protein-dephosphorylation#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/togophostac-delivery-ready-platform-targeted-protein-dephosphorylation#comments</comments>
</item>
<item>
 <title>Effects of homozygous PARK7 gene mutations L166P and M26I on BNIP3/BNIP3L interactions and ER-mitochondria proximity.</title>
 <link>https://www.alzforum.org/papers/effects-homozygous-park7-gene-mutations-l166p-and-m26i-bnip3bnip3l-interactions-and-er</link>
 <description>Biol Direct. 2026 Aug 5;21(1)&lt;br&gt;Authors: Wu J, Jin K, Shen M, Lai X, Guo J, Wang T, Tian Z, Yan J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42723107&quot;&gt;42723107&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/effects-homozygous-park7-gene-mutations-l166p-and-m26i-bnip3bnip3l-interactions-and-er#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/effects-homozygous-park7-gene-mutations-l166p-and-m26i-bnip3bnip3l-interactions-and-er#comments</comments>
</item>
<item>
 <title>Gut Microbiota, Neuroinflammation, and Autonomic Dysfunction in Neurodegenerative Diseases: A Systematic Review of Mechanistic and Translational Evidence.</title>
 <link>https://www.alzforum.org/papers/gut-microbiota-neuroinflammation-and-autonomic-dysfunction-neurodegenerative-diseases</link>
 <description>Cureus. 2026 Aug;18(8):e114312.  Epub 2026 Aug 10&lt;br&gt;Authors: Alauddin W, Srivastava C, Goyal P, Shukla M, Garg DK, Prajesh BR, Singh S, Shaikh FI, Khairnar S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42724165&quot;&gt;42724165&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/gut-microbiota-neuroinflammation-and-autonomic-dysfunction-neurodegenerative-diseases#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/gut-microbiota-neuroinflammation-and-autonomic-dysfunction-neurodegenerative-diseases#comments</comments>
</item>
<item>
 <title>Dimethylarginine Dimethylaminohydrolase 1 (DDAH1)-Arginine Metabolic Axis Is Independently Associated With Alzheimer&#039;s Disease Risk in the UK Biobank.</title>
 <link>https://www.alzforum.org/papers/dimethylarginine-dimethylaminohydrolase-1-ddah1-arginine-metabolic-axis-independently</link>
 <description>Cureus. 2026 Aug;18(8):e114415.  Epub 2026 Aug 12&lt;br&gt;Authors: Lehrer S, Rheinstein P&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42729959&quot;&gt;42729959&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/dimethylarginine-dimethylaminohydrolase-1-ddah1-arginine-metabolic-axis-independently#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/dimethylarginine-dimethylaminohydrolase-1-ddah1-arginine-metabolic-axis-independently#comments</comments>
</item>
<item>
 <title>Demographic and Clinical Characteristics of Patients Treated With Lecanemab Stratified by Amyloid-Related Imaging Abnormality Status.</title>
 <link>https://www.alzforum.org/papers/demographic-and-clinical-characteristics-patients-treated-lecanemab-stratified-amyloid</link>
 <description>Cureus. 2026 Aug;18(8):e114472.  Epub 2026 Aug 13&lt;br&gt;Authors: Rohatgi S, Younan CM, Martinez Imbett RE, Ford JN, Wleklinski M, Zhu S, Romero J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42732414&quot;&gt;42732414&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/demographic-and-clinical-characteristics-patients-treated-lecanemab-stratified-amyloid#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/demographic-and-clinical-characteristics-patients-treated-lecanemab-stratified-amyloid#comments</comments>
</item>
<item>
 <title>Regional juxtacortical microstructural changes and gene expression provide insights into neurodegeneration in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/regional-juxtacortical-microstructural-changes-and-gene-expression-provide-insights</link>
 <description>Transl Psychiatry. 2026 Jul 30;16(1)&lt;br&gt;Authors: Zhang J, Sun L, Yang X, Kang L, Zheng Y, Huang Q, Xu W, Guan Y, Liu J, Deng Y, Xie F, Xu X, Li B, Alzheimer’s Disease Neuroimaging Initiative&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42744775&quot;&gt;42744775&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/regional-juxtacortical-microstructural-changes-and-gene-expression-provide-insights#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/regional-juxtacortical-microstructural-changes-and-gene-expression-provide-insights#comments</comments>
</item>
<item>
 <title>Metabolism and oxygen tension in Alzheimer&#039;s disease mouse model using two-photon FLIM-PLIM microscopy.</title>
 <link>https://www.alzforum.org/papers/metabolism-and-oxygen-tension-alzheimers-disease-mouse-model-using-two-photon-flim-plim</link>
 <description>Neurophotonics. 2026 Jul;13(3):035008.  Epub 2026 Sep 11&lt;br&gt;Authors: Sagar VK, Wallrabe H, Alam SR, Pardo E, Becker W, Norambuena A, Periasamy A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42730105&quot;&gt;42730105&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/metabolism-and-oxygen-tension-alzheimers-disease-mouse-model-using-two-photon-flim-plim#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/metabolism-and-oxygen-tension-alzheimers-disease-mouse-model-using-two-photon-flim-plim#comments</comments>
</item>
<item>
 <title>Cohort profile: a community-based prospective cohort study of Alzheimer&#039;s disease and related dementias in the Democratic Republic of Congo.</title>
 <link>https://www.alzforum.org/papers/cohort-profile-community-based-prospective-cohort-study-alzheimers-disease-and-related-0</link>
 <description>Alzheimers Dement Behav Socioecon Aging. 2026 Jun;2(2):e70085.  Epub 2026 Jun 6&lt;br&gt;Authors: Ikanga J, Obenauf C, Patel SS, Schwinne M, Gikelekele G, Epenge E, Potshi JM, Tomadia T, Kazadi J, Kavugho I, Santolini GL, Nkosi A, Sabowa FM, Musewu BM, Mawisa E, Tsangu JP, Beya FM, Mampunza S, Mananga L, Bukabau J, Teunissen CE, Karikari T, Gross AL, Rojas JC, Alonso A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42751573&quot;&gt;42751573&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/cohort-profile-community-based-prospective-cohort-study-alzheimers-disease-and-related-0#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/cohort-profile-community-based-prospective-cohort-study-alzheimers-disease-and-related-0#comments</comments>
</item>
<item>
 <title>Abortive transcripts in exosomes - A potential biomarker for Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/abortive-transcripts-exosomes-potential-biomarker-alzheimers-disease</link>
 <description>PLoS One. 2026;21(9):e0357752.  Epub 2026 Sep 11&lt;br&gt;Authors: Wu H, Zhang N, Yan W, Li C, Zhang X, Xv X, Fang F, Qin S, Zhao L&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42726720&quot;&gt;42726720&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/abortive-transcripts-exosomes-potential-biomarker-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/abortive-transcripts-exosomes-potential-biomarker-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Utilization of transcranial direct current stimulation for neuromodulation in frontotemporal dementia.</title>
 <link>https://www.alzforum.org/papers/utilization-transcranial-direct-current-stimulation-neuromodulation-frontotemporal-dementia</link>
 <description>Ind Psychiatry J. 2026;35(2):231-233.  Epub 2026 May 22&lt;br&gt;Authors: Sinha SS, Ashwin JV, Singh N, Shahi MK, Kar SK, Singh B&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42725249&quot;&gt;42725249&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/utilization-transcranial-direct-current-stimulation-neuromodulation-frontotemporal-dementia#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/utilization-transcranial-direct-current-stimulation-neuromodulation-frontotemporal-dementia#comments</comments>
</item>
<item>
 <title>Interpretable self-supervised transformers for resting-state EEG analysis in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/interpretable-self-supervised-transformers-resting-state-eeg-analysis-alzheimers-disease</link>
 <description>Front Neuroinform. 2026;20:1899573.  Epub 2026 Aug 27&lt;br&gt;Authors: Zareen SS, Alzaben N, Ahmad U, Alam TM, Algarni A, Wang J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42725030&quot;&gt;42725030&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/interpretable-self-supervised-transformers-resting-state-eeg-analysis-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/interpretable-self-supervised-transformers-resting-state-eeg-analysis-alzheimers-disease#comments</comments>
</item>
<item>
 <title>The gut-brain axis in Alzheimer&#039;s disease: traditional Chinese medicine constituents as modulators of gut-brain homeostasis.</title>
 <link>https://www.alzforum.org/papers/gut-brain-axis-alzheimers-disease-traditional-chinese-medicine-constituents-modulators-gut</link>
 <description>Front Microbiol. 2026;17:1852198.  Epub 2026 Aug 27&lt;br&gt;Authors: Liang Y, Kong Q, Du X, Sun Y, Wang S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42725024&quot;&gt;42725024&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/gut-brain-axis-alzheimers-disease-traditional-chinese-medicine-constituents-modulators-gut#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/gut-brain-axis-alzheimers-disease-traditional-chinese-medicine-constituents-modulators-gut#comments</comments>
</item>
<item>
 <title>Transcriptomic signatures as biomarkers for the progression of mild cognitive impairment.</title>
 <link>https://www.alzforum.org/papers/transcriptomic-signatures-biomarkers-progression-mild-cognitive-impairment</link>
 <description>Front Aging Neurosci. 2026;18:1901264.  Epub 2026 Aug 27&lt;br&gt;Authors: Yang J, Li J, Mao L, Ren H, Li Q, Geng X, Lu Q, Peng C, Zhang J, Liu X, Zhang Y, Zhu B, Jiang T, Yang J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42724701&quot;&gt;42724701&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/transcriptomic-signatures-biomarkers-progression-mild-cognitive-impairment#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/transcriptomic-signatures-biomarkers-progression-mild-cognitive-impairment#comments</comments>
</item>
<item>
 <title>Mitochondrial ecosystem restoration in Alzheimer&#039;s disease: from mechanisms to multi-target therapeutic strategies.</title>
 <link>https://www.alzforum.org/papers/mitochondrial-ecosystem-restoration-alzheimers-disease-mechanisms-multi-target-therapeutic</link>
 <description>Front Cell Dev Biol. 2026;14:1886145.  Epub 2026 Aug 27&lt;br&gt;Authors: Song D&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42724487&quot;&gt;42724487&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/mitochondrial-ecosystem-restoration-alzheimers-disease-mechanisms-multi-target-therapeutic#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/mitochondrial-ecosystem-restoration-alzheimers-disease-mechanisms-multi-target-therapeutic#comments</comments>
</item>
<item>
 <title>Polygenic score for sleep duration in relation to the risk of Alzheimer&#039;s disease: results from the UK biobank.</title>
 <link>https://www.alzforum.org/papers/polygenic-score-sleep-duration-relation-risk-alzheimers-disease-results-uk-biobank</link>
 <description>Front Dement. 2026;5:1843867.  Epub 2026 Aug 27&lt;br&gt;Authors: Wong AT, Floud S, Reeves GK, Holmes MV, Travis RC, van Duijn CM, Doherty A, Smith-Byrne K&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42724004&quot;&gt;42724004&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/polygenic-score-sleep-duration-relation-risk-alzheimers-disease-results-uk-biobank#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/polygenic-score-sleep-duration-relation-risk-alzheimers-disease-results-uk-biobank#comments</comments>
</item>
<item>
 <title>Expression differences and diagnostic efficacy of core plasma biomarkers in Alzheimer&#039;s disease, cerebral small vessel disease and healthy adults.</title>
 <link>https://www.alzforum.org/papers/expression-differences-and-diagnostic-efficacy-core-plasma-biomarkers-alzheimers-disease</link>
 <description>Front Neurol. 2026;17:1934127.  Epub 2026 Aug 27&lt;br&gt;Authors: Xiandong W, Junqi W, Xuan Z, Daichao M, Xiaoyan Z, Lihua H, Hui Z&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42723835&quot;&gt;42723835&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/expression-differences-and-diagnostic-efficacy-core-plasma-biomarkers-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/expression-differences-and-diagnostic-efficacy-core-plasma-biomarkers-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Interpretable AI for neural signal decoding in dementia: an EEG ensemble approach to differential diagnosis.</title>
 <link>https://www.alzforum.org/papers/interpretable-ai-neural-signal-decoding-dementia-eeg-ensemble-approach-differential-diagnosis</link>
 <description>Front Neuroinform. 2026;20:1902549.  Epub 2026 Aug 27&lt;br&gt;Authors: Muhammad F, Usmani IA, Aamir M, Alduailij M, Marzougui M, Nawaz R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42723800&quot;&gt;42723800&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/interpretable-ai-neural-signal-decoding-dementia-eeg-ensemble-approach-differential-diagnosis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/interpretable-ai-neural-signal-decoding-dementia-eeg-ensemble-approach-differential-diagnosis#comments</comments>
</item>
<item>
 <title>ZDWX-25, a dual DYRK1A/GSK3β inhibitor, attenuates tau hyperphosphorylation and neuroinflammation in acute mouse models.</title>
 <link>https://www.alzforum.org/papers/zdwx-25-dual-dyrk1agsk3v-inhibitor-attenuates-tau-hyperphosphorylation-and-neuroinflammation</link>
 <description>Front Pharmacol. 2026;17:1892218.  Epub 2026 Aug 27&lt;br&gt;Authors: Wang W, Xing Y, Xu Z, Liu S, Zhou L, Ning X, Li X, Zheng F, Yang A, Li Z, Ren M, Xu Z, Zhao Q&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42723786&quot;&gt;42723786&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/zdwx-25-dual-dyrk1agsk3v-inhibitor-attenuates-tau-hyperphosphorylation-and-neuroinflammation#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/zdwx-25-dual-dyrk1agsk3v-inhibitor-attenuates-tau-hyperphosphorylation-and-neuroinflammation#comments</comments>
</item>
<item>
 <title>Integrated multi-omics identification of m6A-SNP-related diagnostic biomarkers in amyotrophic lateral sclerosis.</title>
 <link>https://www.alzforum.org/papers/integrated-multi-omics-identification-m6a-snp-related-diagnostic-biomarkers-amyotrophic</link>
 <description>Front Immunol. 2026;17:1914869.  Epub 2026 Aug 27&lt;br&gt;Authors: Wang H, Sun B, Wang S, Pan J, Du R, Pang X, Bai J, Han J, Feng J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42723774&quot;&gt;42723774&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/integrated-multi-omics-identification-m6a-snp-related-diagnostic-biomarkers-amyotrophic#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/integrated-multi-omics-identification-m6a-snp-related-diagnostic-biomarkers-amyotrophic#comments</comments>
</item>
<item>
 <title>Query-based multimodal interaction and adaptive gated fusion for Alzheimer&#039;s disease detection.</title>
 <link>https://www.alzforum.org/papers/query-based-multimodal-interaction-and-adaptive-gated-fusion-alzheimers-disease-detection</link>
 <description>Front Aging Neurosci. 2026;18:1913697.  Epub 2026 Aug 27&lt;br&gt;Authors: Shao Y, Tan C, Huo H, Fang T&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42723693&quot;&gt;42723693&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/query-based-multimodal-interaction-and-adaptive-gated-fusion-alzheimers-disease-detection#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/query-based-multimodal-interaction-and-adaptive-gated-fusion-alzheimers-disease-detection#comments</comments>
</item>
<item>
 <title>Parallel multilink group joint ICA (pmg-jICA): Fusion of 3D structural and 4D functional data across multiple resting fMRI networks.</title>
 <link>https://www.alzforum.org/papers/parallel-multilink-group-joint-ica-pmg-jica-fusion-3d-structural-and-4d-functional-data</link>
 <description>Netw Neurosci. 2026;10(3):787-808.  Epub 2026 Aug 25&lt;br&gt;Authors: Khalilullah KM, Phadikar S, Agcaoglu O, Sui J, Duda M, Adali T, Calhoun VD&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42730199&quot;&gt;42730199&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/parallel-multilink-group-joint-ica-pmg-jica-fusion-3d-structural-and-4d-functional-data#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/parallel-multilink-group-joint-ica-pmg-jica-fusion-3d-structural-and-4d-functional-data#comments</comments>
</item>
<item>
 <title>Slow-4 cerebellar activity tracks MMSE language-related task performance across the Alzheimer&#039;s disease spectrum: a multi-metric resting-state fMRI study.</title>
 <link>https://www.alzforum.org/papers/slow-4-cerebellar-activity-tracks-mmse-language-related-task-performance-across-alzheimers</link>
 <description>Front Neurosci. 2026;20:1820150.  Epub 2026 Aug 28&lt;br&gt;Authors: Mao H, Fu B, Song J, Jia X, Cheng L, Xiao H, Zhang L&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42730172&quot;&gt;42730172&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/slow-4-cerebellar-activity-tracks-mmse-language-related-task-performance-across-alzheimers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/slow-4-cerebellar-activity-tracks-mmse-language-related-task-performance-across-alzheimers#comments</comments>
</item>
<item>
 <title>Developmental brain programmes and biomarker activation in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/developmental-brain-programmes-and-biomarker-activation-alzheimers-disease</link>
 <description>Brain Commun. 2026;8(5):fcag337.  Epub 2026 Sep 3&lt;br&gt;Authors: Pini L, Margoni M, Filippi M, Imbimbo BP&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42729944&quot;&gt;42729944&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/developmental-brain-programmes-and-biomarker-activation-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/developmental-brain-programmes-and-biomarker-activation-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Peripheral-central inflammatory crosstalk in Alzheimer&#039;s disease: immunometabolic functions of circulating soluble metabolites under dynamic blood-brain barrier states.</title>
 <link>https://www.alzforum.org/papers/peripheral-central-inflammatory-crosstalk-alzheimers-disease-immunometabolic-functions</link>
 <description>Front Immunol. 2026;17:1939482.  Epub 2026 Aug 28&lt;br&gt;Authors: Song N, Xing H, Liu F, Xi W&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42729804&quot;&gt;42729804&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/peripheral-central-inflammatory-crosstalk-alzheimers-disease-immunometabolic-functions#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/peripheral-central-inflammatory-crosstalk-alzheimers-disease-immunometabolic-functions#comments</comments>
</item>
<item>
 <title>Spatial covariance of mGluR5 density and structural degeneration in behavioral variant frontotemporal degeneration.</title>
 <link>https://www.alzforum.org/papers/spatial-covariance-mglur5-density-and-structural-degeneration-behavioral-variant</link>
 <description>Imaging Neurosci (Camb). 2026;4 Epub 2026 Sep 10&lt;br&gt;Authors: Matyi MA, Pecsok MK, Olm CA, Radhakrishnan H, Dratch L, Van Deerlin VM, Rhodes E, Phillips JS, Cook PA, Gee JC, Irwin DJ, McMillan CT, Roalf D, Massimo L&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42729732&quot;&gt;42729732&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/spatial-covariance-mglur5-density-and-structural-degeneration-behavioral-variant#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/spatial-covariance-mglur5-density-and-structural-degeneration-behavioral-variant#comments</comments>
</item>
<item>
 <title>Glycyrrhiza glabra exhibits disease-modifying effects in Alzheimer&#039;s disease through restoration of mitochondrial function, synaptic plasticity, and kinase signaling.</title>
 <link>https://www.alzforum.org/papers/glycyrrhiza-glabra-exhibits-disease-modifying-effects-alzheimers-disease-through-restoration</link>
 <description>Front Pharmacol. 2026;17:1894678.  Epub 2026 Aug 28&lt;br&gt;Authors: Amrutha S, Kadandelu M, Paidi MK, Raghu SV, Prasad TS, Modi PK&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42729566&quot;&gt;42729566&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/glycyrrhiza-glabra-exhibits-disease-modifying-effects-alzheimers-disease-through-restoration#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/glycyrrhiza-glabra-exhibits-disease-modifying-effects-alzheimers-disease-through-restoration#comments</comments>
</item>
<item>
 <title>Hippocampal mediation in the lipid-Alzheimer&#039;s disease pathway: A high-dimensional mediation analysis stratified by APOE and sex.</title>
 <link>https://www.alzforum.org/papers/hippocampal-mediation-lipid-alzheimers-disease-pathway-high-dimensional-mediation-analysis</link>
 <description>Alzheimers Dement (N Y). 2026;12(3):e70314.  Epub 2026 Sep 10&lt;br&gt;Authors: Cao Y, Fan Y, Meng Q, Wang J, Chen R, Alzheimer&amp;#039;s Disease Neuroimaging Initiative, Alzheimer&amp;#039;s Disease Metabolomics Consortium&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42729514&quot;&gt;42729514&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/hippocampal-mediation-lipid-alzheimers-disease-pathway-high-dimensional-mediation-analysis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/hippocampal-mediation-lipid-alzheimers-disease-pathway-high-dimensional-mediation-analysis#comments</comments>
</item>
<item>
 <title>Real-world anti-amyloid therapy beyond traditional symptomatic populations: a longitudinal case series.</title>
 <link>https://www.alzforum.org/papers/real-world-anti-amyloid-therapy-beyond-traditional-symptomatic-populations-longitudinal-case</link>
 <description>Front Psychiatry. 2026;17:1900651.  Epub 2026 Aug 28&lt;br&gt;Authors: Han J, Fang Y, Esiaka D, Abraham O&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42729372&quot;&gt;42729372&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/real-world-anti-amyloid-therapy-beyond-traditional-symptomatic-populations-longitudinal-case#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/real-world-anti-amyloid-therapy-beyond-traditional-symptomatic-populations-longitudinal-case#comments</comments>
</item>
<item>
 <title>A guide to selecting high-performing antibodies for TMEM175 (UniProt ID: Q9BSA9) for use in western blot, immunoprecipitation, and immunofluorescence.</title>
 <link>https://www.alzforum.org/papers/guide-selecting-high-performing-antibodies-tmem175-uniprot-id-q9bsa9-use-western-blot</link>
 <description>F1000Res. 2026;15:942.  Epub 2026 Jun 16&lt;br&gt;Authors: Moleón VR, Alende C, Fothouhi M, Bolívar SG, Ayoubi R, Francis V, McPherson PS, Laflamme C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42728995&quot;&gt;42728995&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/guide-selecting-high-performing-antibodies-tmem175-uniprot-id-q9bsa9-use-western-blot#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/guide-selecting-high-performing-antibodies-tmem175-uniprot-id-q9bsa9-use-western-blot#comments</comments>
</item>
<item>
 <title>A guide to selecting high-performing antibodies for DJ-1 ( PARK7) (Q99497) for use in western blot, immunoprecipitation, and immunofluorescence.</title>
 <link>https://www.alzforum.org/papers/guide-selecting-high-performing-antibodies-dj-1-park7-q99497-use-western-blot</link>
 <description>F1000Res. 2026;15:989.  Epub 2026 Jun 23&lt;br&gt;Authors: Zha C, Alende C, Fotouhi M, Bolívar SG, Ayoubi R, Francis V, McPherson PS, Laflamme C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42728985&quot;&gt;42728985&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/guide-selecting-high-performing-antibodies-dj-1-park7-q99497-use-western-blot#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/guide-selecting-high-performing-antibodies-dj-1-park7-q99497-use-western-blot#comments</comments>
</item>
<item>
 <title>Whole-mount diffracted X-ray blinking analysis of intracellular amyloid-β-associated nanoscale dynamics in Caenorhabditis elegans.</title>
 <link>https://www.alzforum.org/papers/whole-mount-diffracted-x-ray-blinking-analysis-intracellular-amyloid-v-associated-nanoscale</link>
 <description>Biol Methods Protoc. 2026;11(1):bpag044.  Epub 2026 Aug 13&lt;br&gt;Authors: Ozaki K, Shinkai Y, Sasaki YC, Kuramochi M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42732361&quot;&gt;42732361&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/whole-mount-diffracted-x-ray-blinking-analysis-intracellular-amyloid-v-associated-nanoscale#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/whole-mount-diffracted-x-ray-blinking-analysis-intracellular-amyloid-v-associated-nanoscale#comments</comments>
</item>
<item>
 <title>Factors associated with phlebotomy failure in an Alzheimer&#039;s Disease Research Center cohort.</title>
 <link>https://www.alzforum.org/papers/factors-associated-phlebotomy-failure-alzheimers-disease-research-center-cohort</link>
 <description>Alzheimers Dement (N Y). 2026;12(3):e70322.  Epub 2026 Sep 11&lt;br&gt;Authors: Pawlus MC, Gorham A, Suarez-Rodriguez C, Risal I, Galvez MA, Simpson BK, Celedon J, Noori A, Ramirez-Gomez L, Das S, Arnold SE, Kivisäkk P, Serrano-Pozo A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42732163&quot;&gt;42732163&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/factors-associated-phlebotomy-failure-alzheimers-disease-research-center-cohort#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/factors-associated-phlebotomy-failure-alzheimers-disease-research-center-cohort#comments</comments>
</item>
<item>
 <title>Health-related factors and their impact on blood-based biomarkers of Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/health-related-factors-and-their-impact-blood-based-biomarkers-alzheimers-disease</link>
 <description>Aging Brain. 2026;10:100166.  Epub 2026 Sep 3&lt;br&gt;Authors: Kurz C, Taute M, Tegethoff P, Hufnagel A, Leonhardt S, Gürsel SÜ, Koriath C, Jethwa A, Kollmorgen G, Bittner T, Keeser D, Brendel M, Haeckert J, Utecht J, Papazov B, Levin J, Höglinger G, Rauchmann BS, Perneczky R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42733904&quot;&gt;42733904&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/health-related-factors-and-their-impact-blood-based-biomarkers-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/health-related-factors-and-their-impact-blood-based-biomarkers-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Insulin resistance increases the risk of conversion to the subcortical small vessel type of dementia.</title>
 <link>https://www.alzforum.org/papers/insulin-resistance-increases-risk-conversion-subcortical-small-vessel-type-dementia</link>
 <description>Cereb Circ Cogn Behav. 2026;11:100561.  Epub 2026 Aug 27&lt;br&gt;Authors: Axelsson Andrén E, Kettunen P, Wallin A, Svensson J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42733490&quot;&gt;42733490&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/insulin-resistance-increases-risk-conversion-subcortical-small-vessel-type-dementia#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/insulin-resistance-increases-risk-conversion-subcortical-small-vessel-type-dementia#comments</comments>
</item>
<item>
 <title>Novel 1,4-Diazepane derivatives as amyloid-beta (Aβ) aggregation inhibitors.</title>
 <link>https://www.alzforum.org/papers/novel-14-diazepane-derivatives-amyloid-beta-av-aggregation-inhibitors</link>
 <description>Front Chem. 2026;14:1919936.  Epub 2026 Sep 1&lt;br&gt;Authors: Karuturi RC, Hefny AA, Shakeri A, Rao PP&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42741787&quot;&gt;42741787&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/novel-14-diazepane-derivatives-amyloid-beta-av-aggregation-inhibitors#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/novel-14-diazepane-derivatives-amyloid-beta-av-aggregation-inhibitors#comments</comments>
</item>
<item>
 <title>Alzheimer&#039;s disease heterogeneity and co-pathologies: Defining novel targets, biomarkers, modalities, and research methodologies.</title>
 <link>https://www.alzforum.org/papers/alzheimers-disease-heterogeneity-and-co-pathologies-defining-novel-targets-biomarkers</link>
 <description>Alzheimers Dement (N Y). 2026;12(3):e70287.  Epub 2026 Sep 14&lt;br&gt;Authors: Tansey MG, Bozeat S, Ackerman P, Atri A, Barnum CJ, Brundin P, de Carvalho CA, Fleisher AS, Graf A, Head E, Kerchner GA, Kolb HC, Koyama A, Kozberg M, Leyns CE, Llibre-Guerra JJ, Mattsson-Carlgren N, McKissock D, Murray ME, Rosenthal LS, Rubel C, Schindler SE, Schneider JA, Schwarz AJ, Scott KM, Seredenina T, Tosun D, Wallings RL, Wang H, Wilcock DM, Carrillo M, Mahinrad S, Weber CJ&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42741654&quot;&gt;42741654&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/alzheimers-disease-heterogeneity-and-co-pathologies-defining-novel-targets-biomarkers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/alzheimers-disease-heterogeneity-and-co-pathologies-defining-novel-targets-biomarkers#comments</comments>
</item>
<item>
 <title>Inflammation and neuropsychiatric symptoms in Parkinson&#039;s disease: a genetic association.</title>
 <link>https://www.alzforum.org/papers/inflammation-and-neuropsychiatric-symptoms-parkinsons-disease-genetic-association</link>
 <description>Front Aging Neurosci. 2026;18:1877657.  Epub 2026 Aug 31&lt;br&gt;Authors: Gonçalves AR, Mendes A, Damásio J, Vila-Chã N, Boleixa D, Santos C, Leal B, Cavaco S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42741404&quot;&gt;42741404&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/inflammation-and-neuropsychiatric-symptoms-parkinsons-disease-genetic-association#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/inflammation-and-neuropsychiatric-symptoms-parkinsons-disease-genetic-association#comments</comments>
</item>
<item>
 <title>Editorial: Cellular and animal models of neurodegenerative and neuroinflammatory conditions.</title>
 <link>https://www.alzforum.org/papers/editorial-cellular-and-animal-models-neurodegenerative-and-neuroinflammatory-conditions</link>
 <description>Front Cell Neurosci. 2026;20:1961369.  Epub 2026 Aug 31&lt;br&gt;Authors: García-León JA, García-Díaz B, Baglietto-Vargas D, Rodriguez-Ortiz CJ&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42741375&quot;&gt;42741375&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/editorial-cellular-and-animal-models-neurodegenerative-and-neuroinflammatory-conditions#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/editorial-cellular-and-animal-models-neurodegenerative-and-neuroinflammatory-conditions#comments</comments>
</item>
<item>
 <title>Utilising speech-derived biomarkers to detect Alzheimer&#039;s disease with BERT-based language models: a machine learning study.</title>
 <link>https://www.alzforum.org/papers/utilising-speech-derived-biomarkers-detect-alzheimers-disease-bert-based-language-models</link>
 <description>Front Artif Intell. 2026;9:1875702.  Epub 2026 Aug 31&lt;br&gt;Authors: Khanna Z, Ho D, Remus A, Raczkowska M, Montalan R, Saha P&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42741373&quot;&gt;42741373&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/utilising-speech-derived-biomarkers-detect-alzheimers-disease-bert-based-language-models#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/utilising-speech-derived-biomarkers-detect-alzheimers-disease-bert-based-language-models#comments</comments>
</item>
<item>
 <title>Interpretable machine learning model based on multimodal MRI radiomics for Alzheimer&#039;s disease diagnosis.</title>
 <link>https://www.alzforum.org/papers/interpretable-machine-learning-model-based-multimodal-mri-radiomics-alzheimers-disease</link>
 <description>Front Aging Neurosci. 2026;18:1876233.  Epub 2026 Aug 31&lt;br&gt;Authors: Keranmu N, Aizezi D, Pan X, Yang L, Liu Y, Liu J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42741328&quot;&gt;42741328&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/interpretable-machine-learning-model-based-multimodal-mri-radiomics-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/interpretable-machine-learning-model-based-multimodal-mri-radiomics-alzheimers-disease#comments</comments>
</item>
<item>
 <title>The spectrum of C9orf72 repeat lengths in Portuguese frontotemporal dementia and amyotrophic lateral sclerosis patients: from pathogenic expansions to intermediate alleles.</title>
 <link>https://www.alzforum.org/papers/spectrum-c9orf72-repeat-lengths-portuguese-frontotemporal-dementia-and-amyotrophic-lateral</link>
 <description>Front Neurosci. 2026;20:1913909.  Epub 2026 Aug 31&lt;br&gt;Authors: Almeida MR, Tábuas-Pereira M, Matos A, Santos A, Teixeira C, Baldeiras I, Lima M, Santana I&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42741310&quot;&gt;42741310&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/spectrum-c9orf72-repeat-lengths-portuguese-frontotemporal-dementia-and-amyotrophic-lateral#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/spectrum-c9orf72-repeat-lengths-portuguese-frontotemporal-dementia-and-amyotrophic-lateral#comments</comments>
</item>
<item>
 <title>Serum metabolomic profiling following cerebellar repetitive transcranial magnetic stimulation combined with cognitive training on Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/serum-metabolomic-profiling-following-cerebellar-repetitive-transcranial-magnetic-stimulation</link>
 <description>Front Neurol. 2026;17:1887127.  Epub 2026 Aug 31&lt;br&gt;Authors: Chen Y, Shi J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42741217&quot;&gt;42741217&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/serum-metabolomic-profiling-following-cerebellar-repetitive-transcranial-magnetic-stimulation#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/serum-metabolomic-profiling-following-cerebellar-repetitive-transcranial-magnetic-stimulation#comments</comments>
</item>
<item>
 <title>Linking cognitive variability and Alzheimer&#039;s disease biomarkers by neurocognitive status.</title>
 <link>https://www.alzforum.org/papers/linking-cognitive-variability-and-alzheimers-disease-biomarkers-neurocognitive-status-0</link>
 <description>Alzheimers Dement (Amst). 2026;18(3):e70481.  Epub 2026 Sep 13&lt;br&gt;Authors: Lin SS, Milam A, Kiselica AM, Aita SL, Saeed M, Webber T, Woods SP, Borgogna NC, Walker KA, Kamath V, Visscher K, Murchison CF, Geldmacher DS, Roberson ED, Hill BD, Bene VA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42741049&quot;&gt;42741049&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/linking-cognitive-variability-and-alzheimers-disease-biomarkers-neurocognitive-status-0#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/linking-cognitive-variability-and-alzheimers-disease-biomarkers-neurocognitive-status-0#comments</comments>
</item>
<item>
 <title>AST/ALT, APOE ε4, and Alzheimer&#039;s disease progression: A longitudinal cohort study.</title>
 <link>https://www.alzforum.org/papers/astalt-apoe-e4-and-alzheimers-disease-progression-longitudinal-cohort-study</link>
 <description>Alzheimers Dement (Amst). 2026;18(3):e70484.  Epub 2026 Sep 13&lt;br&gt;Authors: Ahn YH, Yang CM, Kim DJ, Lee SH, Jung YH, Lee SY, Yoon SH, Alzheimer&amp;#039;s Disease Neuroimaging Initiative&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42741023&quot;&gt;42741023&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/astalt-apoe-e4-and-alzheimers-disease-progression-longitudinal-cohort-study#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/astalt-apoe-e4-and-alzheimers-disease-progression-longitudinal-cohort-study#comments</comments>
</item>
<item>
 <title>Emerging therapeutic targets beyond amyloid and tau in Alzheimer&#039;s Disease: Implications for lifestyle, metabolism and preventive medicine.</title>
 <link>https://www.alzforum.org/papers/emerging-therapeutic-targets-beyond-amyloid-and-tau-alzheimers-disease-implications-lifestyle</link>
 <description>Wiad Lek. 2026;79(7):1685-1691. &lt;br&gt;Authors: Izhytska N, Sobczyk KA, Ogrodnik KW, Mazurkiewicz M, Malentowicz D, Szafraniec NJ, Brożyna D, Sałapski B, Pastuszka M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42748320&quot;&gt;42748320&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/emerging-therapeutic-targets-beyond-amyloid-and-tau-alzheimers-disease-implications-lifestyle#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/emerging-therapeutic-targets-beyond-amyloid-and-tau-alzheimers-disease-implications-lifestyle#comments</comments>
</item>
<item>
 <title>Response: Beyond Oral Hygiene: Medication Burden, Oral Function, and Dysphagia in Alzheimer&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/response-beyond-oral-hygiene-medication-burden-oral-function-and-dysphagia-alzheimers-disease</link>
 <description>Spec Care Dentist. 2026;46(5):e70258. &lt;br&gt;Authors: Silva MG, Vasconcelos MB, Silva RG, Feitosa MÁ&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42746891&quot;&gt;42746891&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/response-beyond-oral-hygiene-medication-burden-oral-function-and-dysphagia-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/response-beyond-oral-hygiene-medication-burden-oral-function-and-dysphagia-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Designing intranasal formulations for Alzheimer&#039;s disease: A material-based perspective.</title>
 <link>https://www.alzforum.org/papers/designing-intranasal-formulations-alzheimers-disease-material-based-perspective</link>
 <description>Tzu Chi Med J. 2026;38(4):446-456.  Epub 2026 Jun 5&lt;br&gt;Authors: Chen YS, Huang HY&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42746628&quot;&gt;42746628&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/designing-intranasal-formulations-alzheimers-disease-material-based-perspective#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/designing-intranasal-formulations-alzheimers-disease-material-based-perspective#comments</comments>
</item>
<item>
 <title>Time to diagnosis in FTLD-associated syndromes in Latin America.</title>
 <link>https://www.alzforum.org/papers/time-diagnosis-ftld-associated-syndromes-latin-america</link>
 <description>Alzheimers Dement (Amst). 2026;18(3):e70476.  Epub 2026 Sep 15&lt;br&gt;Authors: Magrath-Guimet N, Morello-Garcia F, De Los Santos L, Ardohain-Cristalli C, Tabernero E, Chaves H, Bagnati P, Allegri RF, Migeot J, Acosta-Uribe J, Allen IE, Aguillon D, Avila-Funes JA, Behrens MI, Bruno M, Brusco LI, Custodio N, Resende EP, Aniotz CD, Gorno-Tempini M, Ibanez A, Kosik KS, Maito MA, Matallana D, Miller B, Nalls M, Piña-Escudero SD, Possin K, Rocatti G, Santamaria-Garcia H, Slachevsky A, Sosa AL, Takada L, Taylor JW, Zapata-Restrepo LM, Yokoyama JS, Valcour V&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42746372&quot;&gt;42746372&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/time-diagnosis-ftld-associated-syndromes-latin-america#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/time-diagnosis-ftld-associated-syndromes-latin-america#comments</comments>
</item>
<item>
 <title>Cerebral oxygen extraction fraction as an emerging imaging biomarker in mild cognitive impairment and dementia.</title>
 <link>https://www.alzforum.org/papers/cerebral-oxygen-extraction-fraction-emerging-imaging-biomarker-mild-cognitive-impairment-and</link>
 <description>Dement Neuropsychol. 2026;20:e20250412.  Epub 2026 Sep 14&lt;br&gt;Authors: Hussain JM, Lashari A, Nageen W, Siddiqui A, Waris A, Maliha S, Mudasir A, Rehman MB, Rahman MH&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42746331&quot;&gt;42746331&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/cerebral-oxygen-extraction-fraction-emerging-imaging-biomarker-mild-cognitive-impairment-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/cerebral-oxygen-extraction-fraction-emerging-imaging-biomarker-mild-cognitive-impairment-and#comments</comments>
</item>
<item>
 <title>Effects of long-term daily supplementation with vitamin D3 and marine omega-3 fatty acids on change in ADRD biomarkers: A secondary analysis of a randomized clinical trial.</title>
 <link>https://www.alzforum.org/papers/effects-long-term-daily-supplementation-vitamin-d3-and-marine-omega-3-fatty-acids-change-adrd</link>
 <description>Alzheimers Dement (N Y). 2026;12(3):e70312.  Epub 2026 Sep 14&lt;br&gt;Authors: Vyas CM, Ostaszewski BL, Anderson AK, Cook NR, Kang JH, Mischoulon D, Reynolds CF 3rd, Chang G, Gatchel JR, Manson JE, Selkoe DJ, Okereke OI&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42746141&quot;&gt;42746141&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/effects-long-term-daily-supplementation-vitamin-d3-and-marine-omega-3-fatty-acids-change-adrd#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/effects-long-term-daily-supplementation-vitamin-d3-and-marine-omega-3-fatty-acids-change-adrd#comments</comments>
</item>
<item>
 <title>Effect of choline supplementation in presymptomatic APOE ε4 carriers: a pilot study.</title>
 <link>https://www.alzforum.org/papers/effect-choline-supplementation-presymptomatic-apoe-e4-carriers-pilot-study</link>
 <description>Alzheimers Dement (N Y). 2026;12(3):e70323.  Epub 2026 Sep 14&lt;br&gt;Authors: Ray WJ, Lightfoot YL, Trinh RT, Fawver-Kahle J, Cooper S, Tsai LH, Bortz J, Trujillo-Gonzalez I, Zhang T, Wu H, Iv GJ, Schulz PE&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42746101&quot;&gt;42746101&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/effect-choline-supplementation-presymptomatic-apoe-e4-carriers-pilot-study#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/effect-choline-supplementation-presymptomatic-apoe-e4-carriers-pilot-study#comments</comments>
</item>
<item>
 <title>Targeting protein aggregate co-pathologies in neurodegeneration: a viable therapeutic strategy?</title>
 <link>https://www.alzforum.org/papers/targeting-protein-aggregate-co-pathologies-neurodegeneration-viable-therapeutic-strategy</link>
 <description>Mol Neurodegener Adv. 2026;2(1):38.  Epub 2026 Sep 14&lt;br&gt;Authors: Buck SA, Madhavan SS, Sanders LH&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42745993&quot;&gt;42745993&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/targeting-protein-aggregate-co-pathologies-neurodegeneration-viable-therapeutic-strategy#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/targeting-protein-aggregate-co-pathologies-neurodegeneration-viable-therapeutic-strategy#comments</comments>
</item>
<item>
 <title>Autophagy-lysosomal pathway in neurodegeneration.</title>
 <link>https://www.alzforum.org/papers/autophagy-lysosomal-pathway-neurodegeneration</link>
 <description>Mol Neurodegener Adv. 2026;2(1):37.  Epub 2026 Sep 14&lt;br&gt;Authors: McDonough SR, Rao AK, McAleer JM, Babrowicz BM, Sharma M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42745943&quot;&gt;42745943&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/autophagy-lysosomal-pathway-neurodegeneration#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/autophagy-lysosomal-pathway-neurodegeneration#comments</comments>
</item>
<item>
 <title>P-tau181 is longitudinally associated with a proxy measure of mild behavioral impairment among frail older adults: Insights from COGFRAIL.</title>
 <link>https://www.alzforum.org/papers/p-tau181-longitudinally-associated-proxy-measure-mild-behavioral-impairment-among-frail-older</link>
 <description>Alzheimers Dement (Amst). 2026;18(3):e70392.  Epub 2026 Sep 14&lt;br&gt;Authors: Bellelli F, González E, Peluso A, Angioni D, Sourdet S, Martin MS&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42745934&quot;&gt;42745934&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/p-tau181-longitudinally-associated-proxy-measure-mild-behavioral-impairment-among-frail-older#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/p-tau181-longitudinally-associated-proxy-measure-mild-behavioral-impairment-among-frail-older#comments</comments>
</item>
<item>
 <title>Imaging for anti-amyloid therapy eligibility: Comparing GRE and SWI in detecting microhemorrhages and superficial siderosis.</title>
 <link>https://www.alzforum.org/papers/imaging-anti-amyloid-therapy-eligibility-comparing-gre-and-swi-detecting-microhemorrhages-and</link>
 <description>Alzheimers Dement (Amst). 2026;18(3):e70477.  Epub 2026 Sep 14&lt;br&gt;Authors: Ford JN, Ferraciolli SF, Chagui OG, Iii MR, Cadavid EC, Dickson J, Vejdani-Jahromi M, DeSalvo MN, Gomez LA, Yee S, Griffin HR, Kozak B, Rohatgi S, Huang RY, Gomez-Isla T, Romero J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42745918&quot;&gt;42745918&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/imaging-anti-amyloid-therapy-eligibility-comparing-gre-and-swi-detecting-microhemorrhages-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/imaging-anti-amyloid-therapy-eligibility-comparing-gre-and-swi-detecting-microhemorrhages-and#comments</comments>
</item>
<item>
 <title>Beyond Oral Hygiene: Medication Burden, Oral Function, and Dysphagia in Alzheimer&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/beyond-oral-hygiene-medication-burden-oral-function-and-dysphagia-alzheimers-disease</link>
 <description>Spec Care Dentist. 2026;46(5):e70255. &lt;br&gt;Authors: Misra SR, Das R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42753133&quot;&gt;42753133&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/beyond-oral-hygiene-medication-burden-oral-function-and-dysphagia-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/beyond-oral-hygiene-medication-burden-oral-function-and-dysphagia-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Bioinformatics-Driven Discovery of Aβ-Targeted Therapeutics and Diagnostic Biomarkers for Alzheimer&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/bioinformatics-driven-discovery-av-targeted-therapeutics-and-diagnostic-biomarkers-alzheimers</link>
 <description>Biomed Res Int. 2026;2026(1):e8975137. &lt;br&gt;Authors: Li X, Liu X, Song X, Zhou Y, Yang D, Wang Y, Mao S, Rang X, Hong X, Wang X, Yue H, Wang D, Zhang X&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42752992&quot;&gt;42752992&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/bioinformatics-driven-discovery-av-targeted-therapeutics-and-diagnostic-biomarkers-alzheimers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/bioinformatics-driven-discovery-av-targeted-therapeutics-and-diagnostic-biomarkers-alzheimers#comments</comments>
</item>
<item>
 <title>Neuroprotective Effects of Two N-Benzylamides in Models of Oxidative Stress, Neurite Outgrowth and Neurodegeneration.</title>
 <link>https://www.alzforum.org/papers/neuroprotective-effects-two-n-benzylamides-models-oxidative-stress-neurite-outgrowth-and</link>
 <description>Oxid Med Cell Longev. 2026;2026(1):e3092494. &lt;br&gt;Authors: Mamangam S, Dhanabalan AK, Verma K, Prasanth MI, Brimson S, Brimson JM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42751784&quot;&gt;42751784&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/neuroprotective-effects-two-n-benzylamides-models-oxidative-stress-neurite-outgrowth-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/neuroprotective-effects-two-n-benzylamides-models-oxidative-stress-neurite-outgrowth-and#comments</comments>
</item>
<item>
 <title>Pollutants regulate changes in pathological markers of neurodegenerative diseases: a new perspective in environmental toxicology.</title>
 <link>https://www.alzforum.org/papers/pollutants-regulate-changes-pathological-markers-neurodegenerative-diseases-new-perspective</link>
 <description>Front Toxicol. 2026;8:1814795.  Epub 2026 Sep 3&lt;br&gt;Authors: Kou X, Hu Q, Kou Y, An D&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42751714&quot;&gt;42751714&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/pollutants-regulate-changes-pathological-markers-neurodegenerative-diseases-new-perspective#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/pollutants-regulate-changes-pathological-markers-neurodegenerative-diseases-new-perspective#comments</comments>
</item>
<item>
 <title>Alzheimer&#039;s disease: genetic background in the era of next-generation sequencing technologies.</title>
 <link>https://www.alzforum.org/papers/alzheimers-disease-genetic-background-era-next-generation-sequencing-technologies</link>
 <description>Brain Commun. 2026;8(5):fcag332.  Epub 2026 Sep 16&lt;br&gt;Authors: Lukyova L, Zatkova A, Minarik J, Holesova Z, Budis J, Kucharik M, Benes V, Gazdarica J, Szemes T&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42751194&quot;&gt;42751194&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/alzheimers-disease-genetic-background-era-next-generation-sequencing-technologies#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/alzheimers-disease-genetic-background-era-next-generation-sequencing-technologies#comments</comments>
</item>
<item>
 <title>Aducanumab</title>
 <link>https://www.alzforum.org/papers/aducanumab-1</link>
 <description>2026 Jan; StatPearls Publishing, Treasure Island (FL)&lt;br&gt;Authors: Padda IS, Preuss CV, Parmar M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/34424635&quot;&gt;34424635&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/aducanumab-1#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/aducanumab-1#comments</comments>
</item>
<item>
 <title>Neuropsychological Assessment</title>
 <link>https://www.alzforum.org/papers/neuropsychological-assessment</link>
 <description>2026 Jan; StatPearls Publishing, Treasure Island (FL)&lt;br&gt;Authors: Schaefer LA, Sharma NP&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/30020682&quot;&gt;30020682&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/neuropsychological-assessment#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/neuropsychological-assessment#comments</comments>
</item>
</channel>
</rss>
